Bill of Lading No.
Date
HS Code
Importer
Exporter
Product Description
Country of Origin
Destination Country
Port of Loading
Port of Discharge
Weight
(unit)
Quantity
(unit)
Value
(unit)
MAEU216792167
2022-03-24
624900 GLENMARK PHARMACEUTICALS INC US GLENMARK PHARMACEUTICALS LTD 1X40 REF 3858 CARTONS PACKED IN 46 PALLETS PHARMACEUTICALS AS UNDER NAPROXEN TABLETS 50 0MG 500 S NDC CODE:6846201900 5 FDA PRODUCT CODE NO.:-62 G C A 49 H. T. S NO.: 3004.90.9 2.40 ANDA NO.:-78-250 THERAPE UTICE USE:-ANTI-INFLAMMATORY, ANALGESIC PRAMIPEXOLE TABS 1M G 90 S NDC CODE:68462033390 FDA PRODUCT CODE NO.: 62 J C A 15 H. T. S NO.: 3004.90.92.4 0 ANDA NO.: 90-781 THERAPEUTI CE USE: USED IN PARKINSON#S DI SEASE PRAMIPEXOLE TABS 0.25MG 90 S NDC CODE:68462033190 FDA PRODUCT CODE NO.: 62 J C A 15 H. T. S NO.: 3004.90.92. 40 ANDA NO.: 90-781 THERAPEUT ICE USE: USED IN PARKINSON#S D ISEASE PRAMIPEXOLE TABS 0.5MG 90 S NDC CODE:68462033290 F DA PRODUCT CODE NO.: 62 J C A 15 H. T. S NO.: 3004.90.92.40 ANDA NO.: 90-781 THERAPEUTIC E USE: USED IN PARKINSON#S DIS EASE OXCARBAZEPINE TABLETS 30 0MG 100 S NDC CODE:6846201380 1 FDA PRODUCT CODE NO.:-61 M C A 45 H. T. S NO.: 3004.90.9 2.30 ANDA NO.:-77-802 THERAPE UTICE USE:-ANTI CONVULSANT AGE NT OLMESARTAN MEDOXOMIL TABLE TS 5MG 30 S NDC CODE:68462043 630 FDA PRODUCT CODE NO.: 62C CA68 H. T. S NO.: 3004.90.922 0 ANDA NO.: 203281 THERAPEUTI CE USE: -TREATMENT OF HYPERTEN SION, ALONE ORWITH OTHER ANTI HYPERTENSIVE AGENTS, TO LOWER BLOOD PRESSURE POTASSIUM CL ER TAB 20MEQ (1500MG) 500 S N DC CODE:68462047205 FDA PRODU CT CODE NO.: 66 S C A 28 H. T . S NO.: 3004.90.9020 ANDA NO. : 206391 THERAPEUTICE USE: - MEDICATION USED FOR HEART FAIL URE, HIGH BLOOD PRESSURE, AND TO TREAT AND PREVENT CHEST PA IN FROM NOT ENOUGH BLOOD FLOW TO THE HEART URSODIOL TABS 2 50MG 100 S NDC CODE:684620473 01 FDA PRODUCT CODE NO.: 63 N C A 25 H. T. S NO.: 3004.49. 00.10 ANDA NO.: 90-801 THERA PEUTICE USE: - FOR THE TREATME NT OF PATIENTS WITH PRIMARY B ILIARY CIRRHOSIS GABAPENTIN TABLETS 600MG 100 S NDC CODE: 68462012601 FDA PRODUCT COD E NO : 61 N C A 69 H. T. S NO .: 3004.90.92.30 ANDA NO.:-77- 662 THERAPEUTICE USE:-ANTICON VULSANT AGENT NET WT : 10,381 .95 KGS GROSS WT : 12,463.41 KGS COMMERCIAL & CUSTOM INVOI CE NO. F22252005778 DT. 23.02 .2022 F22252005780 DT. 23.02. 2022 SB NO.: 8492215 DT.: 24/ 02/22 SB NO.: 8492102 DT.: 24 /02/22 02 DATA LOGGERS HUM IDITY:65% SET TEMPERATURE : + 20 DEGREES TEMPERATURE RANGE : +15 DEGREES TO +25 DEGREES<br/>
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
12464
KG
46
PKG
0
USD
MAEU216471582
2022-03-09
624900 GLENMARK PHARMACEUTICALS INC US GLENMARK PHARMACEUTICALS LTD 1 X 40 FCL REEFER 49 PACKAGE CONSISTING OF 3295 CARTONS PH ARMACEUTICALS AS UNDER NAPROX EN TABLETS 500MG 100 S NDC CO DE:68462019001 FDA PRODUCT CO DE NO.:-62 G C A 49 H. T. S NO.: 3004.90.92.40 ANDA NO.: -78-250 THERAPEUTICE USE:-AN TI-INFLAMMATORY, ANALGESIC N APROXEN TABLETS 500MG 500 S N DC CODE:68462019005 FDA PRODU CT CODE NO.:-62 G C A 49 H. T. S NO.: 3004.90.92.40 ANDA NO.:-78-250 THERAPEUTICE US E:-ANTI-INFLAMMATORY, ANALGES IC CARVEDILOL TABS 6.25MG 500 S NDC CODE:68462016305 FDA PRODUCT CODE NO : 62 O C A 22 H. T. S NO.: 3004.90.92.20 ANDA NO.:- 78-251 THERAPEUTI CE USE:-BETA- ADRENOACEPTOR ANTAGONIST TOPIRAMATE TABLET S 25MG 60 S NDC CODE:68462010 860 FDA PRODUCT CODE NO.:-61 M C A 40 H. T. S NO.: 3004. 49.00.20 ANDA NO.:- 77-627 T HERAPEUTICE USE:-ANTICONVULSA NT GABAPENTIN TABLETS 600MG 5 00 S NDC CODE:68462012605 FD A PRODUCT CODE NO: 61 N C A 6 9 H. T. S NO.: 3004.90.92.30 ANDA NO.:-77-662 THERAPEUTI CE USE:-ANTICONVULSANT AGENT OMEPRAZOLE DR CAPSULES 40MG 1000 S NDC CODE:68462039710 FDA PRODUCT CODE NO.:62KCF10 H. T. S NO.: 3004.90.9160 A NDA NO.:91672 THERAPEUTICE US E: - TREATMENT OF TREAT GAST ROESOPHAGEAL REFLUX DISEASE 03 DATA LOGGERS COMMERCIAL & CUSTOM INVOICE NO. F222520055 51 DT. 05.02.2022 F2225200555 2 DT. 05.02.2022 F22252005553 DT. 05.02.2022 TOTAL NET.WT. :11610.44KGS SBILL NOS DT. 8053058 07-FEB-2022 80532 61 07-FEB-2022 8053408 07- FEB-2022<br/>
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
13478
KG
49
PKG
0
USD
MAEU608910666
2022-03-09
624900 GLENMARK PHARMACEUTICALS INC US GLENMARK PHARMACEUTICALS LTD 1 X 40 PART OF FCL REEFER 19 PALLETS CONSISTING OF1600 C ARTONS PHARMACEUTICALS AS UNDER NAPROXEN TABLETS 500 MG 500 S NDC CODE: 6846201 9005 FDA PRODUCT CODE NO.: -62 G C A 49 H. T. S NO.: 3004.90.92.40 ANDA NO.:-78-2 50 THERAPEUTICE USE:-ANTI- INFLAMMATORY, ANALGESIC OM EPRAZOLE DR CAPSULES 40MG 30 S NDC CODE:68462039730 FD A PRODUCT CODE NO.: 62KCF10 H. T. S NO.: 3004.90.9160 ANDA NO.: 91672 THERAPEUTI CE USE: - TREATMENT OF TREAT GASTROESOPHAGEAL REFLUX D ISEASE MUPIROCIN CREAM 2% 15GM NDC CODE: 68462056417 FDA PRODUCT CODE NO.: 61G CJ82 H. T. S NO.: 3004.90. 92.45 ANDA NO.: 201587 THE RAPEUTICE USE: - TOPICAL ANT I-BACTERIAL MUPIROCIN CREAM 2% 30GM NDC CODE: 684620 56435 FDA PRODUCT CODE NO. : 61GCJ82 H. T. S NO.: 3 004.90.92.45 ANDA NO.: 20158 7 THERAPEUTICE USE: - TOPI CAL ANTI-BACTERIAL 02 DATA L OGGERS SET TEMPERATURE : +20 DEGREES COMMERCIAL & CUSTOM INVOICE NO. F2225200 5541 DT. 05.02.2022 F2225200 5539 DT. 04.02.2022 TOTAL NE T WT.:3982.30KGS SBILL NO DT. 8023698 06-F EB-2022 8023636 06-FEB- 2022 NOTIFY PARTY:2 GLEN MARK PHARMACEUTICALS INC 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 USA<br/>
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
4880
KG
19
PKG
0
USD
MAEU216273001
2022-03-02
624900 GLENMARK PHARMACEUTICALS INC US GLENMARK PHARMACEUTICALS LTD 1 CONTAINER 19 PALLETS 19 P ALLETS CONSISTING OF 947 CARTO NS 1X40 PART OF FCL REEFER PHARMACEUTICALS AS UNDER NAPROXEN TABLETS 500MG 100 S NDC CODE:6846201900 1 FDA PRODUCT CODE N O.:-62 G C A 49 H. T. S N O.: 3004.90.92.40 AN DA NO.:-78-250 THERAPEUTI CE USE:-ANTI-INFLAMMATORY , ANALGESIC NA PROXEN TABLETS 500MG 500 S NDC CODE:68462019005 FD A PRODUCT CODE NO.:-62 G C A 49 H. T. S NO.: 3004.90.92.40 ANDA NO.:-7 8-250 THERAPEUTICE U SE:-ANTI-INFLAMMATORY, AN ALGESIC PRAMIPEXOLE TABS 1MG 90 S NDC CODE:6 8462033390 FDA PRODUCT CO DE NO.: 62 J C A 15 H. T. S NO.: 3004.90.92.4 0 ANDA NO.: 90-781 T HERAPEUTICE USE: USED IN PARKINSON#S DISEASE GABAPENTIN TABLETS 800MG 500 S NDC CODE:68462012705 FDA PRODUCT CODE NO : 61 N C A 69 H. T. S NO.: 3004.90.92.30 ANDA N O.:-77-662 THERAPEUTICE USE:-ANTICONVULSANT A GENT 01 DATA LOGGERS SET TEMPERATUR E : +20 DEGREES COMMERCIAL & CUSTOM INVOICE NO. F222520053 54 DT. 28.01.2022 F2225200535 6 DT. 28.01.2022 SBILL NOS DT. 7836397 29-JAN-20 22 7835871 29-JAN-2022 T OTAL GR.WT.: 6,067.50 KGS TOT AL NT.WT: 5,359.75 KGS<br/>
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
6067
KG
19
PKG
0
USD
MAEU217679575
2022-05-04
600700 GLENMARK PHARMACEUTICALS INC US GLENMARK PHARMACEUTICALS LTD 4 PALLETS 97 CARTONS PHAR MACEUTICALS AS UNDER LIDOCA INE OINTMENT JAR 5% 50GM NDC CODE:68462041827 FDA PRODUCT CODE NO.:60 Q C J 07 H. T. S NO.: 3004.49.00.50 ANDA NO. :206498 THERAPEUTICE USE: -US ED TO TEMPORARILY RELIEVE PA IN AND ITCHING ASSOCIATED WIT H SKIN COMMERCIAL & CUSTOM INVOICE NO. F22252006369 DT. 31.03.2022 NET WT: 908.17 K GS 00 DATA LOGGERS SET TEM PERATURE : +18 DEGREES NOTI FY PARTY:2 GLENMARK PHARMACEU TICALS INC 750, CORPORATE DRI VE, NEW JERSEY MAHWAH - 0743 0 USA<br/>
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
1065
KG
4
PKG
0
USD
MAEU914132405
2022-05-04
600700 GLENMARK PHARMACEUTICALS INC US GLENMARK PHARMACEUTICALS LTD 42 PALLETS 2220 CARTONS P HARMACEUTICALS AS UNDER LIDOC AINE OINTMENT TUBE 5% 35.44GM NDC CODE:68462041820 FDA PRO DUCT CODE NO.:60 Q C J 07 H. T. S NO.: 3004.49.00.50 AND A NO.:206498 THERAPEUTICE USE : -USED TO TEMPORARILY RELIEV E PAIN AND ITCHING ASSOCIATE D WITH SKIN LIDOCAINE OINTM ENT TUBE 5% 35.44GM NDC CODE: 68462041820 FDA PRODUCT CODE NO.:60 Q C J 07 H. T. S NO.: 3004.49.00.50 ANDA NO.:2064 98 THERAPEUTICE USE: -USED T O TEMPORARILY RELIEVE PAIN AN D ITCHING ASSOCIATED WITH SKI N CICLOPIROX OLAMINE CREAM 0.77% 90GM NDC CODE:684620297 92 FDA PRODUCT CODE NO.:-61 W C J 03 H. T. S NO.: 3004.4 0.49.50 ANDA NO.:- 90 - 273 THERAPEUTICE USE:-ANTIFUNGAL USE. THEOPHYLLINE ER TABS 3 00MG 100 S NDC CODE:684620721 01 63 B C B 30 3004.90.92.85 212184 TO RELEASE TABLETS A RE INDICATED FOR THE TREATME NT OF THE SYMPTOMS AND REVER SIBLE AIRFLOW OBSTRUCTION ASS OCIATED WITH CHRONIC ASTHMA A ND OTHER CHRONIC LUNG DISEASE S, E.G., EMPHYSEMA AND CHRON IC BRONCHITIS LITHIUM CARBO NATE CAPS 300MG 1000 S NDC CO DE:68462022110 FDA PRODUCT CO DE NO.:-61 N C E 37 H. T. S NO.: 3004.49.00.20 ANDA NO.: - 79 -139 THERAPEUTICE USE:- ANTIMANIC AGENT VERAPAMIL H CL ER TABS 120MG 100S NDC COD E:68462029201 FDA PRODUCT COD E NO.: 62 O C B 13 H. T. S N O.: 3004.90.92.20 ANDA NO.: 90-700 THERAPEUTICE USE: - A NGINA LITHIUM CARBONATE ER TABS 450MG 100 S NDC CODE:684 62022401 FDA PRODUCT CODE NO. : 61 N C B 37 H. T. S NO.: 3004.49.00.20 ANDA NO.:91-616 THERAPEUTICE USE: - INDICAT ED IN THE TREATMENT OF MANIC EPISODES OF BIPOLAR DISORDER . BIPOLAR DISORDER, MANIC (D SM-IV) IS EQUIVALENT TO MANIC DEPRESSIVE ILLNESS, MANIC, I N THE OLDER DSM-II TERMINOLOG Y. ALSO INDICATED AS A MAINT ENANCE TREATMENT FOR INDIVIDU ALS WITH A DIAGNOSIS OF BIPO LAR DISORDER. MAINTENANCE THE RAPY REDUCES THE FREQUENCY OF MANIC EPISODES AND DIMINISH ES THE INTENSITY OF THOSE EPI SODES WHICH MAY OCCUR. VER APAMIL HCL ER TABS 240MG 500 S NDC CODE:68462026005 FDA PR ODUCT CODE NO.: 62 O C B 13 H. T. S NO.: 3004.90.92.20 A NDA NO.:-78-906 THERAPEUTICE USE:-ANGINA OLMESARTAN MED OXOMIL TABLETS 20MG NDC CODE: 68462043730 FDA PRODUCT CODE NO.: 62CCA68 H. T. S NO.: 3 004.90.9220 ANDA NO.: 203281 THERAPEUTICE USE: - TREATMEN T OF HYPERTENSION, ALONE OR WITH OTHER ANTIHYPERTENSIVE A GENTS, TO LOWER BLOOD PRESSUR E VERAPAMIL HCL ER TABS 120 MG 100S NDC CODE:68462029201 FDA PRODUCT CODE NO.: 62 O C B 13 H. T. S NO.: 3004.90.9 2.20 ANDA NO.: 90-700 THERAP EUTICE USE: - ANGINA LITHI UM CARBONATE CAPS 300MG 100 S NDC CODE:68462022101 FDA PRO DUCT CODE NO.:-61 N C E 37 H . T. S NO.: 3004.49.00.20 AN DA NO.:- 79 -139 THERAPEUTICE USE:-ANTIMANIC AGENT ZOLM ITRIPTAN TABLETS 5MG 3 S NDC CODE:68462049833 FDA PRODUCT CODE NO.: 60 L C A 90 H. T. S NO.: 3004.90.92.28 ANDA NO .: 201779 THERAPEUTICE USE: - ANALGESIC/ HUMAN - RX/SINGL E INGREDIENT / PROMPT RELEAS E TABLETS / ZOLMITRIPTAN (ANA LGESIC) COMMERCIAL & CUSTOM I NVOICE NO. F22252006340 DT. 3 1.03.2022 F22252006350 DT. 31 .03.2022 F22252006367 DT. 31. 03.2022 F22252006372 DT. 31.0 3.2022 F22252006377 DT. 31.03 .2022 F22252006380 DT. 31.03. 2022 S/BILL NO: 9496822 DT: 05-APR-22 S/BILL NO: 9496828 DT: 05-APR-22 S/BILL NO: 94 97545 DT: 05-APR-22 S/BILL NO : 9496646 DT: 05-APR-22 S/BI LL NO: 9496820 DT: 05-APR-22 S/BILL NO: 9496826 DT: 05-AP R-22 NET WT: 9,414.21 KGS 02 DATA LOGGERS SET TEMPERA TURE : +18 DEGREES NOTIFY P ARTY:2 GLENMARK PHARMACEUTICA LS INC 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 U SA<br/>
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
11501
KG
42
PKG
0
USD
MAEU216329742
2022-03-02
600700 GLENMARK PHARMACEUTICALS INC US GLENMARK PHARMACEUTICALS LTD 1 X 40 FCL REEFER 44 PALLET S CONSISTING OF2477 CARTONS PHARMACEUTICALS AS UNDER LIDOCAINE OINTMENT TUBE 5% 35.44GM NDC CODE:68462041820 FDA PRODUCT CODE NO.:60 Q C J 07 H. T. S NO.: 3004. 49.00.50 ANDA NO.:206498 T HERAPEUTICE USE: -USED TO TE MPORARILY RELIEVE PAIN AND I TCHING ASSOCIATED WITH SKIN OMEPRAZOLE DR CAPSULES 40M G 90 S NDC CODE:68462039790 FDA PRODUCT CODE NO.: 62KC F10 H. T. S NO.: 3004.90.9 160 ANDA NO.: 91672 THERAP EUTICE USE: - TREATMENT OF T REAT GASTROESOPHAGEAL REFLUX DISEASE VERAPAMIL HCL E R TABS 240MG 500 S NDC CODE: 68462026005 FDA PRODUCT CODE NO.: 62 O C B 13 H. T. S NO.: 3004.90.92.20 ANDA NO .:-78-906 THERAPEUTICE USE :-ANGINA TOPIRAMATE TABLET S 50MG 1000 S NDC CODE:68462 015310 FDA PRODUCT CODE NO .:-61 M C A 40 H. T. S NO.: 3004.49.00.20 ANDA NO.:- 7 7-627 THERAPEUTICE USE:-AN TICONVULSANT ROPINIROLE TABS 0.25MG 100 S NDC CODE:684 62025301 FDA PRODUCT CODE NO.:-62 J C A 17 H. T. S NO. : 3004.90.92.40 ANDA NO.:- 90-135 THERAPEUTICE USE:- TREATMENT OF PARKINSONISM GABAPENTIN TABLETS 800MG 500 S NDC CODE: 68462012705 FDA PRODUCT CODE NO : 61 N C A 69 H. T. S NO.: 3004.9 0.92.30 ANDA NO.:-77-662 T HERAPEUTICE USE:-ANTICONVULS ANT AGENT NAPROXEN TABLETS 500MG 500 S NDC CODE:6846 2019005 FDA PRODUCT CODE N O.:-62 G C A 49 H. T. S NO.: 3004.90.92.40 ANDA NO.:-7 8-250 THERAPEUTICE USE:-AN TI-INFLAMMATORY, ANALGESIC 02 DATA LOGGERS SET TEMPE RATURE : +20 DEGREES CUS TOM INVOICE NO.& F22252005384 DT. 29.01.2022 F22252005388 DT. 29.01.2022 F22252005397 DT. 29.01.2022 F22252005376 DT. 29.01.2022 F22252005392 DT. 29.01.2022 TOTAL NET W T.:10695.27KGS SB NO & DATE ON BL 7911492 01-FEB-2022 7911445 01-FEB-2022 7911424 01-FEB-2022 7911407 01-FEB -2022 7910960 01-FEB-2022<br/>
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
12093
KG
44
PKG
0
USD
MAEU218682322
2022-06-22
600700 GLENMARK PHARMACEUTICALS INC US GLENMARK PHARMACEUTICALS LTD 40 PALLETS 1996 CART ONS PHARMACEUTICALS AS UNDER LIDOCAINE OINTMENT JAR 5% 5 0GM NDC CODE:68462041827 FDA PRODUCT CODE NO.:60 Q C J 07 H. T. S NO.: 3004.49.00.50 ANDA NO.:206498 THERAPEUTICE USE: -USED TO TEMPORARILY RE LIEVE PAIN AND ITCHING ASSOC IATED WITH SKIN HEATHER NOR ETHINDRONE 0.35MG 84 NDC CODE :68462030329 FDA PRODUCT CODE NO.: 65 J C A 24 H. T. S NO .: 3006.60.00.00 ANDA NO.:90 -454 THERAPEUTICE USE: PREVE NTION OF PREGNANCY. NORETHI NDRONE 0.35MG 84 NDC CODE:684 62030529 FDA PRODUCT CODE NO. : 65 J C A 26 H. T. S NO.: 3006.60.00.00 ANDA NO.:91-209 THERAPEUTICE USE: PREVENTIO N OF PREGNANCY. FELODIPINE ER TABS 2.5MG 100 S NDC CODE: 68462023301 FDA PRODUCT CODE NO.: 62OCB32 H. T. S NO.: 3 004.90.92.20 ANDA NO.: 90-365 THERAPEUTICE USE: - TREATME NT OF HYPERTENSION TOPIRAM ATE TABLETS 100MG 1000 S NDC CODE:68462010910 FDA PRODUCT CODE NO.:61 M C A 40 H. T. S NO.: 3004.49.00.20 ANDA NO. :- 77-627 THERAPEUTICE USE:- ANTICONVULSANT COMMERCIAL & CUSTOM INVOICE NO. F22352000 718 DT. 26.05.2022 F223520007 19 DT. 26.05.2022 F2235200072 0 DT. 26.05.2022 NET WT: 5 ,794.78 KGS 02 DATA LOGGERS NOTIFY PARTY:2 GLENMARK PH ARMACEUTICALS INC 750, CORPOR ATE DRIVE, NEW JERSEY MAHWAH - 07430 USA S/BILL NO: 1684332 DT 26-MAY-2022 S/BIL L NO: 1684334 DT 26-MAY-2022 S/BILL NO: 1684337 DT 26-MAY-2 022<br/>
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
7497
KG
40
PKG
0
USD
MAEU217387974
2022-04-27
613200 GLENMARK PHARMACEUTICALS INC US GLENMARK PHARMACEUTICALS LTD 3 PALLETS 54 CARTONS PHARMACEUTICAL S AS UNDER APREPITANT CAPSU LES 80MG 2UOU NDC CODE:684620 58458 FDA PRODUCT CODE NO.: 61 T C E 32 H. T. S NO.: 300 4.90.92.40 ANDA NO.:207777 T HERAPEUTICE USE:APREPITANT IS USED WITH OTHER MEDICATIONS TO HELP PREVENT NAUSEA AND V OMITING CAUSED BY CANCER DRUG TREATMENT (CHEMOTHERAPY). TH IS MEDICATION IS ALSO USED T O PREVENT NAUSEA AND VOMITING AFTER SURGERY. A-EMETIC/NAUS EANT / HUMAN - RX/SINGLE ING REDIENT / DELAYED RELEASE TAB LETS / APREPITANT NITROGLY CERIN SUBLING TABS 0.6MG 100 S NDC CODE:68462064001 FDA PR ODUCT CODE NO.: 66 S C A 28 H. T. S NO.: 3004.90.9020 AN DA NO.:206391 THERAPEUTIC USE : -MEDICATION USED FOR HEART FAILURE,HIGH BLOOD PRESSURE, AND TO TREAT AND PREVENT CHES T PAIN FROM NOT ENOUGH BLOOD FLOW TO THE HEART COMMERCI AL & CUSTOM INVOICE NO. F2228 7002071 DT. 30.03.2022 S/BILL NO: 4004810 DT: 31.03.2022 NET WT. 12.37 KGS 03 DATA LO GGERS NOTIFY PARTY:2 GLE NMARK SPECIALTY S.A. SWITZERL AND (GSSA) PLACE NUMA-DROZ 2 NEUCHATEL - 2000 SWITZERLAND<br/>
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
350
KG
3
PKG
0
USD
MAEU913326482
2021-12-02
613200 GLENMARK PHARMACEUTICALS INC US GLENMARK PHARMACEUTICALS LTD 1 X 40 PART OF FCL REEFER 5 P ALLETS CONSISTING OF 408 CARTO NS PHARMACEUTICALS AS UNDER APREPITANT CAPSULES 80MG 6UD NDC CODE:68462058476 FDA PROD UCT CODE NO.: 61 T C E 32 H. T. S NO.: 3004.90.92.40 AND A NO.:207777 THERAPEUTICE US E:APREPITANT IS USED WITH OTH ER MEDICATIONS TO HELP PREVEN T NAUSEA AND VOMITING CAUSED BY CANCER DRUG TREATMENT (CH EMOTHERAPY). THIS MEDICATION IS ALSO USED TO PREVENT NAUSE A AND VOMITING AFTER SURGERY. A-EMETIC/NAUSEANT / HUMAN - RX/SINGLE INGREDIENT / DELAY ED RELEASE TABLETS / APREPIT ANT APREPITANT CAPSULES 125MG 6UD NDC CODE:68462058576 NDC NO.:68462058576 FD A PRODUCT CODE NO.: 61 T C E 32 H. T. S NO.: 300 4.90.92.40 ANDA NO.:207777 THERAPEUTICE USE:APRE PITANT IS USED WITH OTHER MEDICATIONS TO HELP PREVEN T NAUSEA AND VOMITING CAUS ED BY CANCER DRUG TREATMEN T (CHEMOTHERAPY). THIS MEDICATION IS ALSO USED T O PREVENT NAUSEA AND VOMIT ING AFTER SURGERY. A-EMETI C/NAUSEANT / HUMAN - RX/SI NGLE INGREDIENT / DELAYED RELEASE TABLETS / APRE PITANT ROSUVASTATIN TABLET S 10MG 90 S NDC CODE:68462026 290 FDA PRODUCT CODE NO.:61 J C A 16 H. T. S NO.: 3004.4 9.00.10 ANDA NO.: 079172 THE RAPEUTICE USE: - TO TREAT HIG H CHOLESTEROL AND RELATED CON DITIONS, AND TO PREVENT CARD IOVASCULAR DISEASE 05 DATA LO GGERS SET TEMPERATURE : +20 DEGREES TEMPERATURE RANGE : +15 DEGREES TO +25 DEGREES CO MMERCIAL & CUSTOM INVOICE NO. F22287001239 DT. 28.10.2021 F22287001277 DT. 01.11.2021 TOTAL GR.WT.:814.99KGS TOTAL NT.WT.:116.20KGS SBILL NO. DT. 4017276 28.10.2021 4017594 01.11.2021<br/>
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
815
KG
5
PKG
0
USD
MAEU218071767
2022-05-19
662800 GLENMARK PHARMACEUTICALS INC US GLENMARK PHARMACEUTICALS LTD 2 PALLETS 63 CART ONS PHARMACEUTICALS AS UNDER NITROGLYCERIN SUBLING TABS 0.4MG 100 S NDC CODE:68462063 901 FDA PRODUCT CODE NO.: 66 S C A 28 H. T. S NO.: 3004. 90.9020 ANDA NO.: 206391 THE RAPEUTICE USE: MEDICATION USE D FOR HEART FAILURE, HIGH BLO OD PRESSURE,AND TO TREAT AND PREVENT CHEST PAIN FROM NOTE NOUGH BLOOD FLOW TO THE HEART COMMERCIAL & CUSTOM INVOIC E NO. F22387000104 DT. 22.04. 2022 S/BILL NO: 4005813 DT: 23.04.2022 NET WT: 33.11 KG S 02 DATA LOGGERS NOTIFY P ARTY:2 GLENMARK SPECIALTY S.A . SWITZERLAND (GSSA) PLACE N UMA-DROZ 2 NEUCHATEL - 2000 SWITZERLAND<br/>
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
395
KG
2
PKG
0
USD
MAEU217679666
2022-05-04
662800 GLENMARK PHARMACEUTICALS INC US GLENMARK PHARMACEUTICALS LTD 10 PALLETS 288 CARTONS PH ARMACEUTICALS AS UNDER NITR OGLYCERIN SUBLING TABS 0.4MG 4 X25 NDC CODE:68462063945 FDA PRODUCT CODE NO.: 66 S C A 2 8 H. T. S NO.: 3004.90.9020 ANDA NO.:206391 THERAPEUTIC USE: MEDICATION USED FOR HEA RT FAILURE,HIGH BLOOD PRESSUR E,AND TO TREAT AND PREVENT CH EST PAIN FROM NOT ENOUGH BLOO D FLOW TO THE HEART APREPI TANT CAPSULES 40MG 1UD NDC CO DE:68462058340 FDA PRODUCT CO DE NO.: 61 T C E 32 H. T. S NO.: 3004.90.92.40 ANDA NO.: 207777 THERAPEUTICE USE: AP REPITANT IS USED WITH OTHER M EDICATIONS TO HELP PREVENT NA USEA AND VOMITING CAUSED BY CANCER DRUG TREATMENT (CHEMOT HERAPY). THIS MEDICATION IS A LSO USED TO PREVENT NAUSEA AN D VOMITING AFTER SURGERY. A- EMETIC/NAUSEANT / HUMAN - RX/ SINGLE INGREDIENT / DELAYED RELEASE TABLETS / APREPITANT NITROGLYCERIN SUBLING TABS 0.4MG 4X25 NDC CODE:684620639 45 FDA PRODUCT CODE NO.: 66 S C A 28 H. T. S NO.: 3004.9 0.9020 ANDA NO.:206391 THERA PEUTIC USE: MEDICATION USED F OR HEART FAILURE,HIGH BLOOD PRESSURE,AND TO TREAT AND PRE VENT CHEST PAIN FROM NOT ENOU GH BLOOD FLOW TO THE HEART NITROGLYCERIN SUBLING TABS 0. 4MG 4X25 NDC CODE:68462063945 FDA PRODUCT CODE NO.: 66 S C A 28 H. T. S NO.: 3004.90. 9020 ANDA NO.:206391 THERAPE UTIC USE: MEDICATION USED FOR HEART FAILURE,HIGH BLOOD PR ESSURE,AND TO TREAT AND PREVE NT CHEST PAIN FROM NOT ENOUGH BLOOD FLOW TO THE HEART C OMMERCIAL & CUSTOM INVOICE NO. F22287002081 DT. 31.03.2022 F22287002106 DT. 31.03.2022 F22287002112 DT. 31.03.2022 F 22287002120 DT. 31.03.2022 S/ BILL NO:4004991 DT:04/04/2022 S/BILL NO: 4004990 DT:04/04/2 022 S/BILL NO:4004994 DT:04/0 4/2022 S/BILL NO: 4004995 DT: 04/04/2022 NET WT: 128.89 KG S 10 DATA LOGGERS SET TEMP ERATURE : +18 DEGREES NOTIF Y PARTY:2 GLENMARK SPECIALTY S.A. SWITZERLAND (GSSA) PLAC E NUMA-DROZ 2 NEUCHATEL - 200 0 SWITZERLAND<br/>
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
2071
KG
10
PKG
0
USD
MAEU218465385
2022-06-08
662800 GLENMARK PHARMACEUTICALS INC US GLENMARK PHARMACEUTICALS LTD 8 PALLETS 244 CARTONS PHAR MACEUTICALS AS UNDER NITROG LYCERIN SUBLING TABS 0.4MG 4X2 5 NDC CODE:68462063945 FDA P RODUCT CODE NO.: 66 S C A 28 H. T. S NO.: 3004.90.9020 A NDA NO.:206391 THERAPEUTIC US E: MEDICATION USED FOR HEART FAILURE,HIGH BLOOD PRESSURE, AND TO TREAT AND PREVENT CHES T PAIN FROM NOT ENOUGH BLOOD FLOW TO THE HEART NITROGLY CERIN SUBLING TABS 0.4MG 4X25 NDC CODE:68462063945 FDA PRO DUCT CODE NO.: 66 S C A 28 H . T. S NO.: 3004.90.9020 AND A NO.:206391 THERAPEUTIC USE: MEDICATION USED FOR HEART F AILURE,HIGH BLOOD PRESSURE,AN D TO TREAT AND PREVENT CHEST PAIN FROM NOT ENOUGH BLOOD FL OW TO THE HEART NITROGLYCE RIN SUBLING TABS 0.4MG 4X25 N DC CODE:68462063945 FDA PRODU CT CODE NO.: 66 S C A 28 H. T. S NO.: 3004.90.9020 ANDA NO.:206391 THERAPEUTIC USE: MEDICATION USED FOR HEART FAI LURE,HIGH BLOOD PRESSURE,AND TO TREAT AND PREVENT CHEST PA IN FROM NOT ENOUGH BLOOD FLOW TO THE HEART COMMERCIAL & CUSTOM INVOICE NO. F22387000 165 DT. 30.04.2022 F223870001 69 DT. 30.04.2022 F2238700020 7 DT. 11.05.2022 S/BILL NO:40 06762 DT: 11.05.2022 S/BILL N O: 4006764 DT: 11.05.2022 S/B ILL NO: 4006766 DT: 11.05.2022 NET WT: 130.00 KGS 08 DATA LOGGERS SET TEMPERATURE : +18 DEGREES NOTIFY PARTY:2 GLENMARK SPECIALTY S.A. SWIT ZERLAND (GSSA) PLACE NUMA-DRO Z 2 NEUCHATEL - 2000 SWITZER LAND<br/>
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
1984
KG
8
PKG
0
USD
MAEU216355708
2022-03-02
662800 GLENMARK PHARMACEUTICALS INC US GLENMARK PHARMACEUTICALS LTD 1 X 40 PART OF FCL REEFER 07 PALLETS CONSISTING OF 197 C ARTONS PHARMACEUTICALS AS UN DER NITROGLYCERIN SUBLING TABS 0.6MG 100 S NDC CODE:68 462064001 FDA PRODUCT CODE N O.: 66 S C A 28 H. T. S NO .: 3004.90.9020 ANDA NO.:2 06391 THERAPEUTIC USE: MED ICATION USED FOR HEART FAILU RE,HIGH BLOOD PRESSURE,AND T O TREAT AND PREVENT CHEST PA IN FROM NOT ENOUGH BLOOD FLO W TO THE HEART NITROGLYCER IN SUBLING TABS 0.4MG 100 S NDC CODE:68462063901 FDA P RODUCT CODE NO.: 66 S C A 28 H. T. S NO.: 3004.90.9020 ANDA NO.: 206391 THERAPEU TICE USE: MEDICATION USED FO R HEART FAILURE, HIGH BLOOD PRESSURE,AND TO TREAT AND PREVENT CHEST PAIN FROM NOTE NOUGH BLOOD FLOW TO THE HEAR T NITROGLYCERIN SUBLING TA BS 0.4MG 4X25 NDC CODE:68462 063945 FDA PRODUCT CODE NO.: 66 S C A 28 H. T. S NO.: 3004.90.9020 ANDA NO.:2063 91 THERAPEUTIC USE: MEDICA TION USED FOR HEART FAILURE, HIGH BLOOD PRESSURE,AND TO T REAT AND PREVENT CHEST PAIN FROM NOT ENOUGH BLOOD FLOW T O THE HEART 07 DATA LOGGER S COMMERCIAL & CUSTOM INVOICE NO. F22287001739 DT. 31.01.2022 F22287001740 DT. 31.01.2022 F22287001757 DT. 31.01.2022 SBILL NO. DT. 4001696 03. 02.2022 4001685 03.02.2 022 4001684 03.02.2022 TOTAL NET WT. 104.02KG S<br/>
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
1285
KG
7
PKG
0
USD
MAEU214106776
2021-11-18
662800 GLENMARK PHARMACEUTICALS INC US GLENMARK PHARMACEUTICALS LTD 1X40 REEFER PART OF FCL CONTAI NER 9 PALLETS CONSISTING OF 3 48 CARTONS PHARMACEUTICALS AS UNDER NITROGLYCERIN SUBLING TABS 0.4MG 100 S NDC CODE:684 62063901 FDA PRODUCT CODE NO. : 66 S C A 28 H. T. S NO.: 3004.90.9020 ANDA NO.: 206391 THERAPEUTICE USE: MEDICATIO N USED FOR HEART FAILURE, HIG H BLOOD PRESSURE,AND TO TREAT AND PREVENT CHEST PAIN FROM NOTENOUGH BLOOD FLOW TO THE HEART NITROGLYCERIN SUBLING T ABS 0.4MG 4X25 NDC CODE:68462 063945 FDA PRODUCT CODE NO.: 66 S C A 28 H. T. S NO.: 30 04.90.9020 ANDA NO.:206391 T HERAPEUTIC USE: MEDICATION US ED FOR HEART FAILURE,HIGH BLO OD PRESSURE,AND TO TREAT AND PREVENT CHEST PAIN FROM NOT ENOUGH BLOOD FLOW TO THE HEAR T NITROGLYCERIN SUBLING TABS 0.3MG 100 S NDC CODE:68462063 801 FDA PRODUCT CODE NO.: 66 S C A 28 H. T. S NO.: 3004. 90.9020 ANDA NO.:206391 THER APEUTIC USE: MEDICATION USED FOR HEART FAILURE,HIGH BLOOD PRESSURE,AND TO TREAT AND PR EVENT CHEST PAIN FROM NOT ENO UGH BLOOD FLOW TO THE HEART APREPITANT CAPSULES 40MG 5UD NDC CODE:68462058385 FDA PROD UCT CODE NO.: 61 T C E 32 H. T. S NO.: 3004.90.92.40 AND A NO.:207777 THERAPEUTICE US E:APREPITANT IS USED WITH OTH ER MEDICATIONS TO HELP PREVEN T NAUSEA AND VOMITING CAUSED BY CANCER DRUG TREATMENT (CH EMOTHERAPY). THIS MEDICATION IS ALSO USED TO PREVENT NAUSE A AND VOMITING AFTER SURGERY. A-EMETIC/NAUSEANT / HUMAN - RX/SINGLE INGREDIENT / DELAY ED RELEASE TABLETS / APREPIT ANT 09 DATA LOGGERS HUMIDI TY:65% SET TEMPERATURE : +20 DEGREES TEMPERATURE RANGE : + 15 DEGREES TO +25 DEGREES COM MERCIAL & CUSTOM INVOICE NO. F22287001201 DT. 21.10.2021 F 22287001202 DT. 21.10.2021 TO TAL GR.WT.: 1659.31KGS TOTAL NT.WT: 113.27KGS SBILL NOS DT 4016836 21.1 0.2021 4016835 21.10.2 021 NOTIFY PARTY:2 GLENM ARK SPECIALTY S.A. AVENUE L EOPOLD-ROBERT 37 LA CHAUX-D E-FONDS - 2300 SWITZERLAND<br/>
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
1659
KG
9
PKG
0
USD
MAEU914178600
2022-05-11
621000 GLENMARK PHARMACEUTICALS INC US GLENMARK PHARMACEUTICALS LTD 40 PALLETS 2916 CARTONS P HARMACEUTICALS AS UNDER OME PRAZOLE DR CAPSULES 20MG 90 S NDC CODE:68462039690 FDA PRO DUCT CODE NO.: 62KCF10 H. T. S NO.: 3004.90.9160 ANDA NO .: 91672 THERAPEUTICE USE: - TREATMENT OF TREAT GASTROESO PHAGEAL REFLUX DISEASE VER APAMIL HCL ER TABS 180MG 500S NDC CODE:68462029305 FDA PRO DUCT CODE NO.: 62 O C B 13 H . T. S NO.: 3004.90.92.20 AN DA NO.: 90-700 THERAPEUTICE U SE: - ANGINA VERAPAMIL HCL ER TABS 240MG 100 S NDC CODE :68462026001 FDA PRODUCT CODE NO.: 62 O C B 13 H. T. S NO .: 3004.90.92.20 ANDA NO.:-7 8-906 THERAPEUTICE USE:-ANGI NA PRAMIPEXOLE TABS 0.5MG 9 0 S NDC CODE:68462033290 FDA PRODUCT CODE NO.: 62 J C A 1 5 H. T. S NO.: 3004.90.92.40 ANDA NO.: 90-781 THERAPEUTI CE USE: USED IN PARKINSON#S D ISEASE PRAMIPEXOLE TABS 1MG 90 S NDC CODE:68462033390 F DA PRODUCT CODE NO.: 62 J C A 15 H. T. S NO.: 3004.90.92. 40 ANDA NO.: 90-781 THERAPEU TICE USE: USED IN PARKINSON#S DISEASE NAPROXEN TABLETS 5 00MG 30 S NDC CODE:6846201903 0 FDA PRODUCT CODE NO.:-62 G C A 49 H. T. S NO.: 3004.90 .92.40 ANDA NO.:-78-250 THER APEUTICE USE:-ANTI-INFLAMMATO RY, ANALGESIC OXCARBAZEPIN E TABLETS 600MG 100 S NDC COD E:68462013901 FDA PRODUCT COD E NO.:-61 M C A 45 H. T. S N O.: 3004.90.92.30 ANDA NO.:- 77-802 THERAPEUTICE USE:-ANTI CONVULSANT AGENT ROPINIRO LE TABS 3MG 100 S NDC CODE:68 462025701 FDA PRODUCT CODE NO .:-62 J C A 17 H. T. S NO.: 3 004.90.92.40 ANDA NO.:- 90-13 5 THERAPEUTICE USE:-TREATMENT OF PARKINSONISM NORETHINDR ONE 0.35MG 84 NDC CODE:684620 30529 FDA PRODUCT CODE NO.: 65 J C A 26 H. T. S NO.: 300 6.60.00.00 ANDA NO.:91-209 T HERAPEUTICE USE: PREVENTION O F PREGNANCY. COMMERCIAL & C USTOM INVOICE NO. F2235200007 4 DT. 09.04.2022 F22352000094 DT. 12.04.2022 S/BILL NO: 96 60311 DT. 12.04.2022 S/BILL N O: 9660309 DT. 12.04.2022 NET WT. 7,876.88 KGS 02 DATA LOGGERS HUMIDITY:65% SET TEM PERATURE : +18 DEGREES TEMPER ATURE RANGE : +15 DEGREES TO + 25 DEGREES NOTIFY PARTY:2 GLENMARK PHARMACEUTICALS INC 750, CORPORATE DRIVE, NEW JER SEY MAHWAH - 07430 USA<br/>
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
9576
KG
40
PKG
0
USD
MAEU218335981
2022-06-08
621000 GLENMARK PHARMACEUTICALS INC US GLENMARK PHARMACEUTICALS LTD 39 PALLETS 1638 CARTONS PH ARMACEUTICALS AS UNDER OMEP RAZOLE DR CAPSULES 40MG 1000 S NDC CODE:68462039710 FDA PR ODUCT CODE NO.:62KCF10 H. T. S NO.: 3004.90.9160 ANDA NO .:91672 THERAPEUTICE USE: - TREATMENT OF TREAT GASTROESOP HAGEAL REFLUX DISEASE LAMO TRIGINE TABLETS FOR OS(CD)25MG 100 S NDC CODE:68462022901 F DA PRODUCT CODE NO.:- 61 M C A 38 H. T. S NO.: 3004.90.92 .30 ANDA NO.:-79 # 099 THERA PEUTICE USE:- ANTICONVULSANT ONDANSETRON TABLETS 8MG 30 S NDC CODE:68462010630 FDA P RODUCT CODE NO.:-61 T C A 28 H. T. S NO.: 3004.90.92.40 A NDA NO.:- 77-535 THERAPEUTICE USE:-ANTI EMETIC NAPROXEN TABLETS 500MG 500 S NDC CODE :68462019005 FDA PRODUCT CODE NO.:-62 G C A 49 H. T. S NO .: 3004.90.92.40 ANDA NO.:-7 8-250 THERAPEUTICE USE:-ANTI -INFLAMMATORY, ANALGESIC T RANDOLAPRIL-VERAPAMIL TAB 2/18 0MG 100 S NDC CODE:6846202950 1 FDA PRODUCT CODE NO.:-62 O D A 11 H. T. S NO.: 3004.90 .92.20 ANDA NO.:-79-135 THER APEUTICE USE:-TREATMENT OF H YPERTENSION NORGEST/EE 0.18 ,0.215,0.25/0.035MG 84 NDC CO DE:68462056529 FDA PRODUCT CO DE NO.: 65 J D A 27 H. T. S NO.: 3006.60.00.00 ANDA NO.: 200494 THERAPEUTICE USE: - O RAL CONTRACEPTIVES 08 DA TA LOGGERS HUMIDITY:65% SET TEMPERATURE : +18 DEGREES TEM PERATURE RANGE : +15 DEGREES T O +25 DEGREES COMMERCIAL & CUSTOM INVOICE NO. F223520003 95 DT. 30.04.2022 F2235200050 7 DT. 10.05.2022 S/BILL NO: 1 282151 DT: 10/05/2022 S/BILL NO: 1321682 DT:11/05/2022 NE T WT: 6247.98 KGS NOTIFY PART Y:2 GLENMARK PHARMACEUTICALS INC 750, CORPORATE DRIVE, NE W JERSEY MAHWAH - 07430 USA<br/>
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
7301
KG
39
PKG
0
USD
MAEU218637299
2022-06-22
615100 GLENMARK PHARMACEUTICALS INC US GLENMARK PHARMACEUTICALS LTD 34 PALLETS 1730 CARTONS PHARMACEUTICALS AS UNDER LE VOCETIRIZINE DIHY TABS 5MG 90 S NDC CODE:68462034690 FDA P RODUCT CODE NO.: 61 X C A 51 H. T. S NO.: 3004.90.91.80 ANDA NO.:90385 THERAPEUTICE U SE: TREATMENT OF CHRONIC IDI OPATHIC URTICARIA OMEPRAZOL E DR CAPSULES 20MG 1000 S NDC CODE:68462039610 FDA PRODUCT CODE NO.: 62KCF10 H. T. S N O.: 3004.90.9160 ANDA NO.: 9 1672 THERAPEUTICE USE: - TRE ATMENT OF TREAT GASTROESOPHAG EAL REFLUX DISEASE COMMERC IAL & CUSTOM INVOICE NO. F223 52000649 DT. 19.05.2022 S/BIL L NO: 1527298 DT 20-MAY-2022 NET WT: 5870.6 KGS 02 DATA LOGGERS SET TEMPERATURE : + 18 DEGREES NOTIFY PARTY:2 GLENMARK PHARMACEUTICALS INC 750, CORPORATE DRIVE, NEW JER SEY MAHWAH - 07430 USA<br/>
INDIA
UNITED STATES
52330, SALALAH
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
6948
KG
34
PKG
0
USD
MAEU914140069
2022-05-04
615100 GLENMARK PHARMACEUTICALS INC US GLENMARK PHARMACEUTICALS LTD 41 PALLETS 3561 CARTONS P HARMACEUTICALS AS UNDER ONDAN SETRON TABLETS 4MG 30 S NDC C ODE:68462010530 FDA PRODUCT C ODE NO.:-61 T C A 28 H. T. S NO.: 3004.90.92.40 ANDA NO. :- 77-535 THERAPEUTICE USE:-A NTI EMETIC LEVOCETIRIZINE DIHY TABS 5MG 90 S NDC CODE:6 8462034690 FDA PRODUCT CODE N O.: 61 X C A 51 H. T. S NO.: 3004.90.91.80 ANDA NO.:9038 5 THERAPEUTICE USE: TREATMEN T OF CHRONIC IDIOPATHIC URTIC ARIA OXCARBAZEPINE TABLETS 600MG 100 S NDC CODE:68462013 901 FDA PRODUCT CODE NO.:-61 M C A 45 H. T. S NO.: 3004. 90.92.30 ANDA NO.:-77-802 TH ERAPEUTICE USE:-ANTI CONVULSA NT AGENT PRAVASTATIN SODIUM TAB 40MG 500 S NDC CODE:6846 2019705 FDA PRODUCT CODE NO.: 61 J C A 13 H. T. S NO.: 3 004.90.92.20 ANDA NO.: 77-987 THERAPEUTICE USE: HYPOLIPDA EMIC OLMESARTAN MEDOXOMIL T ABLETS 40MG 90 S NDC CODE:684 62043890 FDA PRODUCT CODE NO. : 62 CCA 68 H. T. S NO.: 30 04.90.9220 ANDA NO.: 203281 TREATMENT OF HYPERTENSION, AL ONE OR WITH OTHER ANTIHYPERT ENSIVE AGENTS, TO LOWER BLOOD PRESSURE ZOLMITRIPTAN ODT 5MG 3 S NDC CODE:68462050033 FDA PRODUCT CODE NO.: 60 L C A 90 H. T. S NO.: 3004.90.9 2.28 ANDA NO.: 202560 THERAP EUTICE USE: - ANALGESIC/ HUMA N - RX/SINGLE INGREDIENT / P ROMPT RELEASE TABLETS / ZOLM ITRIPTAN (ANALGESIC) COMMERCI AL & CUSTOM INVOICE NO. F2225 2006298 DT. 31.03.2022 S/BILL NO: 9462490 DT:04-APR-22 NE T WT: 6,837.35 KGS 02 DATA LOGGERS NOTIFY PARTY:2 GLE NMARK PHARMACEUTICALS INC 750 , CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 USA<br/>
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
8638
KG
41
PKG
0
USD
MAEU214106806
2021-11-18
620900 GLENMARK PHARMACEUTICALS INC US GLENMARK PHARMACEUTICALS LTD 1X40 REEFER FCL CONTAINER 48 PALLETS CONSISTING OF 3532 CAR TONS PHARMACEUTICALS AS UNDER TELMISARTAN TABLETS 40MG 30 S NDC CODE:68462020030 FDA P RODUCT CODE NO.: 62 O C A 09 H. T. S NO.: 3004.90.92.20 ANDA NO.:090032 THERAPEUTICE USE: INDICATED FOR THE TREAT MENT OF HYPERTENSION, TO LOWE R BLOOD PRESSURE OMEPRAZOLE DR CAPSULES 40MG 30 S NDC COD E:68462039730 FDA PRODUCT COD E NO.: 62KCF10 H. T. S NO.: 3004.90.9160 ANDA NO.: 91672 THERAPEUTICE USE: - TREATME NT OF TREAT GASTROESOPHAGEAL REFLUX DISEASE PRAMIPEXOLE T ABS 0.125MG 90 S NDC CODE:684 62033090 FDA PRODUCT CODE NO. : 62 J C A 15 H. T. S NO.: 3004.90.92.40 ANDA NO.: 90-78 1 THERAPEUTICE USE: USED IN PARKINSON#S DISEASE CALCIPOTR IENE OINTMENT 0.005% 60GM NDC CODE:68462031065 FDA PRODUCT CODE NO.: 62 N C J 04 H. T. S NO.: 3004.90.92.45 ANDA N O.: 209297 THIS MEDICATION IS USED TO TREAT PSORIASIS. CA LCIPOTRIENE IS A FORM OF VITA MIN D. IT WORKS BY SLOWING DO WN THE GROWTH OF SKIN CELLS. CLOTRIMAZOLE CREAM 1% 30GM N DC CODE:68462018135 FDA PRODU CT CODE NO :61 W C J 04 H. T . S NO.: 3004.90.92.45 ANDA NO.: 90-219 THERAPEUTICE USE: TREATMENT OF CANDIDIASIS 02 DATA LOGGERS HUMIDITY:65% S ET TEMPERATURE : +20 DEGREES TEMPERATURE RANGE : +15 DEGREE S TO +25 DEGREES COMMERCIAL & CUSTOM INVOICE NO. F22252003 759 DT. 20.10.2021 F222520037 60 DT. 20.10.2021 SBILL NO. D T. 5472027 22-OCT-2021 5473 740 22-OCT-2021 TOTAL GR.WT. : 12055.14KGS TOTAL NT.WT: 95 10.15KGS FREIGHT PREPAID<br/>
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
12055
KG
48
PKG
0
USD
MAEU914178639
2022-05-11
652600 GLENMARK PHARMACEUTICALS INC US GLENMARK PHARMACEUTICALS LTD 52 PALLETS 2258 CART ONS PHARMACEUTICALS AS UNDER NORETHINDRONE 0.35MG 84 ND C CODE:68462030529 FDA PRODUC T CODE NO.: 65 J C A 26 H. T . S NO.: 3006.60.00.00 ANDA NO.:91-209 THERAPEUTICE USE: PREVENTION OF PREGNANCY. N ORETHINDRONE ACE/EE TABS 1/0.0 2MG 63 NDC CODE:68462013281 FDA PRODUCT CODE NO.:65 J C A 25 H. T. S NO.: 3006.60.00. 00 ANDA NO.:206969 THERAPEUT ICE USE: - SECONDARY AMENORR HEA,ENDOMETRIOS IS AND ABNORM AL UTERINE BLEEDING OMEPRA ZOLE DR CAPSULES 40MG 1000 S NDC CODE:68462039710 FDA PROD UCT CODE NO.:62KCF10 H. T. S NO.: 3004.90.9160 ANDA NO.: 91672 THERAPEUTICE USE: - TR EATMENT OF TREAT GASTROESOPHA GEAL REFLUX DISEASE INDOME THACIN CAPS 50MG 100 S NDC CO DE:68462030201 FDA PRODUCT CO DE NO.: 62 G C E 42 H. T. S NO.: 3004.90.92.40 ANDA NO.: 91-276 THERAPEUTICE USE: ANT I-INFLAMATORY INDOMETHACIN CAPS 50MG 500 S NDC CODE:6846 2030205 FDA PRODUCT CODE NO.: 62 G C E 42 H. T. S NO.: 3 004.90.92.40 ANDA NO.:91-276 THERAPEUTICE USE: ANTI-INFLA MATORY INDOMETHACIN CAPS 25 MG 100 S NDC CODE:68462040601 FDA PRODUCT CODE NO.: 62 G C E 42 H. T. S NO.: 3004.90. 92.40 ANDA NO.:91-276 THERAP EUTICE USE: ANTI-INFLAMATORY COMMERCIAL & CUSTOM INVOICE NO. F22352000129 DT. 14.04.2 022 F22352000132 DT. 14.04.20 22 F22352000134 DT. 14.04.202 2 S/BILL NO: 9731836 DT:16.04 .2022 S/BILL NO:9733093 DT: 1 6.04.2022 S/BILL NO: 9733164 DT: 16.04.2022 NET WT: 6,52 5.58 KGS 02 DATA LOGGERS SET TEMPERATURE : +18 DEGREES NOTIFY PARTY:2 GLENMARK PHARM ACEUTICALS INC 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 074 30 USA<br/>
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
8269
KG
52
PKG
0
USD
MAEU216328357
2022-03-02
652600 GLENMARK PHARMACEUTICALS INC US GLENMARK PHARMACEUTICALS LTD 1 X 40 PART OF FCL REEFER 23 PACKAGES CONSISTING OF 1084 C ARTONS PHARMACEUTICALS AS U NDER NORETHINDRONE 0.35MG 84 NDC CODE: 68462030529 FDA PRODUCT CODE NO.: 65 J C A 26 H. T. S NO.: 3006.6 0.00.00 ANDA NO.:91-209 TH ERAPEUTICE USE: PREVENTION O F PREGNANCY. DROSPIRENONE/EE 3.0/0.02MG 84 NDC CODE: 68462072029 FDA PRODUCT COD E NO.: 65 J D A 39 H. T. S NO.: 3006.60.00.00 ANDA N O.: 204296 THERAPEUTICE US E: - ORAL CONTRACEPTIVE 01 DATA LOGGERS SET TEMP ERATURE : +20 DEGREES SB ILL NO. DT. 7835434 29-JA N-2022 COMMERCIAL & CUSTOM IN VOICE NO. F22252005352 DT. 2 8.01.2022 TOTAL NET.WT: 2 569.90KGS<br/>
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
3547
KG
23
PKG
0
USD
MAEU218682321
2022-06-22
652600 GLENMARK PHARMACEUTICALS INC US GLENMARK PHARMACEUTICALS LTD 33 PALLETS 1642 CARTONS PH ARMACEUTICALS AS UNDER NORE THINDRONE 0.35MG 84 NDC CODE: 68462030529 FDA PRODUCT CODE NO.: 65 J C A 26 H. T. S NO. : 3006.60.00.00 ANDA NO.:91- 209 THERAPEUTICE USE: PREVEN TION OF PREGNANCY. NORETHIN DRONE 0.35MG 84 NDC CODE:6846 2030529 FDA PRODUCT CODE NO.: 65 J C A 26 H. T. S NO.: 3 006.60.00.00 ANDA NO.:91-209 THERAPEUTICE USE: PREVENTION OF PREGNANCY. ASHLYNA LEVO /EE 0.15/0.03MG 182 NDC CODE: 68462064693 FDA PRODUCT CODE NO.: 64 G D A 2 H. T. S NO.: 3006.60.0000 ANDA NO.: 2031 63 THERAPEUTICE USE: - INDIC ATED FOR USE BY WOMEN TO PREV ENT PREGNANCY PIMECROLIMUS CREAM 1% 30GM NDC CODE:68462 060935 FDA PRODUCT CODE NO.: 61 S C J 04 H. T. S NO.: 30 04.90.92.45 ANDA NO.: 211769 THERAPEUTICE USE: - AS SECOU ND-LINE THERAPY FOR THE SHORT -TERM AND NON-CONTINUOS CHRON IC TRERTMENT OF MILD TO MODE RATE ATOPIC DERMATITIS IN NO NIMMUNOCOMPROMISED ADULT AND CHILDREN 2 YEARS OF AGE DI LTIAZEM HCL ER CAPS 12HR 60MG 100 S NDC CODE:68462085001 6 2 O C B 24 3004.49.00.10 212 317 FOR THE TREATMENT OF HYP ERTENSION. CARVEDILOL TABS 12.5MG 100 S NDC CODE:6846201 6401 FDA PRODUCT CODE NO : 6 2 O C A 22 H. T. S NO.: 3004 .90.92.20 ANDA NO.:- 78-251 THERAPEUTICE USE:-BETA- ADRE NOACEPTOR ANTAGONIST COMME RCIAL & CUSTOM INVOICE NO. F2 2352000708 DT. 25.05.2022 F22 352000710 DT. 25.05.2022 F223 87000238 DT. 20.05.2022 F2238 7000240 DT. 20.05.2022 F22387 000241 DT. 20.05.2022 S/BILL NO: 1680051 DT: 26/05/2022 S /BILL NO: 1680054 DT:26/05/20 22 S/BILL NO: 4007229 DT:20/ 05/2022 S/BILL NO: 4007220 D T:20/05/2022 S/BILL NO: 40072 34 DT:20/05/2022 NET WT. 3, 859.20 KGS 07 DATA LOGGERS H UMIDITY:65% SET TEMPERATURE : +18 DEGREES TEMPERATURE RANG E : +15 DEGREES TO +25 DEGREES NOTIFY PARTY:2 GLENMARK PHA RMACEUTICALS INC 750, CORPORA TE DRIVE, NEW JERSEY MAHWAH - 07430 USA NOTIFY PARTY:3 GLENMARK PHARMACEUTICALS LTD. PLOT NO 2, ISEZ, PHASE II,PHA RMA ZONE PITHAMPUR, DIST DHAR , MADHYA PRADESH INDIA GST NO . : 23AAACG2207L2ZZ<br/>
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
5639
KG
33
PKG
0
USD
MAEU216470570
2022-03-09
611600 GLENMARK PHARMACEUTICALS INC US GLENMARK PHARMACEUTICALS LTD 1 X 40 PART OF FCL REEFER 26 PALLETS CONSISTING 2583 C ARTONS PHARMACEUTICALS AS UNDER ROSUVASTATIN TABLETS 10MG 90 S NDC CODE: 68462 026290 FDA PRODUCT CODE NO .:61 J C A 16 H. T. S NO.: 3004.49.00.10 ANDA NO.: 079 172 THERAPEUTICE USE: - TO TREAT HIGH CHOLESTEROL AND RELATED CONDITIONS, AND TO PREVENT CARDIOVASCULAR DISE ASE AZELAIC ACID GEL 15% 5 0GM NDC CODE: 68462062652 FDA PRODUCT CODE NO.: 62 S C J 03 H. T. S NO.: 3004. 49.00.50 ANDA NO.: 204637 INDICATED FOR TOPICAL TREATM ENT OF THE INFLAMMATORY PAPU LES AND PUSTULES OF MILD TO MODERATE ROSACEA 26 DATA L OGGERS SET TEMPERATURE : +20 DEGREES COMMERCIAL & CUSTOM INVOICE NO. F222520 05540 DT. 05.02.2022 F2225 2005538 DT. 04.02.2022 SBILL NO. DT. 8023741 06- FEB-2022 8023564 06-FEB-20 22 TOTAL NET WT.4483.56KGS GLENMARK SPECIALTY S.A. S WITZERLAND (GSSA) PLACE NUMA- DROZ 2 NEUCHATEL - 2000 SWITZERLAND<br/>
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
5756
KG
26
PKG
0
USD
MAEU216791108
2022-03-24
611600 GLENMARK PHARMACEUTICALS INC US GLENMARK PHARMACEUTICALS LTD 1X40 REF 267 CARTONS PACKED I N 6 PALLETS PHARMACEUTICALS A S UNDER ROSUVASTATIN TABLETS 40MG 500 S NDC CODE:684620264 05 61 J C A 16 3004.49.00.10 79172 TO TREAT HIGH CHOLEST EROL AND RELATED CONDITIONS, AND TO PREVENT CARDIOVASCULAR DISEASE ROSUVASTATIN TABLETS 20MG 1000 S NDC CODE:68462026 310 FDA PRODUCT CODE NO.: 61 J C A 16 H. T. S NO.: 3004 .49.00.10 ANDA NO.: 79172 TH ERAPEUTICE USE: TO TREAT HIGH CHOLESTEROL AND RELATED CONDI TIONS, AND TO PREVENT CARDIOV ASCULAR DISEASE NET WT: 1,3 74.96 KGS GROSS WT: 1,541.19 KGS 06 DATA LOGGERS SET TEMPERATURE : +20 DEGREES C ONTAINER NO. TTNU8759835 CO MMERCIAL & CUSTOM INVOICE NO. F22252005768 DT. 23.02.2022 F22252005786 DT. 23.02.2022 SB NO.: 8492798 DT.: 25/02/22 SB NO,: 8492826 DT.: 25/02/2 2<br/>
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
1541
KG
6
PKG
0
USD
MAEU218800472
2022-07-01
611600 GLENMARK PHARMACEUTICALS INC US GLENMARK PHARMACEUTICALS LTD 4 PALLETS 357 CARTONS PHA RMACEUTICALS AS UNDER ROSUV ASTATIN TABLETS 10MG 90 S NDC CODE:68462026290 FDA PRODUCT CODE NO.:61 J C A 16 H. T. S NO.: 3004.49.00.10 ANDA NO .: 079172 THERAPEUTICE USE: - TO TREAT HIGH CHOLESTEROL AN D RELATED CONDITIONS, AND TO PREVENT CARDIOVASCULAR DISEA SE COMMERCIAL & CUSTOM INVO ICE NO. F22352000775 DT. 29.0 5.2022 NET WT: 496.223 KGS 0 4 DATA LOGGERS HUMIDITY:65% SET TEMPERATURE : +18 DEGREES TEMPERATURE RANGE : +15 DEGRE ES TO +25 DEGREES NOTIFY PART Y:2 GLENMARK SPECIALTY S.A. SWITZERLAND (GSSA) PLACE NUMA -DROZ 2 NEUCHATEL - 2000 SWI TZERLAND<br/>
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
646
KG
4
PKG
0
USD
MAEU219009636
2022-07-07
611600 GLENMARK PHARMACEUTICALS INC US GLENMARK PHARMACEUTICALS LTD 19 PALLETS 1637 CART ONS PHARMACEUTICALS AS UNDE R ROSUVASTATIN TAB 5MG 1000 NDC CODE:68462026110 FDA PR ODUCT CODE NO.: 61 J C A 16 H. T. S NO.: 3004.49.00.10 A NDA NO.: 79172 THERAPEUTICE U SE: TO TREAT HIGH CHOLESTEROL AND RELATED CONDITIONS, AND TO PREVENT CARDIOVASCULAR DI SEASE. ROSUVASTATIN TAB 5MG 90 NDC CODE:68462026190 FDA PRODUCT CODE NO.:61 J C A 16 H. T. S NO.: 3004.49.00.10 ANDA NO.: 079172 THERAPEUTIC E USE: - TO TREAT HIGH CHOLES TEROL AND RELATED CONDITIONS, AND TO PREVENT CARDIOVASCUL AR DISEASE COMMERCIAL & CUS TOM INVOICE NO. F22352000973 DT. 08.06.2022 NET WT. 2,057 .62 KGS 19 DATA LOGGERS S ET TEMPERATURE : +18 DEGREES NOTIFY PARTY:2 GLENMARK S PECIALTY S.A. SWITZERLAND (GS SA) PLACE NUMA-DROZ 2 NEUCHA TEL - 2000 SWITZERLAND S/B ILL NO: 2009620 DT: 09-JUN-22<br/>
INDIA
UNITED STATES
52330, SALALAH
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
2709
KG
19
PKG
0
USD
MAEU214152367
2021-11-18
611600 GLENMARK PHARMACEUTICALS INC US GLENMARK PHARMACEUTICALS LTD 1X40 PART OF FCL REEFER 8 (EI GHT)PALLETS CONSISTING OF 1060 CARTONS PHARMACEUTICALS AS U NDER ROSUVASTATIN TABLETS 40M G 30 S NDC CODE:68462026430 FDA PRODUCT CODE NO.:61 J C A 16 H. T. S NO.: 3004.49.00.10 ANDA NO.: 079172 THERAPEUTICE USE: - TO TREAT HIGH CHOLESTER OL AND RELATED CONDITIONS , AND TO PREVENT CAR DIOVASCULAR DISEASE ROSUVASTATIN TABLETS 5MG 90 S NDC CODE:68462026190 FDA PRODUCT CODE NO.:61 J C A 16 H. T. S NO.: 3004.49.00.10 ANDA NO. : 079172 THERAPEUTICE USE : - TO TREAT HIGH CHOLEST EROL AND RELATED CONDITIO NS, AND TO PREVENT C ARDIOVASCULAR DISEASE 08 DATA LOGGERS SET TEMPERATURE : +20 DEGREES TEMPERATURE RANGE : +15 D EGREES TO +25 DEGREES COMME RCIAL & CUSTOM INVOIC E NO. F22287001173 DT. 18.10.2021 S BILL NO. 4016671 DT. 18/10/20 21 TOTAL GR.WT.: 2090.95KGS TOTAL NT.WT.:391.78KGS<br/>
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
2091
KG
8
PKG
0
USD
MAEU216791392
2022-03-24
652700 GLENMARK PHARMACEUTICALS INC US GLENMARK PHARMACEUTICALS LTD 1X40 REF 1994 CARTONS PACKED IN40 PALLETS PHARMACEUTICALS AS UNDER NORGEST/EE 0.25/0.03 5MG 84 NDC CODE:68462030929 FDA PRODUCT CODE NO.: 65 J D A 27 H. T. S NO.: 3006.60.00.0 0 ANDA NO.: 200538 THERAPEUT ICE USE: - ORAL CONTRACEPTIVE S DROSPIRENONE/EE 3.0/0.02MG 84 NDC CODE:68462072029 FDA PRODUCT CODE NO.: 65 J D A 39 H. T. S NO.: 3006.60.00 00 ANDA NO.: 204296 THERAPEUTIC E USE: - ORAL CONTRACEPTIVE DROSPIRENONE/EE 3.0/0.03MG 84 NDC CODE:68462073329 FDA PRO DUCT CODE NO.: 65 J D A 39 H. T. S NO.: 3006.60.00.00 ANDA NO.: 204848 THERAPEUTICE USE : - CONTRACEPTION TO PREVENT PREGNANCY NET WT: 4,361.42 KGS GROSS WT: 6,062.05 KGS 02 DATA LOGGERS SET TEMPE RATURE : +20 DEGREES CONTAI NER NO. MNBU9139449 COMMERC IAL & CUSTOM INVOICE NO. F222 52005773 DT. 23.02.2022 SB NO.: 8463761 DT.: 24/02/22<br/>
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
6062
KG
40
PKG
0
USD
MAEU218335970
2022-06-08
652700 GLENMARK PHARMACEUTICALS INC US GLENMARK PHARMACEUTICALS LTD 40 PALLETS 2000 CARTONS P HARMACEUTICALS AS UNDER NOR GEST/EE 0.18,0.215,0.25/0.035M G 84 NDC CODE:68462056529 FD A PRODUCT CODE NO.: 65 J D A 27 H. T. S NO.: 3006.60.00.0 0 ANDA NO.: 200494 THERAPEUT ICE USE: - ORAL CONTRACEPTIVE S COMMERCIAL & CUSTOM INVOI CE NO. F22352000512 DT. 11.05 .2022 S/BILL NO:1324415 DT 11 -MAY-2022 NET WT: 5,880.00 KGS 02 DATA LOGGERS SET TE MPERATURE : +18 DEGREES NOT IFY PARTY:2 GLENMARK PHARMACE UTICALS INC 750, CORPORATE DR IVE, NEW JERSEY MAHWAH - 074 30 USA<br/>
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
7458
KG
40
PKG
0
USD
MAEU216796759
2022-03-24
652700 GLENMARK PHARMACEUTICALS INC US GLENMARK PHARMACEUTICALS LTD 1X40 REF 1966 CARTONS PACKED IN 40 PALLETS PHARMACEUTICALS AS UNDER NORGEST/EE 0.18,0.2 15,0.25/0.035MG 84 NDC CODE:6 8462056529 FDA PRODUCT CODE N O.: 65 J D A 27 H. T. S NO.: 3006.60.00.00 ANDA NO.: 200 494 THERAPEUTICE USE: - ORAL CONTRACEPTIVES NORGEST/EE 0. 25/0.035MG 84 NDC CODE:6846 2030929 FDA PRODUCT CODE NO.: 65 J D A 27 H. T. S NO.: 3 006.60.00.00 ANDA NO.: 200538 THERAPEUTICE USE: - ORAL CO NTRACEPTIVES NORGEST/EE 0.25/ 0.035MG 84 NDC CODE:684620309 29 FDA PRODUCT CODE NO.: 65 J D A 27 H. T. S NO.: 3006.6 0.00.00 ANDA NO.: 200538 THE RAPEUTICE USE: - ORAL CONTRAC EPTIVES NET WT.: 5898.00 KGS GROSS WT.: 7521.61 KGS COMME RCIAL & CUSTOM INVOICE NO. F2 2252005658 DT. 15.02.2022 F22 252005745 DT. 21.02.2022 F222 52005746 DT. 21.02.2022 SB NO.: 8265334 DT.: 16/02/22 SB NO.: 8418073 DT.: 22/02/22 S B NO.: 8422454 DT.: 22/02/22 03 DATA LOGGERS SET TEMPERA TURE : +20 DEGREES CONTAINE R NO.: MNBU0513120 MANUFACT URE D FOR GLENMARK PHARMACE UTICAL S INC., USA 301, ISLA ND RD MAHWAH<br/>
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
7522
KG
10
PKG
0
USD
MAEU216471482
2022-03-09
642800 GLENMARK PHARMACEUTICALS INC US GLENMARK PHARMACEUTICALS LTD 1 X 40 FCL REEFER CONTAINER 45 PALLETS CONSISTING OF 282 1 CARTONS PHARMACEUTICALS AS UNDER ESTRADIOL VAG INSERTS USP 10MCG 8 S NDC CODE: 68 462071171 FDA PRODUCT CODE NO .: 64 G C A 28 H. T. S NO.: 3006.60.00.00 ANDA NO.:21026 4 THERAPEUTICE USE:THE TREAT MENT OF ATROPIC VAGINITIS DUE TO MENOPAUSE. GABAPENTIN TA BLETS 600MG 500 S NDC CODE: 68462012605 FDA PRODUCT CODE NO: 61 N C A 69 H. T. S NO. : 3004.90.92.30 ANDA NO.:-77 -662 THERAPEUTICE USE:-ANTIC ONVULSANT AGENT NAPROXEN TAB LETS 500MG 500 S NDC CODE: 68462019005 FDA PRODUCT CODE NO.:-62 G C A 49 H. T. S NO. : 3004.90.92.40 ANDA NO.:-78 -250 THERAPEUTICE USE:-ANTI- INFLAMMATORY, ANALGESIC 02 D ATA LOGGERS SET TEMPERATURE : +20 DEGREES COMMERCIAL & C USTOM INVOICE NO. F2225200556 6 DT. 07.02.2022 F2225200556 7 DT. 07.02.2022 F2225200556 8 DT. 07.02.2022 TOTAL NET.W T. 11031.92KGS SBILL NO 808 1445 DT 08-FEB-2022 8081704 D T 08-FEB-2022 8081645 DT 08-F EB-2022<br/>
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
12738
KG
45
PKG
0
USD
MAEU914081948
2022-04-20
642800 GLENMARK PHARMACEUTICALS INC US GLENMARK PHARMACEUTICALS LTD 41 PALLETS 1568 CARTONS P HARMACEUTICALS AS UNDER EST RADIOL VAG INSERTS USP 10MCG 1 8 S NDC CODE:68462071188 NDC NO.:68462071188 FDA PRODUCT CODE NO.: 64 G C A 28 H. T. S NO.: 3006.60.00.00 ANDA NO .:210264 THERAPEUTICE USE:THE TREATMENT OF ATROPIC VAGINI TIS DUE TO MENOPAUSE. DESM OPRESSIN ACETATE TABLETS 0.2MG 100S NDC CODE:68462027601 F DA PRODUCT CODE NO.: 61QCA03 H. T. S NO.: 2937.19.0000 A NDA NO.:201831 THERAPEUTICE U SE: - MANAGEMENT OF CENTRAL DIABETES INSIPIDUS AND TEMPOR ARY POLYURIA AND POLYDIPSIA ASHLYNA LEVO/EE 0.15/0.03MG 182 NDC CODE:68462064693 FDA PRODUCT CODE NO.: 64 G D A 2 H. T. S NO.: 3006.60.0000 ANDA NO.: 203163 THERAPEUTICE USE: - INDICATED FOR USE BY WOMEN TO PREVENT PREGNANCY GABAPENTIN TABLETS 800MG 500 S NDC CODE:68462012705 FDA PRODUCT CODE NO : 61 N C A 69 H. T. S NO.: 3004.90.92.30 ANDA NO.:-77-662 THERAPEUTIC E USE:-ANTICONVULSANT AGENT COMMERCIAL & CUSTOM INVOICE NO. F22252006158 DT. 22.03.2 022 F22252006148 DT. 21.03.20 22 F22252006153 DT. 21.03.202 2 S/BILL NO: 9120133 DT:22-MA R-22 S/BILL NO: 9120061 DT :22-MAR-22 S/BILL NO: 9120267 DT:22-MAR-22 02 DATA LOGGER S HUMIDITY:65% SET TEMPERATU RE : +18 DEGREES TEMPERATURE RANGE : +15 DEGREES TO +25 DEG REES NET WT.: 9,712.12 KGS NOTIFY PARTY:2 GLENMARK PHA RMACEUTICALS INC 750, CORPORA TE DRIVE, NEW JERSEY MAHWAH - 07430 USA<br/>
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
11046
KG
41
PKG
0
USD
MAEU214625872
2021-12-08
642800 GLENMARK PHARMACEUTICALS INC US GLENMARK PHARMACEUTICALS LTD 1 X 40 PART OF FCL REEFER CONT AINER 10 PALLETS CONSISTING OF 199 CARTONS PHARMACEUTICA LS AS UNDER FLUOCINONIDE CREAM 0.1% 120GM NDC CODE:68 462050566 FDA PRODUCT CODE N O.: 64 L C L 28 H. T. S NO .: 3004.32.00.00 ANDA NO.: 91-282 THERAPEUTICE USE: - INDICATED FOR THE RELIEF OF VARIOUS INFLAMMATORY AND P RURITIC MANIFESTATIONS OF CO RTICOSTEROID RESPONSIVE DERM ATOSES IN PATIENTS. FLUOCI NONIDE CREAM 0.1% 60GM NDC C ODE:68462050565 FDA PRODUCT CODE NO.: 64 L C L 28 H. T . S NO.: 3004.32.00.00 AND A NO.: 91-282 THERAPEUTICE U SE: - INDICATED FOR THE RELI EF OF VARIOUS INFLAMMATORY A ND PRURITIC MANIFESTATIONS O F CORTICOSTEROID RESPONSIVE DERMATOSES IN PATIENTS. CLOBETASOL PROP SOLUTION 0. 05% 50ML NDC CODE:6846205325 3 FDA PRODUCT CODE NO.: 64 L C L 67 H. T. S NO.: 300 4.90.92.45 ANDA NO.: 210190 THERAPEUTICE USE: - GLUCOC ORTICOID / HUMAN - RX/SINGLE INGREDIENT / NONSTERILE LIQ UID / CLOBETASOL PROPIONATE (GLUCOCORTICOID) HYDROC ORTISONE VAL OINTMENT 0.2% 15G M NDC CODE:68462083617 FDA PRODUCT CODE NO.: 64 L C L 71 H. T. S NO.: 3004.49.00 .50 ANDA NO.: 211750 THERA PEUTICE USE: - INDICATED FOR THE RELIEF OF THE INFLAMMAT ORY AND PRURITIC MANIFESTATI ONS OF CORTICOSTEROID RESPON SIVE DERMATOSES IN ADULT P ATIENTS 07 DATA LOGGERS SE T TEMPERATURE : +20 DEGREES TEMPERATURE RANGE : +15 DEGREE S TO +25 DEGREES COMMERCIAL & CUSTOM INVOICE NO. F222350 02998 DT. 31.10.2021 F222350 03000 DT. 31.10.2021 F222350 03004 DT. 31.10.2021 TOTAL G R.WT.:1796.71KGS TOTAL NT.WT .:922.56 KGS SBILL NO. DT. 5825919 05-11 -21 5825940 05-11-21 5 797455 03-11-21 NOTIFY PARTY:2 GLENMARK PHARMACEUTI CALS INC 750, CORPORATE DRIVE , NEW JERSEY MAHWAH - 07430 USA<br/>
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
1797
KG
10
PKG
0
USD
MAEU218466073
2022-06-08
642800 GLENMARK PHARMACEUTICALS INC US GLENMARK PHARMACEUTICALS LTD 40 PALLETS 1716 CARTONS P HARMACEUTICALS AS UNDER EST RADIOL VAG INSERTS USP 10MCG 1 8 S NDC CODE:68462071188 NDC NO.:68462071188 FDA PRODUCT CODE NO.: 64 G C A 28 H. T. S NO.: 3006.60.00.00 ANDA NO .:210264 THERAPEUTICE USE:THE TREATMENT OF ATROPIC VAGINI TIS DUE TO MENOPAUSE. ESTR ADIOL VAG INSERTS USP 10MCG 8 S NDC CODE:68462071171 FDA P RODUCT CODE NO.: 64 G C A 28 H. T. S NO.: 3006.60.00.00 ANDA NO.:210264 THERAPEUTICE USE:THE TREATMENT OF ATROPIC VAGINITIS DUE TO MENOPAUSE. ESTRADIOL VAG INSERTS USP 1 0MCG 8 S NDC CODE:68462071171 FDA PRODUCT CODE NO.: 64 G C A 28 H. T. S NO.: 3006.60. 00.00 ANDA NO.:210264 THERAP EUTICE USE:THE TREATMENT OF A TROPIC VAGINITIS DUE TO MENO PAUSE. NORGEST/EE 0.25/0.03 5MG 84 NDC CODE:68462030929 FDA PRODUCT CODE NO.: 65 J D A 27 H. T. S NO.: 3006.60.00 .00 ANDA NO.: 200538 THERAPE UTICE USE: - ORAL CONTRACEPTI VES INV NO: F22352000401 DT. 30.04.2022 INV NO: F22352 000472 DT. 06.05.2022 INV NO: F22352000473 DT. 06.05.2022 S/BILL NO:1279038 DT: 09/05/20 22 S/BILL NO:1276595 DT:09/05 /2022 S/BILL NO:1276586 DT: 09/05/2022 NET WT: 4,528.6 1 KGS 04 DATA LOGGERS SET TEMPERATURE : +18 DEGREES N OTIFY PARTY:2 GLENMARK PHARMA CEUTICALS INC 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 0 7430 USA<br/>
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
5935
KG
40
PKG
0
USD
MAEU214629272
2021-12-08
642800 GLENMARK PHARMACEUTICALS INC US GLENMARK PHARMACEUTICALS LTD 1 X 40 PART OF FCL REEFER CONT AINER 24 PALLETS CONSISTING OF 695 CARTONS PHARMACEUTICA LS AS UNDER ESTRADIOL VAG IN SERTS USP 10MCG 18 S NDC COD E:68462071188 NDC NO.:684620 71188 FDA PRODUCT CODE NO.: 64 G C A 28 H. T. S NO.: 3006.60.00.00 ANDA NO.:2102 64 THERAPEUTICE USE:THE TR EATMENT OF ATROPIC VAGINITIS DUE T ESTRADIOL VAG INSE RTS USP 10MCG 18 S NDC CODE: 68462071188 NDC NO.:68462071 188 FDA PRODUCT CODE NO.: 64 G C A 28 H. T. S NO.: 3 006.60.00.00 ANDA NO.:210264 THERAPEUTICE USE:THE TREA TMENT OF ATROPIC VAGINITIS D UE TO MENOPAUSE. LIDOCA INE OINTMENT JAR 5% 50GM NDC CODE:68462041827 FDA PRODUC T CODE NO.:60 Q C J 07 H. T. S NO.: 3004.49.00.50 AN DA NO.:206498 THERAPEUTICE U SE: -USED TO TEMPORARILY REL IEVE PAIN AND ITCHING ASSO CIATED WITH SKIN 05 DAT A LOGGERS SET TEMPERATURE : +20 DEGREES TEMPERATURE RANG E : +15 DEGREES TO +25 DEGREES COMMERCIAL & CUSTOM INVOICE NO. F22252004069 DT. 03.11.2 021 F22252004070 DT. 03.11.2 021 F22252004074 DT. 03.11.2 021 SBILL NOS DT. 5827009 0 5-NOV-21 5827010 05-NOV-21 5 828596 05-NOV-21 TOTAL G R.WT.:3828.18 KGS TOTAL NT.W T:3058.16 KGS<br/>
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
3828
KG
24
PKG
0
USD
MAEU608906311
2022-03-02
642800 GLENMARK PHARMACEUTICALS INC US GLENMARK PHARMACEUTICALS LTD 1 X 40 FCL REEFER PHARMACEUTI CALS 41 PALLETS CONSISTING OF 2446 CARTONS AS UNDER ES TRADIOL VAG INSERTS USP 10 MCG 8 S NDC CODE: 68462071 171 FDA PRODUCT CODE NO.: 64 G C A 28 H. T. S NO.: 3006.60.00.00 ANDA NO.:2102 64 THERAPEUTICE USE:THE TR EATMENT OF ATROPIC VAGINITIS DUE TO MENOPAUSE. DESMOPR ESSIN ACETATE TABLETS 0.2M G 100S NDC CODE:68462027601 FDA PRODUCT CODE NO.: 61QC A03 H. T. S NO.: 2937.19.0 000 ANDA NO.:201831 THERAP EUTICE USE: - MANAGEMENT OF CENTRAL DIABETES INSIPIDUS A ND TEMPORARY POLYURIA AND POLYDIPSIA DROSPIRENONE/EE 3.0/0.03MG 84 NDC CODE: 6 8462073329 FDA PRODUCT CODE NO.: 65 J D A 39 H. T. S N O.: 3006.60.00.00 ANDA NO. : 204848 THERAPEUTICE USE: - CONTRACEPTION TO PREVENT PREGNANCY 03 DATA LOGGERS SET TEMPERATURE : +20 DEGR EES COMMERCIAL & CUSTOM INVOICE NO. F22252005475 D T. 31.01.2022 F22252005489 DT. 31.01.2022 F22252005495 DT. 31.01.2022 TOTAL NET WT. :5174.25KGS SBILL NOS. DT. 7934626 DT 02-F EB-2022 7934341 DT 02-FEB-202 2<br/>
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
6916
KG
41
PKG
0
USD
MAEU217545827
2022-04-27
642800 GLENMARK PHARMACEUTICALS INC US GLENMARK PHARMACEUTICALS LTD 25 PALLETS 1630 CARTONS PHARMACEUTICALS AS UNDER ESTRADIOL VAG INSERT S USP 10MCG 8 S NDC CODE:6846 2071171 FDA PRODUCT CODE NO.: 64 G C A 28 H. T. S NO.: 3 006.60.00.00 ANDA NO.:210264 THERAPEUTICE USE:THE TREATME NT OF ATROPIC VAGINITIS DUE T O MENOPAUSE. VIORELE DESO/ EE-EE .15/.02-.01MG 84 NDC CO DE:68462031829 FDA PRODUCT CO DE NO.: 64 G D A 27 H. T. S NO.: 3004.39.00.50 ANDA NO.: 091346 THERAPEUTICE USE: - O RAL CONTRACEPTIVES LEVONOR GESTREL/EE 0.09/0.02MG 84 NDC CODE:68462063729 FDA PRODUCT CODE NO.: 64 G D A 29 H. T. S NO.: 3006.60.0000 ANDA NO .: 202791 THERAPEUTICE USE: - : USED FOR PREVENTING PREGN ANCY NORETHINDRONE ACE/EE T AB 0.5MG/2.5MCG 84 NDC CODE:6 8462065629 FDA PRODUCT CODE N O.: 65 J D A 25 H. T. S NO.: 3006.60.00.00 ANDA NO.: 203 038 THERAPEUTICE USE: - TREA TMENT OF MODERATE TO SEVERE V ASOMOTOR SYMPTOMS DUE TO MEN OPAUSE; OSTEOPOROSIS PREVENTI ON NORETHINDRONE ACE/EE TAB S 1/0.005MG 90 NDC CODE:68462 065790 FDA PRODUCT CODE NO.: 65 J D A 25 H. T. S NO.: 30 06.60.00.00 ANDA NO.: 203038 THERAPEUTICE USE: - TREATMEN T OF MODERATE TO SEVERE VASOM OTOR SYMPTOMS DUE TO MENOPAU SE; OSTEOPOROSIS PREVENTION COMMERCIAL & CUSTOM INVOICE NO. F22252006289 DT. 30.03.20 22 F22252006339 DT. 31.03.202 2 F22252006368 DT. 31.03.2022 S/BILL NO: 9426141 DT:01-APR -22 S/BILL NO: 9426027 DT:01- APR-22 S/BILL NO: 9426166 DT: 01-APR-22 NET WT. 3,369.64 KG S NOTIFY PARTY:2 GLENMARK PH ARMACEUTICALS INC 750, CORPOR ATE DRIVE, NEW JERSEY MAHWAH - 07430 USA<br/>
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
4437
KG
25
PKG
0
USD
MAEU217983079
2022-05-18
653900 GLENMARK PHARMACEUTICALS INC US GLENMARK PHARMACEUTICALS LTD 25 PALLETS 1216 CARTONS PHARMACEUTICALS AS UNDER DROSPIRENONE/EE 3. 0/0.02MG 84 NDC CODE:68462072 029 FDA PRODUCT CODE NO.: 65 J D A 39 H. T. S NO.: 3006. 60.00.00 ANDA NO.: 204296 TH ERAPEUTICE USE: - ORAL CONTRA CEPTIVE 01 DATA LOGGERS SET TEMPERATURE : +18 DEGREE S COMMERCIAL & CUSTOM INVOI CE NO. F22352000228 DT. 22.04 .2022 S/BILL NO: 9894475 DT:2 3-APR-22 NET WT: 2503.99 KGS NOTIFY PARTY:2 GLENMARK PHA RMACEUTICALS INC 750, CORPORA TE DRIVE, NEW JERSEY MAHWAH - 07430 USA<br/>
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
3556
KG
25
PKG
0
USD
MAEU217895027
2022-05-18
653900 GLENMARK PHARMACEUTICALS INC US GLENMARK PHARMACEUTICALS LTD 15 PALLETS 750 CART ONS PHARMACEUTICALS AS UNDER DROSPIRENONE/EE 3.0/0.02MG 84 NDC CODE:68462072029 FDA PRODUCT CODE NO.: 65 J D A 39 H. T. S NO.: 3006.60.00.00 ANDA NO.: 204296 THERAPEUTIC E USE: - ORAL CONTRACEPTIVE COMMERCIAL & CUSTOM INVOICE NO. F22352000240 DT. 22.04.20 22 S/BILL NO:9894467 DT: 23. 04.2022 NET WT: 1,555.20 KG S 01 DATA LOGGERS SET TEMPER ATURE : +18 DEGREES NOTIFY PA RTY:2 GLENMARK PHARMACEUTICAL S INC 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 US A<br/>
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
2222
KG
15
PKG
0
USD
MAEU217385008
2022-04-20
646700 GLENMARK PHARMACEUTICALS INC US GLENMARK PHARMACEUTICALS LTD 24 PALLETS 495 CARTO NS PHARMACEUTICALS AS UNDER CLOBETASOL PROP SOLUTION 0.0 5% 50ML NDC CODE:68462053253 FDA PRODUCT CODE NO.: 64 L C L 67 H. T. S NO.: 3004.90.9 2.45 ANDA NO.: 210190 THERAP EUTICE USE: - GLUCOCORTICOID / HUMAN - RX/SINGLE INGREDIEN T / NONSTERILE LIQUID / CLOB ETASOL PROPIONATE (GLUCOCORTI COID) CLOBETASOL PROP SOLUT ION 0.05% 50ML NDC CODE:68462 053253 FDA PRODUCT CODE NO.: 64 L C L 67 H. T. S NO.: 30 04.90.92.45 ANDA NO.: 210190 THERAPEUTICE USE: - GLUCOCOR TICOID / HUMAN - RX/SINGLE IN GREDIENT / NONSTERILE LIQUID / CLOBETASOL PROPIONATE (GLU COCORTICOID) COMMERCIAL & C USTOM INVOICE NO. F2223500526 1 DT. 18.03.2022 F22235005273 DT. 21.03.2022 S/BILL NO: 9 054625 DT:19/03/2022 S/BILL NO: 9180281 DT:24/03/2022 NE T WT: 2,376.00 KGS 24 DATA LOGGERS SET TEMPERATURE : +18 DEGREES NOTIFY PARTY:2 GL ENMARK PHARMACEUTICALS INC 75 0, CORPORATE DRIVE, NEW JERSE Y MAHWAH - 07430 USA<br/>
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
4720
KG
24
PKG
0
USD
MAEU216806221
2022-03-24
646700 GLENMARK PHARMACEUTICALS INC US GLENMARK PHARMACEUTICALS LTD 1X40 REF 861 CARTONS PACKED I N 42 PALLETS PHARMACEUTICALS AS UNDER CLOBETASOL PROP SOLU TION 0.05% 50ML NDC CODE:6846 2053253 FDA PRODUCT CODE NO.: 64 L C L 67 H. T. S NO.: 3 004.90.92.45 ANDA NO.: 210190 THERAPEUTICE USE: - GLUCOCO RTICOID / HUMAN - RX/SINGLE I NGREDIENT / NONSTERILE LIQU ID / CLOBETASOL PROPIONATE ( GLUCOCORTICOID) MOMETASONE FU ROATE OINTMENT 0.1% 15GM NDC CODE:68462022517 FDA PRODUCT CODE NO.: 62 F C J 53 H. T. S NO.: 3004.40.49.50 ANDA NO .:78-571 THERAPEUTICE USE: A NTI-INFLAMMATORY- DERMATOLOGI C NYSTATIN-TRIAM 100K UNIT/0. 1% CREAM 15GM NDC CODE:684620 31417 FDA PRODUCT CODE NO.: 64 L D J 61 H. T. S NO.: 300 4.40.0050 ANDA NO.: 208136 T HERAPEUTICE USE: - TREATMENT OF FUNGAL INFECTIONS OF THE S KIN, ESPECIALLY YEAST INFECT IONS. NYSTATIN-TRIAM 100K UNI T/0.1% OINT 15GM NDC CODE:684 62079917 FDA PRODUCT CODE NO. : 64 L D J 60 H. T. S NO.: 3004.49.00.50 ANDA NO.: 20830 0 THERAPEUTICE USE: - TREA TMENT OF FUNGAL INFECTIONS OF THE SKIN, ESPECIALLY YEAST INFECTIONS. NYSTATIN-TRIAM 10 0K UNIT/0.1% OINT 30GM NDC CO DE:68462079935 FDA PRODUCT CO DE NO.: 64 L D J 60 H. T. S NO.: 3004.49.00.50 ANDA NO.: 208300 THERAPEUTICE USE: - TREATMENT OF FUNGAL INFECTION S OF THE SKIN, ESPECIALLY YEA ST INFECTIONS. CLOBETASOL PR OP SOLUTION 0.05% 50ML NDC CO DE:68462053253 FDA PRODUCT CO DE NO.: 64 L C L 67 H. T. S NO.: 3004.90.92.45 ANDA NO.: 210190 THERAPEUTICE USE: - GLUCOCORTICOID / HUMAN - RX/S INGLE INGREDIENT / NONSTERILE LIQUID / CLOBETASOL PROPIONA TE (GLUCOCORTICOID) TRIAMCIN OLONE ACE OINT 0.5% 15GM NDC CODE:68462079817 FDA PRODUCT CODE NO.:64 L C J 61 T. S NO.: 3004.49.00.50 ANDA NO.: 206379 THERAPEUTICE USE: - R EDUCES THE SWELLING, ITCHING, AND REDNESS OF SKIN TRIAMCI NOLONE ACE OINT 0.5% 15GM NDC CODE:68462079817 FDA PRODUCT CODE NO.:64 L C J 61 H. T. S NO.: 3004.49.00.50 ANDA NO .:206379 THERAPEUTICE USE: - REDUCES THE SWELLING, ITCHIN G, AND REDNESS OF SKIN NET W T.: 3046.85 KGS GROSS WT.: 83 73.58 KGS COMMERCIAL & CUSTOM INVOICE NO. F22235004705 DT. 14.02.2022 F22235004711 DT. 14.02.2022 F22235004712 DT. 1 4.02.2022 F22235004734 DT. 16 .02.2022 F22235004769 DT. 18. 02.2022 SB NO.: 8242942 DT. : 15/02/22 SB NO.: 8242987 DT .: 15/02/22 SB NO.: 8242994 D T.: 15/02/22 SB NO.: 8286010 DT.: 17/02/22 SB NO.: 8337852 DT.: 18/02/22 42 DATA LOGG ERS HUMIDITY:65% SET TEMPERA TURE : +20 DEGREES TEMPERATUR E RANGE : +15 DEGREES TO +25 D EGREES CONTAINER NO. MANUFAC TURE D FOR GLENMARK PHARMAC EUTICAL S INC., USA 301, ISL AND RD MAHWAH<br/>
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
8373
KG
10
PKG
0
USD
MAEU216806230
2022-03-24
646700 GLENMARK PHARMACEUTICALS INC US GLENMARK PHARMACEUTICALS LTD 1X40 REF 485 CARTONS PACKED I N 21 PALLETS PHARMACEUTICAL S AS UNDER CLOBETASOL PROP SOLUTION 0.05% 50ML NDC CODE: 68462053253 FDA PRODUCT CODE NO.: 64 L C L 67 H. T. S NO. : 3004.90.92.45 ANDA NO.: 21 0190 THERAPEUTICE USE: - GLU COCORTICOID / HUMAN - RX/SING LE INGREDIENT / NONSTERILE LI QUID / CLOBETASOL PROPIONATE (GLUCOCORTICOID) CLOBETASO L PROP SOLUTION 0.05% 25ML ND C CODE:68462053228 FDA PRODUC T CODE NO.: 64 L C L 67 H. T . S NO.: 3004.90.92.45 ANDA NO.: 210190 THERAPEUTICE USE: - GLUCOCORTICOID / HUMAN - RX/SINGLE INGREDIENT / NONSTE RILE LIQUID / CLOBETASOL PROP IONATE (GLUCOCORTICOID) FL UOCINOLONE ACE BODY OIL 0.01% 118ML NDC CODE:68462059189 F DA PRODUCT CODE NO.: 64 L C L 27 H. T. S NO.: 3004.49.00. 50 ANDA NO.: 210556 SYNTHETI C CORTICOSTEROID FOR TOPICAL DERMATOLOGIC USE FOR THE TREA TMENT OF PSORIASIS OF THE SCA LP NYSTATIN-TRIAM 100K UNIT /0.1% OINT 15GM NDC CODE:6846 2079917 FDA PRODUCT CODE NO.: 64 L D J 60 H. T. S NO.: 3 004.49.00.50 ANDA NO.: 208300 THERAPEUTICE USE: - TREATME NT OF FUNGAL INFECTIONS OF TH E SKIN, ESPECIALLY YEAST INF ECTIONS. NYSTATIN-TRIAM 100 K UNIT/0.1% OINT 60GM NDC COD E:68462079965 FDA PRODUCT COD E NO.: 64 L D J 60 H. T. S N O.: 3004.49.00.50 ANDA NO.: 208300 THERAPEUTICE USE: - T REATMENT OF FUNGAL INFECTIONS OF THE SKIN, ESPECIALLY YEAS T INFECTIONS. MOMETASONE F UROATE CREAM 0.1% 45GM NDC CO DE:68462019255 FDA PRODUCT CO DE NO.: 62 F C J 53 H. T. S NO.: 3004.40.49.50 ANDA NO.: 78-541 THERAPEUTICE USE: ANT I-INFLAMMATORY- DERMATOLOGIC FLUOCINOLONE ACE SCALP OIL 0.01% 118ML NDC CODE:68462059 089 FDA PRODUCT CODE NO.: 64 L C L 27 H. T. S NO.: 3004. 49.00.50 ANDA NO.: 210539 SY NTHETIC CORTICOSTEROID FOR TO PICAL DERMATOLOGIC USE FOR TH E TREATMENT OF PSORIASIS OF T HE SCALP GROSS WT. : 4,035. 32 KGS NET WT.: 2,019.00 KG S COMMERCIAL & CUSTOM INVOI CE NO. F22235004770 DT. 18.02 .2022 F22235004795 DT. 19.02. 2022 F22235004837 DT. 22.02.2 022 SB NO.: 8337857 DT.: 18 /02/2022 SB NO.: 8391230 DT.: 21/02/2022 SB NO.: 8435491 D T.: 23/02/2022 21 DATA LO GGERS HUMIDITY:65% SET TEMPE RATURE : +20 DEGREES TEMPERAT URE RANGE : +15 DEGREES TO +25 DEGREES CONTAINER NO. MNBU3 560002 MANUFACTURE D FOR GLENMARK PHARMACEUTICAL S IN C., USA 301, ISLAND RD MAHWA H<br/>
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
4035
KG
10
PKG
0
USD
MAEU214781163
2021-12-14
646700 GLENMARK PHARMACEUTICALS INC US GLENMARK PHARMACEUTICALS LTD 1X 40 PART OF FCL REEFER 16 PALLETS CONSISTING OF324 CARTO NS PHARMACEUTICALS AS UNDER CLOBETASOL PROP SOLUTION 0.0 5% 50ML NDC CODE:68462053253 FDA PRODUCT CODE NO.: 64 L C L 67 H. T. S NO.: 3004 .90.92.45 ANDA NO.: 210190 16 DATA LOGGERS SET TEMPERA TURE : +20 DEGREES TEMPERATU RE RANGE : +15 DEGREES TO +25 DEGREES COMMERCIAL & CUSTOM INVOICE NO. F22235003089 DT. 12.11.2021 SBILL NO. DT. TOTAL GR.WT.:3094.46KGS TOTAL NT. WT.:1555.20KGS<br/>
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
3094
KG
16
PKG
0
USD
MAEU216632828
2022-03-16
201500 GLENMARK PHARMACEUTICALS INC US GLENMARK PHARMACEUTICALS LTD 1X40 REF HC 2015 CARTONS PHA RMACEUTICALS AS UNDER EZETIMI BE-SIMVASTATIN TAB 10/20MG 30 S NDC CODE:68462032230 FDA P RODUCT CODE NO.: 61 J D C 15 H. T. S NO.: 3004.49.00.10 AN DA NO.: 208699 THERAPEUTICE U SE: - THIS COMBINATION MEDICAT ION IS USED TO HELP LOWER BAD CHOLESTEROL AND FATS (SUCH A S LDL, TRIGLYCERIDES) AND RAIS E EZETIMIBE-SIMVASTATIN TAB 1 0/40MG 90 S NDC CODE:68462032 390 FDA PRODUCT CODE NO.: 61 J D C 15 H. T. S NO.: 3004.49 .00.10 ANDA NO.: 208699 THERA PEUTICE USE: - THIS COMBINATI ON MEDICATION IS USED TO HELP LOWER BAD CHOLESTEROL AND FAT S (SUCH AS LDL, TRIGLYCERIDES ) AND RAISE PRAVASTATIN SODIU M TAB 80MG 90 S NDC CODE:6846 2019890 FDA PRODUCT CODE NO.: -61 J C A 13 H. T. S NO.: 300 4.90.92.20 ANDA NO.:-77-987 T HERAPEUTICE USE:-HYPOLIPDAEMI C PRAVASTATIN SODIUM TAB 20 MG 90 S NDC CODE:68462019690 FDA PRODUCT CODE NO.:-61 J C A 13 H. T. S NO.: 3004.90.9 2.20 ANDA NO.:-77-987 THERAP EUTICE USE:-HYPOLIPDAEMIC VORICONAZOLE TABLETS 200MG 30 S NDC CODE:68462057330 FDA P RODUCT CODE NO.:61 W C A 59 H . T. S NO.: 3004.90.92.10 AND A NO.:203503 THERAPEUTICE USE : -USED TO TREAT FUNGAL INFEC TIONS FENOFIBRATE CAPSULES 67 MG 100 S NDC CODE:68462058001 FDA PRODUCT CODE NO.: 61 JCE 09 H. T. S NO.: 3004.90.92.2 0 ANDA NO.: 205566 THERAPEUT ICE USE: - INDICATED AS ADJUNC TIVE THERAPY TO DIET FOR THE REDUCTION OF LDL-C, TOTAL-C, TRIGLYCERIDES AND APO B IN DUL T PATIENTS WITH PRMARY HYPER CHOLESTEROLEMIA OR MIXED DYSLI PIDEMIA AMLODIPINE-OLMESARTAN TABS 5/40MG 30 S NDC CODE:68 462056830 FDA PRODUCT CODE NO.: 62 C D A 68 H. T. S NO.: 3004.90.92.20 ANDA NO.: 2078 07 THERAPEUTICE USE: MEDICATI ON USED TO TREAT HIGH BLOOD P RESSURE AND CORONARY ARTERY DI SEASE PIMECROLIMUS CREAM 1% 3 0GM NDC CODE:68462060935 FDA PRODUCT CODE NO.: 61 S C J 04 H. T. S NO.: 3004.90.92.45 ANDA NO.: 211769 THERAPEUTICE USE: - AS SECOUND-LINE THERAP Y FOR THE SHORT-TERM AND NON- CONTINUOS CHRONIC TRERTMENT O F MILD TO MODERATE ATOPIC DER MATITIS IN NONIMMUNOCOMPROMISE D ADULT AND CHILDREN 2 YEARS OF AGE AMLODIPINE-OLMESARTAN TABS 10/40MG 90 S NDC CODE:68 462056990 FDA PRODUCT CODE NO .: 62 C D A 68 H. T. S NO.: 3 004.90.92.20 ANDA NO.: 207807 THERAPEUTICE USE: MEDICATION USED TO TREAT HIGH BLOOD PRE SSURE AND CORONARY ARTERY DISE ASE COMMERCIAL & CUSTOM INV OICE NO. F22287001811 DT. 14. 02.2022 F22287001813 DT. 14.0 2.2022 F22287001814 DT. 14.02 .2022 F22287001815 DT. 15.02. 2022 SB NO.: 4002236 DT.: 1 5-02-22 SB NO.: 4002233 DT.: 15-02-22 SB NO.: 4002235 DT.: 15-02-22 SB NO.: 4002225 DT. : 15-02-22 NET WT: 3,240.09 KGS GROSS WT: 6,630.27 KGS 02 DATA LOGGERS SET TEMPERA TURE : +20 DEGREES<br/>
INDIA
UNITED STATES
52330, SALALAH
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
6630
KG
32
PKG
0
USD
MAEU914105094
2022-04-27
621800 GLENMARK PHARMACEUTICALS INC US GLENMARK PHARMACEUTICALS LTD 5 PALLETS 161 CARTONS PHAR MACEUTICALS AS UNDER DICLOF ENAC SODIUM GEL 3% 100GM NDC CODE:68462035594 FDA PRODUCT CODE NO.:62 G C J 18 H. T. S NO.: 3004.90.92.40 ANDA NO. :208301 THERAPEUTICE USE: - USED FOR THE RELIEF OF JOINT PAIN OF OSTEOARTHRITIS COMM ERCIAL & CUSTOM INVOICE NO. F 22252006226 DT. 26.03.2022 S/ BILL NO: 9287406 DT:28-MAR-22 NET WT. 978.42 KGS 00 DATA LOGGERS SET TEMPERATURE : +18 DEGREES NOTIFY PARTY: 2 GLENMARK PHARMACEUTICALS INC 750, CORPORATE DRIVE, NE W JERSEY MAHWAH - 07430 USA<br/>
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
1179
KG
5
PKG
0
USD
MAEU218320982
2022-06-08
622200 GLENMARK PHARMACEUTICALS INC US GLENMARK PHARMACEUTICALS LTD 53 PALLETS 3372 CARTONS PH ARMACEUTICALS AS UNDER CARV EDILOL TABS 12.5MG 500 S NDC CODE:68462016405 FDA PRODUCT CODE NO : 62 O C A 22 H. T. S NO.: 3004.90.92.20 ANDA NO .:- 78-251 THERAPEUTICE USE: -BETA- ADRENOACEPTOR ANTAGON IST CARVEDILOL TABS 3.125MG 500 S NDC CODE:68462016205 FDA PRODUCT CODE NO ; 62 O C A 22 H. T. S NO.: 3004.90.92.2 0 ANDA NO.:- 78-251 THERAPEU TICE USE:-BETA-ADRENOACEPTOR ANTAGONIST OMEPRAZOLE DR CA PSULES 40MG 30 S NDC CODE:684 62039730 FDA PRODUCT CODE NO. : 62KCF10 H. T. S NO.: 3004 .90.9160 ANDA NO.: 91672 THE RAPEUTICE USE: - TREATMENT OF TREAT GASTROESOPHAGEAL REFLU X DISEASE ROPINIROLE TABS 0.5MG 100 S NDC CODE:68462025 401 FDA PRODUCT CODE NO.:-62 J C A 17 H. T. S NO.: 3004. 90.92.40 ANDA NO.:- 90-135 T HERAPEUTICE USE:-TREATMENT OF PARKINSONISM INDOMETHACIN CAPS 50MG 500 S NDC CODE:684 62030205 FDA PRODUCT CODE NO. : 62 G C E 42 H. T. S NO.: 3004.90.92.40 ANDA NO.:91-276 THERAPEUTICE USE: ANTI-INFL AMATORY ADAPALENE GEL 0.1% 15GM (PLD) NDC CODE:698420088 05 NDC NO.:69842008805 FDA P RODUCT CODE NO.: 62 S C J 02 H. T. S NO.: 3004.40.00.50 ANDA NO.: 091314 THERAPEUTICE USE: - TREATMENT OF ACNE COMMERCIAL & CUSTOM INVOICE NO . F22352000554 DT. 13.05.2022 F22352000555 DT. 13.05.2022 F22352000556 DT. 13.05.2022 F22352000557 DT. 13.05.2022 F 22352000559 DT. 13.05.2022 S/ BILL NO: 1396876 DT 14-MAY-20 22 S/BILL NO: 1396881 DT 14- MAY-2022 S/BILL NO: 1396855 DT 14-MAY-2022 S/BILL NO: 13 97264 DT 14-MAY-2022 S/BILL N O: 1397019 DT 14-MAY-2022 NE T WT: 7551.23 KGS 04 DATA L OGGERS SET TEMPERATURE : +1 8 DEGREES NOTIFY PARTY:2 GLENMARK PHARMA CEUTICALS INC 750, CO RPORATE DRIVE, NEW JERSEY MAHWAH - 0 7430 USA NOTIFY PARTY:3 P&L DEVELOPMENT, LLC 275 GRAND BLVD NEW YORK WE STBURY USA- 11590 LABELER CODE : 68462:<br/>
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
9554
KG
53
PKG
0
USD
MAEU914167343
2022-05-04
622200 GLENMARK PHARMACEUTICALS INC US GLENMARK PHARMACEUTICALS LTD 46 PALLETS 2575 CART ONS PHARMACEUTICALS AS UNDER CARVEDILOL TABS 6.25MG 500 S NDC CODE:68462016305 FDA P RODUCT CODE NO : 62 O C A 22 H. T. S NO.: 3004.90.92.20 ANDA NO.:- 78-251 THERAPEUTIC E USE:-BETA- ADRENOACEPTOR ANTAGONIST TOPIRAMATE TABLE TS 100MG 500 S NDC CODE:68462 010905 OMEPRAZOLE DR CAPSUL ES 40MG 1000 S NDC CODE:68462 039710 FDA PRODUCT CODE NO.: 62KCF10 H. T. S NO.: 3004.90 .9160 ANDA NO.:91672 THERAPE UTICE USE: - TREATMENT OF TRE AT GASTROESOPHAGEAL REFLUX D ISEASE CARVEDILOL TABS 6.25 MG 100 S NDC CODE:68462016301 FDA PRODUCT CODE NO : 62 O C A 22 H. T. S NO.: 3004.90. 92.20 ANDA NO.:- 78-251 THER APEUTICE USE:-BETA- ADRENOAC EPTOR ANTAGONIST CALCIPOTR IENE OINTMENT 0.005% 60GM NDC CODE:68462031065 FDA PRODUCT CODE NO.: 62 N C J 04 H. T. S NO.: 3004.90.92.45 ANDA N O.: 209297 THIS MEDICATION IS USED TO TREAT PSORIASIS. CA LCIPOTRIENE IS A FORM OF VITA MIN D. IT WORKS BY SLOWING DO WN THE GROWTH OF SKIN CELLS. MUPIROCIN OINTMENT 2% 22GM NDC CODE:68462018022 FDA PRO DUCT CODE NO.: 61 G J J 81 H . T. S NO.: 3004.90.92.45 AN DA NO.: 90-480 THERAPEUTICE U SE: - ANTI-BACTERIAL COMME RCIAL & CUSTOM INVOICE NO. F2 2352000058 DT. 08.04.2022 F22 352000059 DT. 08.04.2022 F223 52000061 DT. 08.04.2022 S/BIL L NO:9592888 DT:09042022 S/BI LL NO:9592875 DT: 09042022 S/ BILL NO:9592943 DT: 09042022 NET WT: 8,564.06 KGS 02 DAT A LOGGERS SET TEMPERATURE : + 18 DEGREES NOTIFY PARTY:2 GLE NMARK PHARMACEUTICALS INC 750, CORPORATE DRIVE, NEW JERSEY M AHWAH - 07430 USA<br/>
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
10246
KG
46
PKG
0
USD
MAEU914132399
2022-05-04
622200 GLENMARK PHARMACEUTICALS INC US GLENMARK PHARMACEUTICALS LTD 48 PALLETS 2299 CARTONS P HARMACEUTICALS AS UNDER CARVE DILOL TABS 3.125MG 100 S NDC CODE:68462016201 FDA PRODUCT CODE NO - 62 O C A 22 H. T. S NO.: 3004.90.92.20 ANDA NO .:- 78-251 THERAPEUTICE USE: -BETA- ADRENOACEPTOR ANTAGON IST LEVOCETIRIZINE DIHY TAB S 5MG 90 S NDC CODE:684620346 90 FDA PRODUCT CODE NO.: 61 X C A 51 H. T. S NO.: 3004.9 0.91.80 ANDA NO.:90385 THERA PEUTICE USE: TREATMENT OF CHR ONIC IDIOPATHIC URTICARIA LITHIUM CARBONATE ER TABS 450M G 100 S NDC CODE:68462022401 FDA PRODUCT CODE NO.: 61 N C B 37 H. T. S NO.: 3004.49.0 0.20 ANDA NO.:91-616 THERAPE UTICE USE: - INDICATED IN THE TREATMENT OF MANIC EPISODES OF BIPOLAR DISORDER. BIPOLA R DISORDER, MANIC (DSM-IV) IS EQUIVALENT TO MANIC DEPRESSI VE ILLNESS, MANIC, IN THE OLD ER DSM-II TERMINOLOGY. ALSO INDICATED AS A MAINTENANCE T REATMENT FOR INDIVIDUALS WITH A DIAGNOSIS OF BIPOLAR DISOR DER. MAINTENANCE THERAPY RED UCES THE FREQUENCY OF MANIC E PISODES AND DIMINISHES THE IN TENSITY OF THOSE EPISODES WHI CH MAY OCCUR. TOPIRAMATE T ABLETS 100MG 60 S NDC CODE:68 462010960 FDA PRODUCT CODE N O.:-61 M C A 40 H. T. S NO.: 3004.49.00.20 ANDA NO.:- 77- 627 THERAPEUTICE USE:-ANTICO NVULSANT LITHIUM CARBONATE CAPS 150MG 100 S NDC CODE:684 62022001 FDA PRODUCT CODE NO .:-61 N C E 37 H. T. S NO.: 3004.49.00.20 ANDA NO.:- 79 - 139 THERAPEUTICE USE:-ANTIMA NIC AGENT CARVEDILOL TABS 3 .125MG 500 S NDC CODE:6846201 6205 FDA PRODUCT CODE NO ; 6 2 O C A 22 H. T. S NO.: 3004 .90.92.20 ANDA NO.:- 78-251 THERAPEUTICE USE:-BETA- ADRE NOACEPTOR ANTAGONIST MUPIR OCIN OINTMENT 2% 22GM NDC COD E:68462018022 FDA PRODUCT COD E NO.: 61 G J J 81 H. T. S N O.: 3004.90.92.45 ANDA NO.: 90-480 THERAPEUTICE USE: - A NTI-BACTERIAL COMMERCIAL & CUSTOM INVOICE NO. F223520000 26 DT. 05.04.2022 F2235200002 7 DT. 05.04.2022 F22352000028 DT. 05.04.2022 F22352000029 DT. 05.04.2022 S/BILL NO: 95 16546 DT: 06-APR-22 S/BILL NO : 9516749 DT:06-APR-22 S/BILL NO: 9516453 DT:06-APR-22 S/B ILL NO: 9516743 DT:06-APR-22 NET WT: 9,033.02 KGS 02 DAT A LOGGERS HUMIDITY:65% SET T EMPERATURE : +18 DEGREES TEMP ERATURE RANGE : +15 DEGREES TO +25 DEGREES NOTIFY PARTY:2 GLENMARK PHARMACEUTICALS INC 750, CORPORATE DRIVE, NEW JER SEY MAHWAH - 07430 USA<br/>
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
11030
KG
48
PKG
0
USD
MAEU218550142
2022-06-15
622200 GLENMARK PHARMACEUTICALS INC US GLENMARK PHARMACEUTICALS LTD 48 PALLETS 2640 CART ONS PHARMACEUTICALS AS UNDER CARVEDILOL TABS 12.5MG 500 S NDC CODE:68462016405 FDA P RODUCT CODE NO : 62 O C A 22 H. T. S NO.: 3004.90.92.20 ANDA NO.:- 78-251 THERAPEUTIC E USE:-BETA-ADRENOACEPTOR AN TAGONIST NAPROXEN TABLETS 2 50MG 100 S NDC CODE:684620188 01 FDA PRODUCT CODE NO.:-62 G C A 49 H. T. S NO.: 3004.9 0.92.40 ANDA NO.:-78-250 THE RAPEUTICE USE:-ANTI-INFLAMMAT ORY, ANALGESIC NAPROXEN TA BLETS 250MG 500 S NDC CODE:68 462018805 FDA PRODUCT CODE N O.:-62 G C A 49 H. T. S NO.: 3004.90.92.40 ANDA NO.:-78-2 50 THERAPEUTICE USE:-ANTI-IN FLAMMATORY, ANALGESIC NAPR OXEN TABLETS 375MG 100 S NDC CODE:68462018901 FDA PRODUCT CODE NO.:-62 G C A 49 H. T. S NO.: 3004.90.92.40 ANDA NO .:-78-250 THERAPEUTICE USE:- ANTI-INFLAMMATORY, ANALGESIC NAPROXEN TABLETS 375MG 500 S NDC CODE:68462018905 FDA P RODUCT CODE NO.:-62 G C A 49 H. T. S NO.: 3004.90.92.40 ANDA NO.:-78-250 THERAPEUTICE USE:-ANTI-INFLAMMATORY, ANA LGESIC VERAPAMIL HCL ER TAB S 120MG 100S NDC CODE:6846202 9201 FDA PRODUCT CODE NO.: 6 2 O C B 13 H. T. S NO.: 3004 .90.92.20 ANDA NO.: 90-700 T HERAPEUTICE USE: - ANGINA OMEPRAZOLE DR CAPSULES 10MG 10 0 S NDC CODE:68462039501 FDA PRODUCT CODE NO.: 62KCF10 H . T. S NO.: 3004.90.9160 AND A NO.: 91672 THERAPEUTICE USE : - TREATMENT OF TREAT GASTR OESOPHAGEAL REFLUX DISEASE OMEPRAZOLE DR CAPSULES 10MG 3 0 S NDC CODE:68462039530 FDA PRODUCT CODE NO.: 62KCF10 H . T. S NO.: 3004.90.9160 AND A NO.: 91672 THERAPEUTICE USE : - TREATMENT OF TREAT GASTR OESOPHAGEAL REFLUX DISEASE ADAPALENE-BPO GEL PUMP 0.1/2. 5% 45GM NDC CODE:68462030147 FDA PRODUCT CODE NO.: 62 S D O 02 H. T. S NO.: 3004.90.9 2.45 ANDA NO.: 208108 THERAP EUTICE USE: - USED ON THE SKI N TO TREAT ACNE MUPIROCIN O INTMENT 2% 22GM NDC CODE:6846 2018022 FDA PRODUCT CODE NO.: 61 G J J 81 H. T. S NO.: 3 004.90.92.45 ANDA NO.: 90-480 THERAPEUTICE USE: - ANTI-BA CTERIAL COMMERCIAL & CUSTOM INVOICE NO. F22352000604 DT. 16.05.2022 F22352000605 DT. 16.05.2022 F22352000606 DT. 1 6.05.2022 S/BILL NO: 1454763 DT: 17-MAY-22 S/BILL NO:1454 691 DT: 17-MAY-22 S/BILL NO:1 454753 DT: 17-MAY-22 NET WT.8 ,233.98 KGS 02 DATA LOGGERS HUMIDITY:65% SET TEMPERATURE : +18 DEGREES TEMPERATURE RAN GE : +15 DEGREES TO +25 DEGREE S NOTIFY PARTY:2 GLENMARK PH ARMACEUTICALS INC 750, CORPOR ATE DRIVE, NEW JERSEY MAHWAH - 07430 USA<br/>
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
9858
KG
48
PKG
0
USD
MAEU216471626
2022-03-09
684620 GLENMARK PHARMACEUTICALS INC US GLENMARK PHARMACEUTICALS LTD 1 X 40 PART OF FCL REEFER 16 PALLETS CONSISTING OF 314 CART ONS PHARMACEUTICALS AS UNDER CLOTRIM-BETAMETHASO NE CRM 1.0/.05% 15GM NDC CODE :68462029817 FDA PRODUCT CODE NO.:61 W D J 04 H. T. S NO.: 3004.90.92. 45 ANDA NO.:202894 T HERAPEUTICE USE: - TREATM ENT A VARIETY OF INFLAMED FUNGAL SKIN INFECTIONS CLOTRIM-BETAMETHASON E CRM 1.0/.05% 45GM NDC CODE: 68462029855 FDA PRODUCT C ODE NO.: 61 W D J 04 H. T. S NO.: 3004.90.92. 45 ANDA NO.: 202894 THERAPEUTICE USE: - TREAT MENT A VARIETY OF INFLAME D FUNGAL SKIN INFECTIONS CLOTRIM-BETAMETHASO NE CRM 1.0/.05% 45GM NDC CODE :68462029855 FDA PRODUCT CODE NO.: 61 W D J 04 H. T. S NO.: 3004.90.92 .45 ANDA NO.: 202894 THERAPEUTICE USE: - TREA TMENT A VARIETY OF INFLAM ED FUNGAL SKIN INFECTIONS 16 DATA LOGG ERS SET TEMPERATURE : + 20 DEGREES COMMERCIAL & CUS TOM INVOICE NO. F22235004575 DT. 03.02.2022 F22235004576 D T. 03.02.2022 TOTAL GR WT .:2835.33KGS TOTAL NT WT:1356 .48KGS SBILL NO. DT. 797 0459 04/02/2022 7970462 04/02/2022<br/>
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
2835
KG
16
PKG
0
USD
MAEU914132397
2022-04-27
684620 GLENMARK PHARMACEUTICALS INC US GLENMARK PHARMACEUTICALS LTD 13 PALLETS 352 CARTONS PHARMACEUTICALS AS UNDER CLOTRIM-BETAMETHASO NE CRM 1.0/.05% 45GM NDC CODE :68462029855 FDA PRODUCT CODE NO.: 61 W D J 04 H. T. S NO .: 3004.90.92.45 ANDA NO.: 2 02894 THERAPEUTICE USE: - TR EATMENT A VARIETY OF INFLAMED FUNGAL SKIN INFECTIONS CL OBETASOL PROP OINTMENT 0.05% 4 5GM NDC CODE:68462053047 FDA PRODUCT CODE NO.: 64 L C J 6 7 H. T. S NO.: 3004.90.92.45 ANDA NO.: 208933 THERAPEUTI CE USE: - INDICATED FOR THE R ELIEF OF THE INFLAMMATORY AND PRURITIC MANIFESTATIONS OF CORTICOSTEROID-RESPONSIVE DER MATOESE CLOBETASOL PROP OIN TMENT 0.05% 30GM NDC CODE:684 62053035 FDA PRODUCT CODE NO. : 64 L C J 67 H. T. S NO.: 3004.90.92.45 ANDA NO.: 20893 3 THERAPEUTICE USE: - INDICA TED FOR THE RELIEF OF THE INF LAMMATORY AND PRURITIC MANIFE STATIONS OF CORTICOSTEROID-RE SPONSIVE DERMATOESE COMMERCI AL & CUSTOM INVOICE NO. F2223 5005315 DT. 24.03.2022 F22235 005316 DT. 24.03.2022 S/BILL NO: 9274327 DT: 28-MAR-22 S/ BILL NO: 9266795 DT:28-MAR-22 NET WT: 1,166.40 KGS 13 D ATA LOGGERS SET TEMPERATURE : +18 DEGREES NOTIFY PARTY:2 GLENMARK SPECIALTY S.A. SWIT ZERLAND (GSSA) PLACE NUMA-DRO Z 2 NEUCHATEL - 2000 SWITZER LAND<br/>
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
2357
KG
13
PKG
0
USD
MAEU215646325
2022-02-03
684620 GLENMARK PHARMACEUTICALS INC US GLENMARK PHARMACEUTICALS LTD 1X 40 PART OF FCL REEFER CONTA INER 4 PALLETS CONSISTING OF 122 CARTONS PHARMACEUTICALS A S UNDER NITROGLYCERIN SUBLING TABS 0.4MG 4X25 NDC CODE :68462063945 FDA PRODUCT CODE NO.: 66 S C A 28 H. T. S NO.: 3004.90.90 20 ANDA NO.:206391 T HERAPEUTIC USE: MEDICATIO N USED FOR HEART FAILURE, HIGH BLOOD PRESSURE,AND T O TREAT AND PREVENT CHEST PAIN FROM NOT ENOUGH BLO OD FLOW TO THE HEART 04 DATA LOGGERS SET TEMP ERATURE : +20 DEGREES COMMERCIAL & CUSTOM INVOICE NO. F22287001555 DT. 29.12.20 21 TOTAL GR.WT.:972.398 KGS TOTAL NT.WT.:65.00KGS SBILL NO. DT. 4020681 29/12/202 1<br/>
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
972
KG
4
PKG
0
USD
MAEU216632278
2022-03-16
462978 GLENMARK PHARMACEUTICALS INC US GLENMARK PHARMACEUTICALS LTD 1X40 REF HC 46 PALLETS CONT AINS 2978 CARTONS. PHARMAC EUTICALS AS UNDER OMEPRAZOLE DR CAPSULES 40MG 100 S NDC CO DE:68462039701 FDA PRODUCT CO DE NO.: 62KCF10 H. T. S NO.: 3004.90.9160 ANDA NO.: 91672 THERAPEUTICE USE: - TREATMENT OF TREAT GASTROESOPHAGEAL RE FLUX DISEASE. LAMOTRIGINE TAB LETS FOR OS (CD)5MG100 S NDC CODE:68462022801 FDA PRODUCT CODE NO.:- 61 M C A 38 H. T. S NO.: 3004.90.92.30 ANDA N O.:-79 # 099 THERAPEUTICE USE :- ANTICONVULSANT ROPINIROLE TABS 4MG 100 S NDC CODE:68462 025801 FDA PRODUCT CODE NO.:- 62 J C A 17 H. T. S NO.: 3004 .90.92.40 ANDA NO.:- 90-135 T HERAPEUTICE USE:-TREATMENT OF PARKINSONISM TOPIRAMATE TABL ETS 50MG 60 S NDC CODE:684620 15360 FDA PRODUCT CODE NO.:-6 1 M C A 40 H. T. S NO.: 3004. 49.00.20 ANDA NO.:- 77-627 TH ERAPEUTICE USE:-ANTICONVULSAN T PRAVASTATIN SODIUM TAB 40MG 90 S NDC CODE:68462019790 F DA PRODUCT CODE NO.: 61 J C A 13 H. T. S NO.: 3004.90.92.20 ANDA NO.: 77-987 THERAPEUTIC E USE: HYPOLIPDAEMIC VERAPAM IL HCL ER TABS 240MG 100 S ND C CODE:68462026001 FDA PRODUC T CODE NO.: 62 O C B 13 H. T. S NO.: 3004.90.92.20 ANDA NO .:-78-906 THERAPEUTICE USE:-A NGINA VERAPAMIL HCL ER TABS 2 40MG 500 S NDC CODE:684620260 05 FDA PRODUCT CODE NO.: 62 O C B 13 H. T. S NO.: 3004.90. 92.20 ANDA NO.:-78-906 THER APEUTICE USE:-ANGINA PRAVAST ATIN SODIUM TAB 40MG 500 S ND C CODE:68462019705 FDA PRODUC T CODE NO.: 61 J C A 13 H. T. S NO.: 3004.90.92.20 ANDA NO .: 77-987 THERAPEUTICE USE: H YPOLIPDAEMIC VERAPAMIL HCL ER TABS 240MG 100 S NDC CODE:68 462026001 FDA PRODUCT CODE NO .: 62 O C B 13 H. T. S NO.: 3 004.90.92.20 ANDA NO.:-78-906 THERAPEUTICE USE:-ANGINA VE RAPAMIL HCL ER TABS 240MG 500 S NDC CODE:68462026005 FDA P RODUCT CODE NO.: 62 O C B 13 H. T. S NO.: 3004.90.92.20 DI CLOFENAC SODIUM GEL 3% 100GM NDC CODE:68462035594 FDA PROD UCT CODE NO.:62 G C J 18 H. T. S NO.:3004.90.92.40 ANDA N O.:208301 THERAPEUTICE USE: - USED FOR THE RELIEF OF JOINT PAIN OF OSTEOARTHRITIS COM MERCIAL & CUSTOM INVOICE NO. F22252005671 DT. 16.02.2022 F 22252005676 DT. 16.02.2022 F2 2252005678 DT. 16.02.2022 N ET WT: 10,089.40 KGS GROSS WT : 11,856.85 KGS SB NO.: 830 2065 DT.: 17-02-22 SB NO.: 83 02581 DT.: 17-02-22 SB NO.: 8 302322 DT.: 17-02-22 02 DAT A LOGGERS HUMIDITY:65% SET T EMPERATURE : +20 DEGREES TEMP ERATURE RANGE : +15 DEGREES TO +25 DEGREES CONTAINER NO. MN BU4205091<br/>
INDIA
UNITED STATES
52330, SALALAH
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
11857
KG
46
PKG
0
USD
MAEU218832456
2022-07-07
614000 GLENMARK PHARMACEUTICALS INC US GLENMARK PHARMACEUTICALS LTD 58 PALLETS 4577 CARTONS PH ARMACEUTICALS AS UNDER TOPI RAMATE TAB 50MG 500 NDC CODE: 68462015305 FDA PRODUCT CODE NO.: 61 M C A 40 H. T. S NO. : 3004.49.00.20 ANDA NO.:077 627 THERAPEUTICE USE: ANTICO NVULSANT TOPIRAMATE TAB 50M G 60 NDC CODE:68462015360 FD A PRODUCT CODE NO.:-61 M C A 40 H. T. S NO.: 3004.49.00.2 0 ANDA NO.:- 77-627 THERAPEU TICE USE:-ANTICONVULSANT O XCARBAZEPINE TAB 600MG 100 ND C CODE:68462013901 FDA PRODUC T CODE NO.:-61 M C A 45 H. T . S NO.: 3004.90.92.30 ANDA NO.:-77-802 THERAPEUTICE USE: -ANTI CONVULSANT AGENT OXC ARBAZEPINE TAB 300MG 100 NDC CODE:68462013801 FDA PRODUCT CODE NO.:-61 M C A 45 H. T. S NO.: 3004.90.92.30 ANDA NO .:-77-802 THERAPEUTICE USE:-A NTI CONVULSANT AGENT PRAVA STATIN SOD TAB 40MG 500 NDC C ODE:68462019705 FDA PRODUCT C ODE NO.: 61 J C A 13 H. T. S NO.: 3004.90.92.20 ANDA NO. : 77-987 THERAPEUTICE USE: H YPOLIPDAEMIC POTASSIUM CL E R TAB 20MEQ 100 NDC CODE:6846 2047201 FDA PRODUCT CODE NO.: 65 R C A 14 H. T. S NO.: 3 004.90.9190 ANDA NO.: 203562 THERAPEUTICE USE: - TO TREAT OR PREVENT LOW AMOUNTS OF PO TASSIUM IN THE BLOOD CARVE DILOL TAB 6.25MG 500 NDC CODE :68462016305 FDA PRODUCT CODE NO : 62 O C A 22 H. T. S NO .: 3004.90.92.20 ANDA NO.:- 78-251 THERAPEUTICE USE:-BET A- ADRENOACEPTOR ANTAGONIST OXCARBAZEPINE TAB 600MG 100 NDC CODE:68462013901 FDA PR ODUCT CODE NO.:-61 M C A 45 H. T. S NO.: 3004.90.92.30 A NDA NO.:-77-802 THERAPEUTICE USE:-ANTI CONVULSANT AGENT OMEPRAZOLE DR CAP 40MG 30 ND C CODE:68462039730 FDA PRODUC T CODE NO.: 62KCF10 H. T. S NO.: 3004.90.9160 ANDA NO.: 91672 THERAPEUTICE USE: - TR EATMENT OF TREAT GASTROESOPHA GEAL REFLUX DISEASE COMMER CIAL & CUSTOM INVOICE NO. F22 352000936 DT. 06.06.2022 F223 52000937 DT. 06.06.2022 F2235 2000938 DT. 06.06.2022 F22352 000942 DT. 06.06.2022 S/BILL NO: 1939395 DT 06-JUN-22 S/BI LL NO: 1939400 DT 06-JUN-22 S /BILL NO: 1939468 DT 06-JUN-22 S/BILL NO: 1945362 DT 07-JUN -2022 NET WT: 11,188.47 KGS 02 DATA LOGGERS SET TEMPERA TURE : +18 DEGREES NOTIFY PAR TY:2 GLENMARK PHARMACEUTICALS INC 750, CORPORATE DRIVE, N EW JERSEY MAHWAH - 07430 USA<br/>
INDIA
UNITED STATES
52330, SALALAH
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
13375
KG
58
PKG
0
USD
MAEU216471136
2022-03-09
614000 GLENMARK PHARMACEUTICALS INC US GLENMARK PHARMACEUTICALS LTD 1 X 40 FCL REEFER CONTAINER 44 PALLETS CONSISTING OF 420 4 CARTONS PHARMACEUTICALS AS UNDER TOPIRAMATE TABLETS 25MG 500 S NDC CODE: 684 62010805 FDA PRODUCT CODE NO .: 61 M C A 40 H. T. S NO. : 3004.49.00.20 ANDA NO.:0 77627 THERAPEUTICE USE: AN TICONVULSANT TOPIRAMATE TABL ETS 25MG 60 S NDC CODE: 68462010860 FDA PRODUCT CODE NO.:-61 M C A 40 H. T. S NO.: 3004.49.00.20 ANDA NO .:- 77-627 THERAPEUTICE US E:-ANTICONVULSANT OXCARBAZEP INE TABLETS 600MG 100 S ND C CODE:68462013901 FDA PRODU CT CODE NO.:-61 M C A 45 H . T. S NO.: 3004.90.92.30 ANDA NO.:-77-802 THERAPEUTIC E USE:-ANTI CONVULSANT AGENT OMEPRAZOLE DR CAPSULES 40 MG 30 S NDC CODE:68462039730 FDA PRODUCT CODE NO.: 62K CF10 H. T. S NO.: 3004.90. 9160 ANDA NO.: 91672 THERA PEUTICE USE: - TREATMENT OF TREAT GASTROESOPHAGEAL REF LUX DISEASE ATOVAQUONE-PROGU ANIL TAB 250/100MG 24S NDC CODE:68462040467 FDA PRODUC T CODE NO.: 62 L D A 44 H. T. S NO.: 3004.90.92.90 A NDA NO.: 91-211 THERAPEUTICE USE: - ANTI MALARIAL NAPR OXEN TABLETS 500MG 500 S N DC CODE: 68462019005 FDA P RODUCT CODE NO.:-62 G C A 49 H. T. S NO.: 3004.90.92.4 0 ANDA NO.:-78-250 THERAPE UTICE USE:-ANTI-INFLAMMATORY , ANALGESIC 02 DATA LOGGER S SET TEMPERATURE : +20 DEGREES COMMERCIAL & CUS TOM INVOICE NO. F22252005416 DT. 30.01.2022 F222520055 34 DT. 04.02.2022 F2225200 5537 DT. 04.02.2022 TOT AL NET WT. 9214.16KGS<br/>
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
11438
KG
44
PKG
0
USD
MAEU914132385
2022-04-27
614000 GLENMARK PHARMACEUTICALS INC US GLENMARK PHARMACEUTICALS LTD 42 PALLETS 1745 CARTONS P HARMACEUTICALS AS UNDER TOP IRAMATE TABLETS 50MG 500 S ND C CODE:68462015305 FDA PRODUC T CODE NO.: 61 M C A 40 H. T . S NO.: 3004.49.00.20 ANDA NO.:077627 THERAPEUTICE USE: ANTICONVULSANT OMEPRAZOLE DR CAPSULES 20MG 1000 S NDC C ODE:68462039610 FDA PRODUCT C ODE NO.: 62KCF10 H. T. S NO. : 3004.90.9160 ANDA NO.: 916 72 THERAPEUTICE USE: - TREAT MENT OF TREAT GASTROESOPHAGEA L REFLUX DISEASE OXCARBAZE PINE TABLETS 300MG 100 S NDC CODE:68462013801 FDA PRODUCT CODE NO.:-61 M C A 45 H. T. S NO.: 3004.90.92.30 ANDA NO .:-77-802 THERAPEUTICE USE:-A NTI CONVULSANT AGENT COMME RCIAL & CUSTOM INVOICE NO. F2 2252006288 DT. 30.03.2022 S/B ILL NO:9426433 DT: 01-APR-22 NET WT: 7,534.86 KGS 02 DAT A LOGGERS SET TEMPERATURE : +18 DEGREES NOTIFY PARTY:2 GLENMARK PHARMACEUTICALS INC 750, CORPORATE DRIVE, NEW J ERSEY MAHWAH - 07430 USA<br/>
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
8846
KG
42
PKG
0
USD
MAEU914074440
2022-04-20
614000 GLENMARK PHARMACEUTICALS INC US GLENMARK PHARMACEUTICALS LTD 34 PALLETS 1521 CART ONS PHARMACEUTICALS AS UNDER TOPIRAMATE TABLETS 200MG 60 S NDC CODE:68462011060 FDA PRODUCT CODE NO.:-61 M C A 40 H. T. S NO.: 3004.49.00.20 ANDA NO.:- 77-627 THERAPEUTI CE USE:-ANTICONVULSANT THE OPHYLLINE ER TABS 400MG 100 S NDC CODE:68462038001 FDA PRO DUCT CODE NO.: 63 B C B 30 H . T. S NO.: 3004.90.92.85 AN DA NO.: 90-355 THERAPEUTICE U SE: XANTHINE BRONCHODILATOR ATOVAQUONE-PROGUANIL TAB 250 /100MG 24S NDC CODE:684620404 67 FDA PRODUCT CODE NO.: 62 L D A 44 H. T. S NO.: 3004.9 0.92.90 ANDA NO.: 91-211 THE RAPEUTICE USE: - ANTI MALARIA L POTASSIUM CL ER TAB 20MEQ (1500MG) 500 S NDC CODE:6846 2047205 FDA PRODUCT CODE NO.: 66 S C A 28 H. T. S NO.: 3 004.90.9020 ANDA NO.: 206391 THERAPEUTICE USE: - MEDICATI ON USED FOR HEART FAILURE, HI GH BLOOD PRESSURE, AND TO TRE AT AND PREVENT CHEST PAIN FR OM NOT ENOUGH BLOOD FLOW TO T HE HEART METRONIDAZOLE VAGI NAL GEL 0.75% 70GM NDC CODE:6 8462018449 FDA PRODUCT CODE N O.: 62 L C J 40 H. T. S NO.: 3004.90.92.45 ANDA NO.: 215 794 THERAPEUTICE USE: METRON IDAZOLE VAGINAL GEL IS INDICA TED IN THE TREATMENT OF BACTE RIAL VAGINOSIS (FORMERLY REF ERRED TO AS HAEMOPHILUS VAGI NITIS, GARDNERELLA VAGINITIS, NONSPECIFIC VAGINITIS, CORY NEBACTERIUM VAGINITIS, OR ANA EROBIC VAGINOSIS). COMMERCIA L & CUSTOM INVOICE NO. F22252 006222 DT. 26.03.2022 F222520 06211 DT. 25.03.2022 S/BILL N O: 9246750 DT: 26-MAR-22 S/B ILL NO: 9246776 DT: 26-MAR-2 2 NET WT: 6,181.02 KGS 02 DATA LOGGERS HUMIDITY:65% SE T TEMPERATURE : +18 DEGREES T EMPERATURE RANGE : +15 DEGREES TO +25 DEGREES NOTIFY PARTY: 2 GLENMARK PHARMACEUTICALS IN C 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 USA<br/>
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
7599
KG
34
PKG
0
USD
MAEU218682087
2022-07-01
612800 GLENMARK PHARMACEUTICALS INC US GLENMARK PHARMACEUTICALS LTD 55 PALLETS 3832 CARTONS PH ARMACEUTICALS AS UNDER OXCA RBAZEPINE TAB 150MG 100 NDC C ODE:68462013701 FDA PRODUCT C ODE NO.:-61 M C A 45 H. T. S NO.: 3004.90.92.30 ANDA NO. :-77-802 THERAPEUTICE USE:-AN TI CONVULSANT AGENT OXCARB AZEPINE TAB 300MG 100 NDC COD E:68462013801 FDA PRODUCT COD E NO.:-61 M C A 45 H. T. S N O.: 3004.90.92.30 ANDA NO.:- 77-802 THERAPEUTICE USE:-ANTI CONVULSANT AGENT ONDANSET RON TAB 8MG 30 NDC CODE:68462 010630 FDA PRODUCT CODE NO.: -61 T C A 28 H. T. S NO.: 300 4.90.92.40 ANDA NO.:- 77-535 THERAPEUTICE USE:-ANTI EMETI C VERAPAMIL HCL ER TAB 240M G 100 NDC CODE:68462026001 F DA PRODUCT CODE NO.: 62 O C B 13 H. T. S NO.: 3004.90.92. 20 ANDA NO.:-78-906 THERAPEU TICE USE:-ANGINA PRAMIPEXO LE TAB 0.125MG 90 NDC CODE:68 462033090 FDA PRODUCT CODE NO .: 62 J C A 15 H. T. S NO.: 3004.90.92.40 ANDA NO.: 90-7 81 THERAPEUTICE USE: USED IN PARKINSON#S DISEASE NAPROX EN TAB 500MG 100 NDC CODE:684 62019001 FDA PRODUCT CODE NO .:-62 G C A 49 H. T. S NO.: 3004.90.92.40 ANDA NO.:-78-25 0 THERAPEUTICE USE:-ANTI-INF LAMMATORY, ANALGESIC VERAP AMIL HCL ER TAB 240MG 500 NDC CODE:68462026005 FDA PRODUCT CODE NO.: 62 O C B 13 H. T. S NO.: 3004.90.92.20 ANDA N O.:-78-906 THERAPEUTICE USE: -ANGINA TELMISARTAN TAB 40M G 30 NDC CODE:68462020030 FD A PRODUCT CODE NO.: 62 O C A 09 H. T. S NO.: 3004.90.92.2 0 ANDA NO.:090032 THERAPEUTI CE USE: INDICATED FOR THE TR EATMENT OF HYPERTENSION, TO L OWER BLOOD PRESSURE PRAMIP EXOLE TAB 0.125MG 90 NDC CODE :68462033090 FDA PRODUCT CODE NO.: 62 J C A 15 H. T. S NO .: 3004.90.92.40 ANDA NO.: 9 0-781 THERAPEUTICE USE: USED IN PARKINSONS DISEASE COMM ERCIAL & CUSTOM INVOICE NO. F 22352000773 DT. 29.05.2022 F2 2352000774 DT. 29.05.2022 F22 352000776 DT. 29.05.2022 F223 52000777 DT. 29.05.2022 F2235 2000788 DT. 30.05.2022 NET WT : 8,872.81 KGS 02 DATA LOGGE RS HUMIDITY:65% SET TEMPERAT URE : +18 DEGREES TEMPERATURE RANGE : +15 DEGREES TO +25 DE GREES NOTIFY PARTY:2 GLENMAR K PHARMACEUTICALS INC 750, CO RPORATE DRIVE, NEW JERSEY MA HWAH - 07430 USA S/BILL NO: 1772988 DT 30-MAY-2022 S/ BILL NO: 1772943 DT 30-MAY-202 2 S/BILL NO: 1772987 DT 30-MA Y-2022 S/BILL NO: 1799668 DT 31-MAY-2022 S/BILL NO: 180035 0 DT 31-MAY-2022..<br/>
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
10956
KG
55
PKG
0
USD
MAEU215646371
2022-02-03
646100 GLENMARK PHARMACEUTICALS INC US GLENMARK PHARMACEUTICALS LTD 1X 40 PART OF FCL REEFER 20 P ALLETS CONSISTING OF 760 CARTO NS PHARMACEUTICALS AS UNDER NYSTATIN-TRIAM 100K UNIT/0.1% CREAM 60GM NDC CODE:68462031465 FDA PROD UCT CODE NO.: 64 L D J 61 H. T. S NO.: 3004.4 0.0050 ANDA NO.: 208136 THERAPEUTICE USE: - T REATMENT OF FUNGAL INFECT IONS OF THE SKIN, ESPECIA LLY YEAST INFECTIONS. DESOXIMETASONE OINTMEN T 0.25% 60GM NDC CODE:684 62053165 FDA PRODUCT CODE NO.: 62 G C J 17 H. T. S NO.: 3004.39.0050 ANDA NO.:202838 THERA PEUTICE USE: FOR THE RELI EF OF VARIOUS INFLAMMATOR Y SKIN CONDITIONS, INCLUD ING RASHES HYD ROCORTISONE VALERATE CREAM 0.2 % 15GM NDC CODE:684620575 17 FDA PRODUCT CODE NO.: 64 L C J 71 H. T. S NO.: 3004.49.00.50 A NDA NO.: 211129 THERAPEUT ICE USE: - MEDIUM-STRENGT H CORTICOSTEROID TO TREAT SKIN CONDITIONS. HYDROCORTISONE VALERATE CR EAM 0.2% 60GM NDC CODE:68 462057565 FDA PRODUCT COD E NO.: 64 L C J 71 H . T. S NO.: 3004.49.00.50 ANDA NO.: 211129 TH ERAPEUTICE USE: - MEDIUM- STRENGTH CORTICOSTEROID T O TREAT SKIN CONDITIONS NYSTATIN-TRIAM 100K UNIT/0.1% OINT 30GM NDC C ODE:68462079935 FDA PRODU CT CODE NO.: 64 L D J 60 H. T. S NO.: 3004.49 .00.50 ANDA NO.: 208300 THERAPEUTICE USE: - T REATMENT OF FUNGAL INFECT IONS OF THE SKIN, ESPECIA LLY YEAST INFECTIONS. HYDROCORTISONE VAL OIN TMENT 0.2% 60GM NDC CODE: 68462083665 FDA PRODUCT C ODE NO.: 64 L C L 71 H. T. S NO.: 3004.49.00. 50 ANDA NO.: 211750 THERAPEUTICE USE: - INDIC ATED FOR THE RELIEF OF TH E INFLAMMATORY AND PRURIT IC MANIFESTATIONS OF CORT ICOSTEROID RESPONSIVE DER MATOSES IN ADULT PATIENTS . HYDROCORTISONE VA LERATE CREAM 0.2% 45GM ND C CODE:68462057547 NDC NO .:68462057547 FDA PRODUCT CODE NO.: 64 L C J 71 H. T. S NO.: 3004.49.0 0.50 ANDA NO.: 211129 MEDIUM-STRENGTH CORTICO STEROID TO TREAT SKIN CON DITIONS NYSTATIN-TR IAM 100K UNIT/0.1% OINT 60GM NDC CODE:68462079965 FDA PRODUCT CODE NO.: 64 L D J 60 H. T. S NO.: 3004.49.00.50 ANDA NO.: 208300 THERAPEUTICE USE: - TREATMENT OF FUNGAL INFECTIONS OF THE SKIN, ESPECIALLY YEAST INFECT IONS. 20 DATA LOGGERS SET TEMPERATURE : +20 DEGREES COMMERCIA L & CUSTOM INVOICE NO. F22235 003896 DT. 25.12.2021 F222350 03897 DT. 25.12.2021 TOTAL GR .WT: 3800.16KGS TOTAL NT.WT:2 038.32KGS SBILL NO. DT. 7116511 29/12/2021 7116513 29/12/2021<br/>
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
3800
KG
20
PKG
0
USD
MAEU217980069
2022-05-18
617200 GLENMARK PHARMACEUTICALS INC US GLENMARK PHARMACEUTICALS LTD 12 PALLETS 1116 CART ONS PHARMACEUTICALS AS UNDER SOLIFENACIN SUCCINATE TABS 10MG 30 S NDC CODE:6846203873 0 FDA PRODUCT CODE NO.: 61 K CA 72 H. T. S NO.: 3004 49 00 70 ANDA NO.: 209239 INDICA TED FOR THE TREATMENT OF OVER ACTIVE BLADDER WITH SYMPTOMS OF URGE URINARY INCONTINENCE , URGENCY AND URINARY FREQUEN CY SOLIFENACIN SUCCINATE TA BS 10MG 90 S NDC CODE:6846203 8790 FDA PRODUCT CODE NO.: 6 1 KCA 72 H. T. S NO.: 3004 49 00 70 ANDA NO.: 209239 IND ICATED FOR THE TREATMENT OF O VERACTIVE BLADDER WITH SYMPTO MS OF URGE URINARY INCONTINE NCE, URGENCY AND URINARY FREQ UENCY APREPITANT CAPSULES 4 0MG 1UD NDC CODE:68462058340 FDA PRODUCT CODE NO.: 61 T C E 32 H. T. S NO.: 3004.90.9 2.40 ANDA NO.: 207777 THERAP EUTICE USE: APREPITANT IS USE D WITH OTHER MEDICATIONS TO H ELP PREVENT NAUSEA AND VOMIT ING CAUSED BY CANCER DRUG TRE ATMENT (CHEMOTHERAPY). THIS MEDICATION IS ALSO USED TO PR EVENT NAUSEA AND VOMITING AFT ER SURGERY. A-EMETIC/NAUSEANT / HUMAN - RX/SINGLE INGREDI ENT / DELAYED RELEASE TABLETS / APREPITANT COMMERCIAL & CUSTOM INVOICE NO. F22387000 086 DT. 19.04.2022 NET WT: 3 39.08 KGS 12 DATA LOGGERS S/BILL NO: 4005708 DT: 21/04 /2022 NOTIFY PARTY:2 GLENM ARK SPECIALTY S.A. SWITZERLAN D (GSSA) PLACE NUMA-DROZ 2 N EUCHATEL - 2000 SWITZERLAND<br/>
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
2442
KG
12
PKG
0
USD
MAEU216530798
2022-03-09
621700 GLENMARK PHARMACEUTICALS INC US GLENMARK PHARMACEUTICALS LTD 1 X 40 PART OF FCL REEFER 18 PACKAGES CONSISTING OF 37 3 CARTONS PHARMACEUTICALS AS UNDER DESOXIMETASONE OI NTMENT 0.25% 15GM NDC CODE:6 8462053117 FDA PRODUCT CODE NO.: 62 G C J 17 H. T. S N O.: 3004.39.0050 ANDA NO.: 202838 THERAPEUTICE USE: FOR THE RELIEF OF VARIOUS INF LAMMATORY SKIN CONDITIONS, I NCLUDING RASHES FLUOCINOLO NE ACE EAR DROPS 0.01% 20ML NDC CODE:68462018556 FDA P RODUCT CODE NO.: 64 L C L 27 H. T. S NO.: 3004.49.00.5 0 ANDA NO.: 211815 FOR THE TREATMENT OF CHRONIC ECZEMA TOUS EXTERNAL OTITIS MOMET ASONE FUROATE OINTMENT 0.1% 45GM NDC CODE:68462022555 FDA PRODUCT CODE NO.: 62 F C J 53 H. T. S NO.: 3004.40 .49.50 ANDA NO.:78-571 THE RAPEUTICE USE: ANTI-INFLAMMA TORY- DERMATOLOGIC 18 DATA LOGGERS SET TEMPERATURE : +20 DEGREES COMMERCIAL & CUSTOM INVOICE NO. F22235004 597 DT. 05.02.2022 SBIL L NO. DT. 8037245 07/02/ 2022 -GST NO. : 02AAACG22 07L2Z3 TOTAL NET WT.:1359.36 0KGS<br/>
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
2920
KG
18
PKG
0
USD
MAEU214106893
2021-11-18
621700 GLENMARK PHARMACEUTICALS INC US GLENMARK PHARMACEUTICALS LTD 1 X 40 REEFER FCL CONTAINER 5 2 PALLETS CONSISTING OF 2177 C ARTONS PHARMACEUTICALS AS UND ER ROPINIROLE TABS 0.25MG 100 S NDC CODE:68462025301 FDA PRODUCT CODE NO.:-62 J C A 17 H. T. S NO.: 3004.90.92.40 ANDA NO.:- 90-135 THERAPEUTI CE USE:-TREATMENT OF PARKINS ONISM FELODIPINE ER TABS 5MG 100 S NDC CODE:68462023401 F DA PRODUCT CODE NO.: 62OCB32 H. T. S NO.: 3004.90.92.20 ANDA NO.: 90-365 THERAPEUTICE USE: - TREATMENT OF HYPERTE NSION FELODIPINE ER TABS 10MG 100 S NDC CODE:68462023501 FDA PRODUCT CODE NO.: 62OCB32 H. T. S NO.: 3004.90.92.20 ANDA NO.: 90-365 THERAPEUTIC E USE: - TREATMENT OF HYPERT ENSION OMEPRAZOLE DR CAPSULES 10MG 100 S NDC CODE:68462039 501 FDA PRODUCT CODE NO.: 62 KCF10 H. T. S NO.: 3004.90.9 160 ANDA NO.: 91672 THERAPEU TICE USE: - TREATMENT OF TREA T GASTROESOPHAGEAL REFLUX DI SEASE RIZATRIPTAN BENZOATE OD T TABS 10MG 18 S NDC CODE:684 62046806 FDA PRODUCT CODE NO. : 63 O C A 05 H. T. S NO.:30 04.90.92.28 ANDA NO.: 201914 THERAPEUTICE USE : - ANALGES IC/ HUMAN - RX/SINGLE INGREDI ENT / PROMPT RELEASE TABLETS / RIZATRIPTAN BENZOATE (ANAL GESIC) THEOPHYLLINE ER TABS 3 00MG 100 S NDC CODE:684620721 01 63 B C B 30 3004.90.92.85 212184 TO RELEASE TABLETS A RE INDICATED FOR THE TREATME NT OF THE SYMPTOMS AND REVER SIBLE AIRFLOW OBSTRUCTION ASS OCIATED WITH CHRONIC ASTHMA A ND OTHER CHRONIC LUNG DISEAS ES, E.G., EMPHYSEMA AND CHRO NIC BRONCHITIS GABAPENTIN TAB LETS 800MG 500 S NDC CODE:684 62012705 FDA PRODUCT CODE NO : 61 N C A 69 H. T. S NO.: 3004.90.92.30 ANDA NO.:-77-66 2 THERAPEUTICE USE:-ANTICONV ULSANT AGENT 02 DATA LOGGERS HUMIDITY 65 % SET TEMPERATU RE PLUS 20 DEGREES TEMPERATUR E RANGE PLUS 15 DEGREES TO PLU S 25 DEGREES SBILL NOS. DT. 5432148 20.10.2021 543190 9 20.10.2021 5450534 21. 10.2021 COMMERCIAL & CUSTOM INVOICE NO. F22252003755 DT. 20.10.2021 F22252003756 DT. 20.10.2021 F22252003761 DT. 2 0.10.2021 TOTAL GR.WT: 7726 .01KGS TOTAL NT.WT:6256.61KGS FREIGHT PREPAID<br/>
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
7726
KG
52
PKG
0
USD
MAEU914178597
2022-05-11
621700 GLENMARK PHARMACEUTICALS INC US GLENMARK PHARMACEUTICALS LTD 46 PALLETS 2408 CARTONS P HARMACEUTICALS AS UNDER ROP INIROLE TABS 0.25MG 100 S NDC CODE:68462025301 FDA PRODUCT CODE NO.:-62 J C A 17 H. T. S NO.: 3004.90.92.40 ANDA N O.:- 90-135 THERAPEUTICE USE :-TREATMENT OF PARKINSONISM PRAMIPEXOLE TABS 1MG 90 S N DC CODE:68462033390 FDA PRODU CT CODE NO.: 62 J C A 15 H. T. S NO.: 3004.90.92.40 ANDA NO.: 90-781 THERAPEUTICE USE : USED IN PARKINSON#S DISEASE FELODIPINE ER TABS 2.5MG 1 00 S NDC CODE:68462023301 FD A PRODUCT CODE NO.: 62OCB32 H. T. S NO.: 3004.90.92.20 A NDA NO.: 90-365 THERAPEUTICE USE: - TREATMENT OF HYPERTEN SION PRAMIPEXOLE TABS 0.125 MG 90 S NDC CODE:68462033090 FDA PRODUCT CODE NO.: 62 J C A 15 H. T. S NO.: 3004.90.9 2.40 ANDA NO.: 90-781 THERAP EUTICE USE: USED IN PARKINSON #S DISEASE ROPINIROLE TABS 0.5MG 100 S NDC CODE:68462025 401 FDA PRODUCT CODE NO.:-62 J C A 17 H. T. S NO.: 3004. 90.92.40 ANDA NO.:- 90-135 T HERAPEUTICE USE:-TREATMENT OF PARKINSONISM OMEPRAZOLE D R CAPSULES 20MG 1000 S NDC CO DE:68462039610 FDA PRODUCT CO DE NO.: 62KCF10 H. T. S NO.: 3004.90.9160 ANDA NO.: 91672 THERAPEUTICE USE: - TREATME NT OF TREAT GASTROESOPHAGEAL REFLUX DISEASE CALCIPOTRIEN E OINTMENT 0.005% 120GM NDC C ODE:68462031066 FDA PRODUCT C ODE NO.: 62 N C J 04 H. T. S NO.: 3004.90.92.45 ANDA NO. : 209297 THIS MEDICATION IS U SED TO TREAT PSORIASIS. CALC IPOTRIENE IS A FORM OF VITAMI N D. IT WORKS BY SLOWING DOWN THE GROWTH OF SKIN CELLS. CLINDAMYCIN PHOSPHATE GEL 1% 60GM NDC CODE:68462086665 FD A PRODUCT CODE NO.: 56 J D J 31 H. T. S NO.: 3004.49.00.5 0 ANDA NO.:214251 THERAPEUTI CE USE: CLINDAMYCIN PHOSPHATE GEL IS INDICATED IN THE TRE ATMENT OF ACNE VULGARIS MU PIROCIN OINTMENT 2% 22GM NDC CODE:68462018022 FDA PRODUCT CODE NO.: 61 G J J 81 H. T. S NO.: 3004.90.92.45 ANDA NO .: 90-480 THERAPEUTICE USE: - ANTI-BACTERIAL COMMERCIAL & CUSTOM INVOICE NO. F223520 00069 DT. 09.04.2022 F2235200 0070 DT. 09.04.2022 S/BILL NO : 9599623 DT 10-APR-2022 S/BI LL NO: 9599621 DT 10-APR-2022 NET WT. 9,053.25 KGS 02 DA TA LOGGERS SET TEMPERATURE : +18 DEGREES NOTIFY PARTY: 2 GLENMARK PHARMACEUTICALS IN C 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 USA<br/>
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
10805
KG
46
PKG
0
USD
MAEU217679497
2022-05-04
642700 GLENMARK PHARMACEUTICALS INC US GLENMARK PHARMACEUTICALS LTD 20 PALLETS 766 CARTONS PH ARMACEUTICALS AS UNDER FLUO CINOLONE ACE BODY OIL 0.01% 11 8ML NDC CODE:68462059189 FDA PRODUCT CODE NO.: 64 L C L 2 7 H. T. S NO.: 3004.49.00.50 ANDA NO.: 210556 SYNTHETIC CORTICOSTEROID FOR TOPICAL DE RMATOLOGIC USE FOR THE TREATM ENT OF PSORIASIS OF THE SCALP CLOBETASOL PROP SOLUTION 0 .05% 25ML NDC CODE:6846205322 8 FDA PRODUCT CODE NO.: 64 L C L 67 H. T. S NO.: 3004.90 .92.45 ANDA NO.: 210190 THER APEUTICE USE: - GLUCOCORTICOI D / HUMAN - RX/SINGLE INGREDI ENT / NONSTERILE LIQUID / CL OBETASOL PROPIONATE (GLUCOCOR TICOID) FLUOCINOLONE ACE SC ALP OIL 0.01% 118ML NDC CODE: 68462059089 FDA PRODUCT CODE NO.: 64 L C L 27 H. T. S NO. : 3004.49.00.50 ANDA NO.: 21 0539 SYNTHETIC CORTICOSTEROID FOR TOPICAL DERMATOLOGIC US E FOR THE TREATMENT OF PSORIA SIS OF THE SCALP NYSTATIN-T RIAM 100K UNIT/0.1% OINT 30GM NDC CODE:68462079935 FDA PRO DUCT CODE NO.: 64 L D J 60 H . T. S NO.: 3004.49.00.50 AN DA NO.: 208300 THERAPEUTICE U SE: - TREATMENT OF FUNGAL IN FECTIONS OF THE SKIN, ESPECIA LLY YEAST INFECTIONS. HYDR OCORTISONE VAL OINTMENT 0.2% 6 0GM NDC CODE:68462083665 FDA PRODUCT CODE NO.: 64 L C L 7 1 H. T. S NO.: 3004.49.00.50 ANDA NO.: 211750 THERAPEUTI CE USE: - INDICATED FOR THE R ELIEF OF THE INFLAMMATORY AND PRURITIC MANIFESTATIONS OF CORTICOSTEROID RESPONSIVE DER MATOSES IN ADULT PATIENTS. COMMERCIAL & CUSTOM INVOICE N O. F22235005451 DT. 31.03.202 2 S/BILL NO: 9498224 DT:05/04 /2022 NET WT: 1,805.28 KGS 20 DATA LOGGERS SET TEMPERA TURE : +18 DEGREES NOTIFY P ARTY:2 GLENMARK PHARMACEUTICA LS INC 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 U SA<br/>
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
3462
KG
20
PKG
0
USD
MAEU914167331
2022-05-04
642700 GLENMARK PHARMACEUTICALS INC US GLENMARK PHARMACEUTICALS LTD 13 PALLETS 285 CARTONS PH ARMACEUTICALS AS UNDER FLUO CINOLONE ACE EAR DROPS 0.01% 2 0ML NDC CODE:68462018556 FDA PRODUCT CODE NO.: 64 L C L 2 7 H. T. S NO.: 3004.49.00.50 ANDA NO.: 211815 FOR THE TR EATMENT OF CHRONIC ECZEMATOUS EXTERNAL OTITIS ALCLOMETA SONE DIP OINTMENT 0.05% 15GM NDC CODE:68462029917 FDA PROD UCT CODE NO.: 62 B C J 10 H. T. S NO.: 3004.49.00.50 AND A NO.: 79-227 THERAPEUTICE US E: INDICATED FOR THE RELIEF O F THE INFLAMMATORY AND PRURI TIC MANIFESTATIONS OF CORTICO STEROID-RESPONSIVE DERMATOSES . CLOBETASOL PROP SOLUTION 0.05% 50ML NDC CODE:684620532 53 FDA PRODUCT CODE NO.: 64 L C L 67 H. T. S NO.: 3004.9 0.92.45 ANDA NO.: 210190 THE RAPEUTICE USE: - GLUCOCORTICO ID / HUMAN - RX/SINGLE INGRED IENT / NONSTERILE LIQUID / C LOBETASOL PROPIONATE (GLUCOCO RTICOID) HYDROCORTISONE VAL OINTMENT 0.2% 45GM NDC CODE: 68462083647 FDA PRODUCT CODE NO.: 64 L C L 71 H. T. S NO. : 3004.49.00.50 ANDA NO.: 21 1750 THERAPEUTICE USE: - IND ICATED FOR THE RELIEF OF THE INFLAMMATORY AND PRURITIC MAN IFESTATIONS OF CORTICOSTEROID RESPONSIVE DERMATOSES IN ADU LT PATIENTS. ALCLOMETASONE DIP OINTMENT 0.05% 45GM NDC CODE:68462029947 FDA PRODUCT CODE NO.: 62 B C J 10 H. T. S NO.: 3004.49.00.50 ANDA NO .: 79-227 THERAPEUTICE USE: INDICATED FOR THE RELIEF OF T HE INFLAMMATORY AND PRURITIC MANIFESTATIONS OF CORTICOSTER OID-RESPONSIVE DERMATOSES. COMMERCIAL & CUSTOM INVOICE N O. F22235005479 DT. 31.03.202 2 F22235005480 DT. 31.03.2022 S/BILL NO:9517897 DT:06/04/2 022 S/BILL NO: 9519966 DT:06/ 04/2022 NET WT: 853.97 KGS 13 DATA LOGGERS SET TEMPE RATURE : +18 DEGREES NOTIFY PARTY:2 GLENMARK PHARMACEUTI CALS INC 750, CORPORATE DRIVE , NEW JERSEY MAHWAH - 07430 USA<br/>
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
1829
KG
13
PKG
0
USD
MAEU218446099
2022-06-08
642700 GLENMARK PHARMACEUTICALS INC US GLENMARK PHARMACEUTICALS LTD 20 PALLETS 362 CARTONS PH ARMACEUTICALS AS UNDER FLUO CINOLONE ACE EAR DROPS 0.01% 2 0ML NDC CODE:68462018556 FDA PRODUCT CODE NO.: 64 L C L 2 7 H. T. S NO.: 3004.49.00.50 ANDA NO.: 211815 FOR THE TR EATMENT OF CHRONIC ECZEMATOUS EXTERNAL OTITIS TRIAMCINO LONE ACE OINT 0.5% 15GM NDC C ODE:68462079817 FDA PRODUCT C ODE NO.:64 L C J 61 H. T. S NO.: 3004.49.00.50 ANDA NO.: 206379 THERAPEUTICE USE: - R EDUCES THE SWELLING, ITCHING, AND REDNESS OF SKIN MOMET ASONE FUROATE CREAM 0.1% 45GM NDC CODE:68462019255 FDA PRO DUCT CODE NO.: 62 F C J 53 H . T. S NO.: 3004.40.49.50 AN DA NO.:78-541 THERAPEUTICE US E: ANTI-INFLAMMATORY- DERMAT OLOGIC COMMERCIAL & CUSTOM INVOICE NO. F22335000438 DT. 30.04.2022 F22335000440 DT. 3 0.04.2022 S/BILL NO: 1179292 DT:05/05/2022 S/BILL NO:121 4617 DT:06/05/2022 NET WT: 1,328.64 KGS 20 DATA LOGGE RS SET TEMPERATURE : +18 DE GREES NOTIFY PARTY:2 GLENM ARK PHARMACEUTICALS INC 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 USA<br/>
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
3506
KG
20
PKG
0
USD
MAEU217387319
2022-04-27
642700 GLENMARK PHARMACEUTICALS INC US GLENMARK PHARMACEUTICALS LTD 20 PALLETS 1000 CARTONS PHARMACEUTICALS AS UNDER VIOR ELE DESO/EE-EE .15/.02-.01MG 8 4 NDC CODE:68462031829 FDA P RODUCT CODE NO.: 64 G D A 27 H. T. S NO.: 3004.39.00.50 ANDA NO.: 091346 THERAPEUTICE USE: - ORAL CONTRACEPTIVES COMMERCIAL & CUSTOM INVOICE NO. F22252006266 DT. 28.03.20 22 S/BILL NO: 9333360 DT 30- MAR-2022 NET WT. 2,289.60 K GS 01 DATA LOGGERS SET TEM PERATURE : +18 DEGREES NOTI FY PARTY:2 GLENMARK PHARMACEU TICALS INC 750, CORPORATE DRI VE, NEW JERSEY MAHWAH - 0743 0 USA<br/>
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
3143
KG
20
PKG
0
USD
MAEU218832452
2022-07-01
642700 GLENMARK PHARMACEUTICALS INC US GLENMARK PHARMACEUTICALS LTD PHARMACEUTICALS AS UNDER FL UOCINOLONE ACE SCALP OIL 0.01% 118ML NDC CODE:68462059089 FDA PRODUCT CODE NO.: 64 L C L 27 H. T. S NO.: 3004.49.00 .50 ANDA NO.: 210539 SYNTHET IC CORTICOSTEROID FOR TOPICAL DERMATOLOGIC USE FOR THE TRE ATMENT OF PSORIASIS OF THE SC ALP NYSTATIN-TRIAM 100K UNI T/0.1% OINT 30GM NDC CODE:684 62079935 FDA PRODUCT CODE NO. : 64 L D J 60 H. T. S NO.: 3004.49.00.50 ANDA NO.: 20830 0 THERAPEUTICE USE: - TREATM ENT OF FUNGAL INFECTIONS OF T HE SKIN, ESPECIALLY YEAST IN FECTIONS. BETAMETHASONE DIP AUG CRM USP 0.05% NDC CODE:6 8462029017 FDA PRODUCT CODE N O.: 64 L C J 06 H. T. S NO.: 3004.90.92.45 ANDA NO.:78-9 30 THERAPEUTICE USE: DERMALO GIC USE MOMETASONE FURO TOP SOL 0.1% 60ML NDC CODE:68462 038502 FDA PRODUCT CODE NO.: 62 F C L 53 H. T. S NO.: 30 04.90.92.45 ANDA NO.:090506 THERAPEUTICE USE: MOMETASONE FUROATE TOPICAL SOLUTION (LOT ION) IS A CORTICOSTEROID IND ICATED FOR THE RELIEF OF THE INFLAMMATORY AND PRURITIC MA NIFESTATIONS OF CORTICOSTEROI D-RESPONSIVE DERMATOSES IN PA TIENTS #12 YEARS OF AGE. 13 DATA LOGGERS HUMIDITY:65% SET TEMPERATURE : +18 DEGREES TEMPERATURE RANGE : +15 DEGR EES TO +25 DEGREES NOTIFY PAR TY:2 GLENMARK PHARMACEUTICALS INC 750, CORPORATE DRIVE, N EW JERSEY MAHWAH - 07430 USA<br/>
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
497
KG
3
PKG
0
USD
MAEU217090598
2022-04-06
224900 GLENMARK PHARMACEUTICALS INC US GLENMARK PHARMACEUTICALS LTD 1X40 HC REF 2249 CARTONS PACK ED IN 35 PALLETS PHARMACEUTIC ALS AS UNDER ROPINIROLE TABS 5MG 100 S NDC CODE:6846202590 1 FDA PRODUCT CODE NO.:62 J C A 17 H. T. S NO.: 3004.90.92 .40 ANDA NO.:- 90-135 THERAP 1X40 REF 320 CARTONS PACKED I N 7 PALLETS PHARMACEUTICALS A S UNDER ADAPALENE GEL 0.1% 15 GM (PLD) NDC CODE:69842008805 NDC NO.:69842008805 FDA PRO DUCT CODE NO.: 62 S C J 02 H. T. S NO.: 3004.40.00.50 ANDA EUTICE USE:-TREATMENT OF PARK INSONISM ROPINIROLE TABS 3MG 100 S NDC CODE:68462025701 F DA PRODUCT CODE NO.:-62 J C A 17 H. T. S NO.: 3004.90.92.40 ANDA NO.:- 90-135 THERAPE UTICE USE:-TREATMENT OF PARKI NSONISM PRAMIPEXOLE TABS 0.5M G 90 S NDC CODE:68462033290 FDA PRODUCT CODE NO.: 62 J C A 15 H. T. S NO.: 3004.90.92.4 0 ANDA NO.: 90-781 THERAPEUT ICE USE: USED IN PARKINSON#S DISEASE OXCARBAZEPINE TABLETS 600MG 100 S NDC CODE:6846201 3901 FDA PRODUCT CODE NO.:-61 M C A 45 H. T. S NO.: 3004.9 0.92.30 ANDA NO.:-77-802 THE RAPEUTICE USE:-ANTI CONVULSANT AGENT OMEPRAZOLE DR CAPSULES 10MG 100 S NDC CODE:68462039 501 FDA PRODUCT CODE NO.: 62K CF10 H. T. S NO.: 3004.90.916 0 ANDA NO.: 91672 THERAPEUTI CE USE: - TREATMENT OF TREAT GASTROESOPHAGEAL REFLUX DISEA SE OMEPRAZOLE DR CAPSULES 10M G 30 S NDC CODE:68462039530 FDA PRODUCT CODE NO.: 62KCF10 H. T. S NO.: 3004.90.9160 AN DA NO.: 91672 THERAPEUTICE US E: - TREATMENT OF TREAT GAST ROESOPHAGEAL REFLUX DISEASE POTASSIUM CL ER TAB 20MEQ (15 00MG) 100 S NDC CODE:68462047 201 FDA PRODUCT CODE NO.: 65 R C A 14 H. T. S NO.: 3004. 90.9190 ANDA NO.: 203562 THE RAPEUTICE USE: - TO TREAT OR PREVENT LOW AMOUNTS OF POTASS IUM IN THE BLOOD OMEPRAZOLE DR CAPSULES 20MG 1000 S NDC C ODE:68462039610 FDA PRODUCT C ODE NO.: 62KCF10 H. T. S NO. : 3004.90.9160 ANDA NO.: 916 72 THERAPEUTICE USE: - TREAT MENT OF TREAT GASTROESOPHAGEA L REFLUX DISEASE GROSS WT.: 8,791.96 KGS NET WT.: 7,550.6 4 KGS COMMERCIAL & CUSTOM INV OICE NO. F22252005782 DT. 23. 02.2022 F22252005791 DT. 23.0 2.2022 F22252005815 DT. 24.02 .2022 SB NO.: 8492699 DT.: 24 /02/22 SB NO.: 8494162 DT.: 2 5/02/22 SB NO.: 8515041 DT.: 25/02/22 03 DATA LOGGERS S ET TEMPERATURE : +20 DEGREES CONTAINER NO. MNBU4115887 MAN UFACTURE D FOR GLENMARK PHA RMACEUTICAL S INC., USA 301, ISLAND RD MAHWAH MNBU411588 7 ML-IN4125979 40 REEF 9 6 35 PACKAGE 8791.960 KGS TEMPERAT URE: 20.0 C CUSTOMS SEAL : KL IK20081690 THE PLACE OF ISSUA NCE OF THIS DOCUMENT SHALL BE DEEMED TO BE THE MAERSK LINE I NDIA PVT LTD OFFICE LOCATED E ITHER IN THE SAME STATE OR THE NEAREST STATE WITH RESPECT TO THE ABOVE REFERENCED CARGO P ICK-UP / DROP-OFF LOCATION GO ODS SHIPPED IN REFRIGERATED CO NTAINER(S) SET AT SHIPPER S RE QUESTED CARRIAGE TEMPERATURE AS PER ABOVE SHIPPER S LOAD, STOW, WEIGHT AND COUNT FREI GHT PREPAID ALSO NOTIFY: GLEN MARK PHARMACEUTICALS INC 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 USA CY/CY NO.: 091314 THERAPEUTICE USE : - TREATMENT OF ACNE ADAPALE NE GEL 0.1% 45GM (PLD) NDC CODE:69842008816 NDC NO.:6984 2008816 FDA PRODUCT CODE NO.: 62 S C J 02 H. T. S NO.: 300 4.40.00.50 ANDA NO.: 091314 THERAPEUTICE USE: - TREATMENT OF ACNE 00 DATA LOGGERS CO NTAINER NO. MNBU9046937 NET W T: 1,126.69 KGS GROSS WT: 1,6 26.72 KGS COMMERCIAL & CUSTOM INVOICE NO. F22252005775 DT. 23.02.2022 F22252005776 DT. 23.02.2022<br/>
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
8792
KG
35
PKG
0
USD
MAEU913446777
2021-12-14
649900 GLENMARK PHARMACEUTICALS INC US GLENMARK PHARMACEUTICALS LTD 1X40 PART OF FCL REEFER 19 PA LLETS CONSISTING OF 1606 CARTO NS PHARMACEUTICALS AS UNDER ATOMOXETINE CAPSULES 10MG 30 S NDC CODE:68462026530 FD A PRODUCT CODE NO.: 64 UC A 99 H. T. S NO.: 30 04.90.92.90 ANDA NO.: 079 019 OLMESARTAN MEDO XOMIL TABLETS 40MG 90 S N DC CODE:68462043890 FDA P RODUCT CODE NO.: 62 CCA 6 8 H. T. S NO.: 3004. 90.9220 ANDA NO.: 203281 ATOMOXETINE CAPSULE S 18MG 30 S NDC CODE:6846 2026630 FDA PRODUCT CODE NO.: 64 UCA 99 H. T. S NO.: 3004.90.92.90 ANDA NO.: 079019 ATOMOXETINE CAPSULES 80MG 30 S NDC CODE:68462027030 FDA PRODUCT CODE NO.: 6 4 UCA 99 H. T. S NO. :3004.90.92.90 ANDA NO.: 079019 ROPINIROLE T ABS 5MG 100 S NDC CODE:68 462025901 FDA PRODUCT COD E NO.:62 J C A 17 H. T. S NO.: 3004.90.92.40 ANDA NO.:- 90-135 CICLOPIROX OLAMINE CREAM 0 .77% 30GM NDC CODE:684620 29735 FDA PRODUCT CODE NO.:-61 W C J 03 H. T. S NO.: 3004.40.49.50 ANDA NO.:- 90 - 273 06 DATA LOGGERS SET TEMPERATURE : +20 DEGREES TEMPERATURE RANGE : +15 D EGREES TO +25 DEGREES COM MERCIAL & CUSTOM INVOICE NO. F22252004214 DT. 17.11.2021 F 22252004229 DT. 18.11.2021 F2 2252004230 DT. 18.11.2021 SBI LL NO.6089553 DT: 18.11.2021 / 6107083 / 6107085 DT:19.11.20 21 TOTAL GR.WT.:5243.56KGS TOTAL NT.WT.:4225.97KGS<br/>
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
5244
KG
19
PKG
0
USD
MAEU203258742
2020-07-16
620200 GLENMARK PHARMACEUTICALS INC US GLENMARK PHARMACEUTICALS LTD 46 PALLETS 1545 CARTONS PHARMACEUTICALS AS UNDER ADAPALENE GEL 0.1% 45GM (PL D) NDC CODE:69842008816 FD A PRODUCT CODE NO.: 62 S C J 02 H. T. S NO.: 3004.40.00. 50 ANDA NO.: 091314 THE RAPEUTICE USE: TREATMENT OF ACNE ADAPALENE GEL 0.1% 1 5GM (PLD) NDC CO
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
8772
KG
46
PKG
0
USD
MAEU216796469
2022-03-24
620200 GLENMARK PHARMACEUTICALS INC US GLENMARK PHARMACEUTICALS LTD 1X40 REF 987 CARTONS PACKED I N 21 PALLETS PHARMACEUTICALS AS UNDER ADAPALENE GEL 0.1% 1 5GM (PLD) NDC CODE:6984200880 5 NDC NO.:69842008805 FDA PR ODUCT CODE NO.: 62 S C J 02 H. T. S NO.: 3004.40.00.50 A NDA NO.: 091314 THERAPEUTICE USE: - TREATMENT OF ACNE A DAPALENE GEL 0.1% 45GM (PLD) NDC CODE:69842008816 NDC NO.: 69842008816 FDA PRODUCT CODE NO.: 62 S C J 02 H. T. S NO. : 3004.40.00.50 ANDA NO.: 09 1314 THERAPEUTICE USE: - TRE ATMENT OF ACNE DROSPIRENONE/E E 3.0/0.03MG 84 NDC CODE:6846 2073329 FDA PRODUCT CODE NO.: 65 J D A 39 H. T. S NO.: 3 006.60.00.00 ANDA NO.: 204848 THERAPEUTICE USE: - CONTRAC EPTION TO PREVENT PREGNANCY GROSS WT: 3,648.47 KGS NET WT : 2,583.42 KGS COMMERCIAL & C USTOM INVOICE NO. F2225200577 5 DT. 23.02.2022 F22252005776 DT. 23.02.2022 F22252005788 DT. 23.02.2022 SB NO.: 849249 8 DT.: 24/02/22 SB NO.: 84925 55 DT.: 24/02/22 SB NO.: 8492 590 DT.: 24/02/22 NOTIFY PA RTY 3: P&L DEVELOPMENT, LLC 275 GRAND BLVD NEW YORK WE STBURY USA- 11590 01 DATA LOGGERS HUMIDITY:65% SET TEM PERATURE : +20 DEGREES TEMPER ATURE RANGE : +15 DEGREES TO + 25 DEGREES CONTAINER NO. MNBU 9046937 MANUFACTURE D FOR G LENMARK PHARMACEUTICAL S INC ., USA 301, ISLAND RD MAHWAH<br/>
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
3648
KG
7
PKG
0
USD
MAEU218832458
2022-07-01
620200 GLENMARK PHARMACEUTICALS INC US GLENMARK PHARMACEUTICALS LTD 51 PALLETS IN 2487 CARTONS PHARMACEUTICALS AS UNDER AD APALENE-BPO GEL PUMP 0.1/2.5% 45GM NDC CODE:68462030147 FD A PRODUCT CODE NO.: 62 S D O 02 H. T. S NO.: 3004.90.92.4 5 ANDA NO.: 208108 THERAPEUT ICE USE: - USED ON THE SKIN T O TREAT ACNE PRAVASTATIN S OD TAB 40MG 90 NDC CODE:68462 019790 FDA PRODUCT CODE NO.: 61 J C A 13 H. T. S NO.: 30 04.90.92.20 ANDA NO.: 77-987 THERAPEUTICE USE: HYPOLIPDAE MIC OMEPRAZOLE DR CAP 40MG 1000 NDC CODE:68462039710 FD A PRODUCT CODE NO.:62KCF10 H . T. S NO.: 3004.90.9160 AND A NO.:91672 THERAPEUTICE USE: - TREATMENT OF TREAT GASTRO ESOPHAGEAL REFLUX DISEASE TOPIRAMATE TAB 25MG 500 NDC C ODE:68462010805 FDA PRODUCT C ODE NO.: 61 M C A 40 H. T. S NO.: 3004.49.00.20 ANDA NO. :077627 THERAPEUTICE USE: AN TICONVULSANT FELODIPINE ER TAB 5MG 100 NDC CODE:68462023 401 FDA PRODUCT CODE NO.: 62 OCB32 H. T. S NO.: 3004.90.9 2.20 ANDA NO.: 90-365 THERAP EUTICE USE: - TREATMENT OF H YPERTENSION CARVEDILOL TAB 6.25MG 100 NDC CODE:684620163 01 FDA PRODUCT CODE NO : 62 O C A 22 H. T. S NO.: 3004.9 0.92.20 ANDA NO.:- 78-251 TH ERAPEUTICE USE:-BETA- ADRENO ACEPTOR ANTAGONIST PRAMIPE XOLE TAB 1.5MG 90 NDC CODE:68 462033490 FDA PRODUCT CODE NO .: 62 J C A 15 H. T. S NO.: 3004.90.92.40 ANDA NO.: 90-7 81 THERAPEUTICE USE: USED IN PARKINSON#S DISEASE CARVED ILOL TAB 6.25MG 500 NDC CODE: 68462016305 FDA PRODUCT CODE NO : 62 O C A 22 H. T. S NO. : 3004.90.92.20 ANDA NO.:- 7 8-251 THERAPEUTICE USE:-BETA - ADRENOACEPTOR ANTAGONIST NAPROXEN TAB 500MG 500 NDC CODE:68462019005 FDA PRODUCT CODE NO.:-62 G C A 49 H. T. S NO.: 3004.90.92.40 ANDA NO .:-78-250 THERAPEUTICE USE:- ANTI-INFLAMMATORY, ANALGESIC NAPROXEN TAB 500MG 500 NDC CODE:68462019005 FDA PRODUCT CODE NO.:-62 G C A 49 H. T. S NO.: 3004.90.92.40 ANDA N O.:-78-250 THERAPEUTICE USE: -ANTI-INFLAMMATORY, ANALGESIC COMMERCIAL & CUSTOM INVOICE NO. F22352000803 DT. 30.05.20 22 F22352000806 DT. 30.05.202 2 F22352000819 DT. 31.05.2022 F22352000820 DT. 31.05.2022 F22352000822 DT. 31.05.2022 F22352000855 DT. 31.05.2022 F 22352000860 DT. 31.05.2022 NE T WT.: 8522.40 02 DATA LOGGER S HUMIDITY:65% NOTIFY PARTY: 2 GLENMARK PHARMACEUTICALS IN C 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 USA S/BILL NO: 1834791 DT 01-JUN- 2022 S/BILL NO: 1834793 DT 01 -JUN-2022 S/BILL NO: 1834776 DT 01-JUN-2022 S/BILL NO: 183 4781 DT 01-JUN-2022 S/BILL NO : 1834792 DT 01-JUN-2022 S/BI LL NO: 1834795 DT 01-JUN-2022 S/BILL NO: 1834777 DT 01-JUN- 2022<br/>
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
9987
KG
51
PKG
0
USD
MAEU218832451
2022-07-07
611500 GLENMARK PHARMACEUTICALS INC US GLENMARK PHARMACEUTICALS LTD 22 PALLETS 1497 CARTONS PH ARMACEUTICALS AS UNDER CHLO RPROMAZINE HCL TAB 100MG 100 NDC CODE:68462086401 61 T C A 04 3004.90.92.40 212144 TO TREAT PSYCHOTIC DISORDERS SU CH AS SCHIZOPHRENIA OR MANIC -DEPRESSION IN ADULTS EZET IMIBE-SIMVA TAB 10/80MG 30 ND C CODE:68462032430 FDA PRODUC T CODE NO.: 61 J D C 15 H. T . S NO.: 3004.49.00.10 ANDA NO.: 208699 THERAPEUTICE USE: - THIS COMBINATION MEDICATIO N IS USED TO HELP LOWER BAD CHOLESTEROL AND FATS (SUCH AS LDL, TRIGLYCERIDES) AND RAIS E GOOD CHOLESTEROL (HDL) IN THE BLOOD. EZETIMIBE WORKS BY REDUCING THE AMOUNT OF CHOLE STEROL YOUR BODY ABSORBS FROM YOUR DIET. SIMVASTATIN BELO NGS TO A GROUP OF DRUGS KNOWN AS STATINS. IT WORKS BY RE DUCING THE AMOUNT OF CHOLESTE ROL MADE BY THE LIVER. FRO VATRIPTAN SUCCINATE TAB 2.5MG 9 NDC CODE:68462069497 FDA P RODUCT CODE NO.:60 L C A 93 H. T. S NO.: 3004.90.92.28 A NDA NO.:204730 THERAPEUTICE U SE: - USE:THE TREATMENT OF M IGRAINE HEADACHES AND FOR SHO RT TERM PREVENTION OF MENSTR UAL MIGRAINE CARVEDILOL TAB 25MG 500 NDC CODE:6846201650 5 FDA PRODUCT CODE NO : 62 O C A 22 H. T. S NO.: 3004.90 .92.20 ANDA NO.:- 78-251 THE RAPEUTICE USE:-BETA- ADRENOA CEPTOR ANTAGONIST TOPIRAMA TE ER CAP (Q) 25MG 30 NDC COD E:68462037230 3004.49.00.20 61 M C B 40 210278 PRAVAST ATIN SOD TAB 80MG 90 NDC CODE :68462019890 FDA PRODUCT CODE NO.:-61 J C A 13 H. T. S NO .: 3004.90.92.20 ANDA NO.:-7 7-987 THERAPEUTICE USE:-HYPO LIPDAEMIC RUFINAMIDE TAB 40 0MG 120 NDC CODE:68462071408 61 M C A 99 3004.90.92.30 2 05075 TO USED WITH OTHER MED ICATIONS TO PREVENT OR CONTRO L SEIZURES (EPILEPSY) ASSOCI ATED WITH LENNOX-GASTAUT SYN DROME (LGS PRAVASTATIN SOD TAB 10MG 500 NDC CODE:6846201 9505 FDA PRODUCT CODE NO.:-6 1 J C A 13 H. T. S NO.: 3004 .90.92.20 ANDA NO.:-77-987 T HERAPEUTICE USE:-HYPOLIPDAEMI C COMMERCIAL & CUSTOM INVOI CE NO. F22387000307 DT. 31.05 .2022 F22387000309 DT. 31.05. 2022 F22387000310 DT. 31.05.2 022 F22387000316 DT. 31.05.20 22 F22387000317 DT. 31.05.202 2 F22387000320 DT. 31.05.2022 F22387000329 DT. 31.05.2022 S/BILL NO: 4007990 DT:02/06 /2022 S/BILL NO: 4007992 DT: 02/06/2022 S/BILL NO: 400799 3 DT:02/06/2022 S/BILL NO: 4007995 DT:02/06/2022 S/BILL NO: 4007996 DT:02/06/2022 S/BILL NO: 4007997 DT:02/06/ 2022 S/BILL NO: 4007999 DT: 02/06/2022 NET WT: 2,701.12 K GS 08 DATA LOGGERS HUMIDITY: 65% SET TEMPERATURE : +18 DEG REES TEMPERATURE RANGE : +15 DEGREES TO +25 DEGREES NOTIFY PARTY:2 GLENMARK PHARMACEUTI CALS INC 750, CORPORATE DRIVE , NEW JERSEY MAHWAH - 07430 USA.<br/>
INDIA
UNITED STATES
52330, SALALAH
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
4765
KG
22
PKG
0
USD
MAEU217932729
2022-05-18
611500 GLENMARK PHARMACEUTICALS INC US GLENMARK PHARMACEUTICALS LTD 2 PALLETS 51 CARTONS PHAR MACEUTICALS AS UNDER EZETIM IBE-SIMVASTATIN TAB 10/80MG 90 S NDC CODE:68462032490 FDA PRODUCT CODE NO.: 61 J D C 15 H. T. S NO.: 3004.49.00.10 ANDA NO.: 208699 THERAPEUTIC E USE: - THIS COMBINATION MED ICATION IS USED TO HELP LOWER BAD CHOLESTEROL AND FATS (S UCH AS LDL, TRIGLYCERIDES) AN D RAISE GOOD CHOLESTEROL (HDL ) IN THE BLOOD. EZETIMIBE WO RKS BY REDUCING THE AMOUNT OF CHOLESTEROL YOUR BODY ABSORB S FROM YOUR DIET. SIMVASTATIN BELONGS TO A GROUP OF DRUGS KNOWN AS STATINS. IT WORKS BY REDUCING THE AMOUNT OF CH OLESTEROL MADE BY THE LIVER. COMMERCIAL & CUSTOM INVOICE NO. F22387000094 DT. 21.04.2 022 NET WT: 161.57 KGS 01 DATA LOGGERS SET TEMPERATURE : +18 DEGREES TEMPERATURE RAN GE : +15 DEGREES TO +25 DEGREE S NOTIFY PARTY:2 GLENMARK PH ARMACEUTICALS INC 750, CORPOR ATE DRIVE, NEW JERSEY MAHWAH - 07430 USA<br/>
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
275
KG
2
PKG
0
USD
MAEU216242714
2022-02-24
626800 GLENMARK PHARMACEUTICALS INC US GLENMARK PHARMACEUTICALS LTD 4 PACKAGES CONSISTING OF 256 C ARTONS TOPIRAMATE ER CAPS ULES (Q) 50MG 30 S NDC CODE:6 8462037330 3004.49.00.20 61 M C B 40 210278 AMLODIPINE -OLMESARTAN TABS 5/20MG 30 S NDC CODE:68462056630 FDA PROD UCT CODE NO.: 62 C D A 68 H. T. S NO.: 3004.90.92.20 AND A NO.: 207807 THERAPEUTICE US E: MEDICATION USED TO TREAT HIGH BLOOD PRESSURE AND CORON ARY ARTERY DISEASE CHLORPRO MAZINE HCL TABS 50MG 100 S ND C CODE:68462086301 61 T C A 0 4 3004.90.92.40 212144 TO T REAT PSYCHOTIC DISORDERS SUCH AS SCHIZOPHRENIA OR MANIC-D EPRESSION IN ADULTS 01 D ATA LOGGERS SET TEMPERATURE : +20 DEGREES CONTAINER NO . MNBU0627036 TOTAL NET WT.:4 5.38 KGS SBILL NOS DT. 40012 70 27/01/2022 4001273 27/01/2 022 4001275 27/01/2022 COMME RCIAL & CUSTOM INVOICE NO. F2 2287001713 DT. 27.01.2022 F22 287001716 DT. 27.01.2022 F222 87001717 DT. 27.01.2022<br/>
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
567
KG
4
PKG
0
USD
MAEU218832454
2022-07-07
624400 GLENMARK PHARMACEUTICALS INC US GLENMARK PHARMACEUTICALS LTD 7 PALLETS 643 CARTON S PHARMACEUTICALS AS UNDER ATOVAQUONE ORAL SUSP 750MG/ 5ML 210ML NDC CODE:6846204212 1 FDA PRODUCT CODE NO.: 62 L C L 44 H. T. S NO.: 3004.90 .92.90 ANDA NO.: 209685 USED TO PREVENT OR TREAT A SERIOU S LUNG INFECTION CALLED PNEUM OCYSTIS PNEUMONIA (PCP). THIS MEDICATION HELPS TO STOP IN FECTION SYMPTOMS SUCH AS FEVE R, COUGH, TIREDNESS, AND SHOR TNESS OF BREATH. COMMERCIA L & CUSTOM INVOICE NO. F22335 000936 DT. 31.05.2022 NET WT. 2,361.10 KGS 07 DATA LOGGER S SET TEMPERATURE : +18 DEG REES NOTIFY PARTY:2 GLENMA RK SPECIALTY S.A. SWITZERLAND (GSSA) PLACE NUMA-DROZ 2 NE UCHATEL - 2000 SWITZERLAND S/BILL NO: 1924315 DT: 06-JUN -22<br/>
INDIA
UNITED STATES
52330, SALALAH
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
2685
KG
7
PKG
0
USD
MAEU218320933
2022-06-08
563100 GLENMARK PHARMACEUTICALS INC US GLENMARK PHARMACEUTICALS LTD 25 PALLETS 1399 CARTONS PH ARMACEUTICALS AS UNDER CLIN DAMYCIN PHOSPHATE GEL 1% 30GM NDC CODE:68462086635 FDA PRO DUCT CODE NO.: 56 J D J 31 H . T. S NO.: 3004.49.00.50 AN DA NO.:214251 THERAPEUTICE US E: CLINDAMYCIN PHOSPHATE GEL IS INDICATED IN THE TREATMEN T OF ACNE VULGARIS CLINDAM YCIN PHOSPHATE GEL 1% 60GM ND C CODE:68462086665 FDA PRODUC T CODE NO.: 56 J D J 31 H. T . S NO.: 3004.49.00.50 ANDA NO.:214251 THERAPEUTICE USE: CLINDAMYCIN PHOSPHATE GEL IS INDICATED IN THE TREATMENT O F ACNE VULGARIS NORGEST/EE 0.25/0.035MG 84 NDC CODE:684 62030929 FDA PRODUCT CODE NO. : 65 J D A 27 H. T. S NO.: 3006.60.00.00 ANDA NO.: 20053 8 THERAPEUTICE USE: - ORAL C ONTRACEPTIVES NORGEST/EE 0. 18,0.215,0.25/0.035MG 84 NDC CODE:68462056529 FDA PRODUCT CODE NO.: 65 J D A 27 H. T. S NO.: 3006.60.00.00 ANDA NO .: 200494 THERAPEUTICE USE: - ORAL CONTRACEPTIVES NORET HINDRONE ACETATE TABS 5MG 50 NDC CODE:68462030450 FDA PROD UCT CODE NO.65 J C A 25 H. T . S NO.: 3004.39.00.50 ANDA NO.:-91-090 THERAPEUTICE USE: - SECONDARY AMENORRHEA,ENDOM ETRIOS IS AND ABNORMAL UTERI NE BLEEDING COMMERCIAL & CU STOM INVOICE NO. F22352000515 DT. 11.05.2022 F22352000517 DT. 11.05.2022 F22352000526 D T. 11.05.2022 F22352000535 DT . 12.05.2022 S/BILL NO: 13701 39 DT 13-MAY-2022 S/BILL NO: 1370105 DT 13-MAY-2022 S/BILL NO: 1370141 DT 13-MAY-2022 S /BILL NO: 1372692 DT 13-MAY-20 22 NET WT: 4,205.46 KGS 03 DATA LOGGERS SET TEMPERATU RE : +18 DEGREES NOTIFY PAR TY:2 GLENMARK PHARMACEUTICALS INC 750, CORPORATE DRIVE, N EW JERSEY MAHWAH - 07430 USA<br/>
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
5230
KG
25
PKG
0
USD
MAEU914081958
2022-04-20
563100 GLENMARK PHARMACEUTICALS INC US GLENMARK PHARMACEUTICALS LTD 19 PALLETS 2334 CART ONS PHARMACEUTICALS AS UNDER CLINDAMYCIN-BPO GEL 1%/5% 50G M NDC CODE:68462048627 FDA P RODUCT CODE NO.: 56 J D J 31 H. T. S NO.: 3004.49.00.50 ANDA NO.: 209252 ANTIBIOTIC T HAT STOPS THE GROWTH OF ACNE- CAUSING BACTERIA AS WELL AS REDUCE OIL PRODUCTION IN THE SKIN, HELPING KEEP PORES OPEN ROSUVASTATIN TABLETS 10MG 90 S NO : 08.MAR.2022 29.FEB .2024 NDC CODE:68462026290 F DA PRODUCT CODE NO.:61 J C A 16 H. T. S NO.: 3004.49.00.1 0 ANDA NO.: 079172 THERAPEUT ICE USE: - TO TREAT HIGH CHOL ESTEROL AND RELATED CONDITION S, AND TO PREVENT CARDIOVASC ULAR DISEASE ROSUVASTATIN T ABLETS 5MG 90 S NDC CODE:6846 2026190 FDA PRODUCT CODE NO. :61 J C A 16 H. T. S NO.: 30 04.49.00.10 ANDA NO.: 079172 THERAPEUTICE USE: - TO TREAT HIGH CHOLESTEROL AND RELATED CONDITIONS, AND TO PREVENT CARDIOVASCULAR DISEASE ROSU VASTATIN TABLETS 40MG 30 S ND C CODE:68462026430 FDA PRODUC T CODE NO.:61 J C A 16 H. T. S NO.: 3004.49.00.10 ANDA N O.: 079172 THERAPEUTICE USE: - TO TREAT HIGH CHOLESTEROL A ND RELATED CONDITIONS, AND T O PREVENT CARDIOVASCULAR DISE ASE COMMERCIAL & CUSTOM INVOI CE NO. F22252006177 DT. 23.03 .2022 F22252006178 DT. 23.03. 2022 S/BILL NO: 9186598 DT:2 4-MAR-22 S/BILL NO: 9186691 DT:24-MAR-22 NET WT: 3,649.0 2 KGS 19 DATA LOGGERS HUMID ITY:65% GLENMARK SPECIALTY S.A. SWITZERLAND (GSSA) PLAC E NUMA-DROZ 2 NEUCHATEL - 200 0 SWITZERLAND<br/>
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
4648
KG
19
PKG
0
USD
MAEU217630882
2022-05-04
563100 GLENMARK PHARMACEUTICALS INC US GLENMARK PHARMACEUTICALS LTD 2 PALLETS 34 CART ONS PHARMACEUTICALS AS UNDER CLINDAMYCIN-BPO GEL 1%/5% 25G M NDC CODE:68462048619 FDA P RODUCT CODE NO.: 56 J D J 31 H. T. S NO.: 3004.49.00.50 ANDA NO.: 209252 ANTIBIOTIC T HAT STOPS THE GROWTH OF ACNE- CAUSING BACTERIA AS WELL AS REDUCE OIL PRODUCTION IN THE SKIN, HELPING KEEP PORES OPEN CLINDAMYCIN-BPO GEL 1%/5% 50GM NDC CODE:68462048627 FD A PRODUCT CODE NO.: 56 J D J 31 H. T. S NO.: 3004.49.00.5 0 ANDA NO.: 209252 ANTIBIOTI C THAT STOPS THE GROWTH OF AC NE-CAUSING BACTERIA AS WELL A S REDUCE OIL PRODUCTION IN T HE SKIN, HELPING KEEP PORES O PEN COMMERCIAL & CUSTOM INVOI CE NO. F22252006371 DT. 31.03 .2022 F22252006373 DT. 31.03. 2022 S/BILL NO: 9496667 DT:0 5-APR-22 S/BILL NO: 9496823 DT:05-APR-22 NET WT: 249.68 K GS 02 DATA LOGGERS SET TEM PERATURE : +18 DEGREES NOTI FY PARTY:2 GLENMARK SPECIALTY S.A. SWITZERLAND (GSSA) PLA CE NUMA-DROZ 2 NEUCHATEL - 20 00 SWITZERLAND<br/>
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
311
KG
2
PKG
0
USD
MAEU914077392
2022-04-20
640800 GLENMARK PHARMACEUTICALS INC US GLENMARK PHARMACEUTICALS LTD 4 PALLETS 275 CARTON S PHARMACEUTICALS AS UNDER T ACROLIMUS OINTMENT 0.1% 60GM NDC CODE:68462053465 FDA PROD UCT CODE NO.: 64 T C J 08 H. T. S NO.: 3004.49.00.50 AND A NO.: 210393 THERAPEUTICE US E: - TACROLIMUS IS A TOPICAL IMMUNOSUPPRESSIVE OINTMENT U SED FOR THE TREATMENT OF MOD ERATE-TO-SEVERE ATOPIC DERMAT ITIS (ECZEMA). PIMECROLIMU S CREAM 1% 30GM NDC CODE:6846 2060935 FDA PRODUCT CODE NO.: 61 S C J 04 H. T. S NO.: 3 004.90.92.45 ANDA NO.: 211769 THERAPEUTICE USE: - AS SECO UND-LINE THERAPY FOR THE SHOR T-TERM AND NON-CONTINUOS CHRO NIC TRERTMENT OF MILD TO MOD ERATE ATOPIC DERMATITIS IN N ONIMMUNOCOMPROMISED ADULT AND CHILDREN 2 YEARS OF AGE COM MERCIAL & CUSTOM INVOICE NO. F22287002038 DT. 24.03.2022 N ET WT. 604.51 KGS 02 DATA L OGGERS S/BILL NO: 400427 8 DT:24/03/2022 NOTIFY PAR TY:2 GLENMARK PHARMACEUTICALS INC 750, CORPORATE DRIVE, N EW JERSEY MAHWAH - 07430 USA<br/>
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
934
KG
4
PKG
0
USD
MAEU217985710
2022-05-18
621300 GLENMARK PHARMACEUTICALS INC US GLENMARK PHARMACEUTICALS LTD 42 PALLETS 1759 CARTONS PH ARMACEUTICALS AS UNDER VERAPA MIL HCL ER TABS 120MG 100S ND C CODE:68462029201 FDA PRODUC T CODE NO.: 62 O C B 13 H. T . S NO.: 3004.90.92.20 ANDA NO.: 90-700 THERAPEUTICE USE: - ANGINA OMEPRAZOLE DR CA PSULES 40MG 90 S NDC CODE:684 62039790 FDA PRODUCT CODE NO. : 62KCF10 H. T. S NO.: 3004 .90.9160 ANDA NO.: 91672 THE RAPEUTICE USE: - TREATMENT OF TREAT GASTROESOPHAGEAL REFLU X DISEASE GABAPENTIN TABLET S 600MG 500 S NDC CODE:684620 12605 FDA PRODUCT CODE NO: 6 1 N C A 69 H. T. S NO.: 3004 .90.92.30 ANDA NO.:-77-662 T HERAPEUTICE USE:-ANTICONVULSA NT AGENT COMMERCIAL & CUST OM INVOICE NO. F22352000211 D T. 21.04.2022 F22352000212 DT . 21.04.2022 S/BILL NO:985561 8 DT: 21-APR-22 S/BILL NO: 98 54993 DT:21-APR-22 NET WT: 7 ,308.66 KGS 03 DATA LOGGERS HUMIDITY:65% SET TEMPERATURE : +18 DEGREES TEMPERATURE RA NGE : +15 DEGREES TO +25 DEGRE ES NOTIFY PARTY:2 GLENMARK P HARMACEUTICALS INC 750, CORPO RATE DRIVE, NEW JERSEY MAHWA H - 07430 USA<br/>
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
8161
KG
42
PKG
0
USD
MAEU914178634
2022-05-18
621300 GLENMARK PHARMACEUTICALS INC US GLENMARK PHARMACEUTICALS LTD 54 PALLETS 3337 CARTONS PH ARMACEUTICALS AS UNDER ROPI NIROLE TABS 1MG 100 S NDC COD E:68462025501 FDA PRODUCT COD E NO.:-62 J C A 17 H. T. S N O.: 3004.90.92.40 ANDA NO.:- 90-135 THERAPEUTICE USE:-TR EATMENT OF PARKINSONISM VE RAPAMIL HCL ER TABS 120MG 100S NDC CODE:68462029201 FDA PR ODUCT CODE NO.: 62 O C B 13 H. T. S NO.: 3004.90.92.20 A NDA NO.: 90-700 THERAPEUTICE USE: - ANGINA LITHIUM CARB ONATE ER TABS 300MG 100 S NDC CODE:68462022301 FDA PRODUCT CODE NO.: 61 N C B 37 H. T. S NO.: 3004.49.00.20 ANDA N O.:91-544 THERAPEUTICE USE: - INDICATED IN THE TREATMENT OF MANIC EPISODES OF BIPOL AR DISORDER. BIPOLAR DISORDER , MANIC (DSM-IV) IS EQUIVALEN T TO MANIC DEPRESSIVE ILLNESS , MANIC, IN THE OLDER DSM-II TERMINOLOGY. ALSO INDICATED AS A MAINTENANCE TREATMENT F OR INDIVIDUALS WITH A DIAGNOS IS OF BIPOLAR DISORDER. MAIN TENANCE THERAPY REDUCES THE F REQUENCY OF MANIC EPISODES AN D DIMINISHES THE INTENSITY O F THOSE EPISODES WHICH MAY OC CUR. OMEPRAZOLE DR CAPSULE S 40MG 30 S NDC CODE:68462039 730 FDA PRODUCT CODE NO.: 62 KCF10 H. T. S NO.: 3004.90.9 160 ANDA NO.: 91672 THERAPEU TICE USE: - TREATMENT OF TREA T GASTROESOPHAGEAL REFLUX DI SEASE HAILEY24FE NORE ACE/E E-FE 1/0.02-75MG 84 NDC CODE: 68462073129 FDA PRODUCT CODE NO.: 65 J D A 25 H. T. S NO. : 3006.60.00.00 ANDA NO.: 20 4847 THERAPEUTICE USE: - CON TRACEPTION TO PREVENT PREGNAN CY COMMERCIAL & CUSTOM INVO ICE NO. F22352000178 DT. 18.0 4.2022 F22352000169 DT. 18.04 .2022 S/BILL NO: 9797783 DT: 19-APR-22 S/BILL NO: 9797778 DT:19-APR-22 NET WT: 7,409. 15 KGS 02 DATA LOGGERS SET TEMPERATURE : +18 DEGREES NOT IFY PARTY:2 GLENMARK PHARMACE UTICALS INC 750, CORPORATE DR IVE, NEW JERSEY MAHWAH - 074 30 USA<br/>
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
9477
KG
54
PKG
0
USD
MAEU218682333
2022-06-22
621300 GLENMARK PHARMACEUTICALS INC US GLENMARK PHARMACEUTICALS LTD 31 PALLETS 1789 CARTONS PHARMACEUTICALS AS UNDER EZ ETIMIBE-SIMVASTATIN TAB 10/20M G 90 S NDC CODE:68462032290 COLESEVELAM HCL TABLETS 625M G 180 S NDC CODE:68462043318 FDA PRODUCT CODE NO.: 62 B D A 13 H. T. S NO.: 3004.49.0 0.10 ANDA NO.: 203480 THERAP EUTICE USE: - ANTIHYPERLIPO PROTEINEMIC. CHLORPROMAZINE HCL TABS 50MG 100 S NDC CODE :68462086301 61 T C A 04 300 4.90.92.40 212144 TO TREAT P SYCHOTIC DISORDERS SUCH AS S CHIZOPHRENIA OR MANIC-DEPRESS ION IN ADULTS EZETIMIBE-SI MVASTATIN TAB 10/20MG 30 S ND C CODE:68462032230 EZETIMIB E-SIMVASTATIN TAB 10/40MG 90 S NDC CODE:68462032390 PRAV ASTATIN SODIUM TAB 20MG 500 S NDC CODE:68462019605 FDA PRO DUCT CODE NO.:-61 J C A 13 H . T. S NO.: 3004.90.92.20 AN DA NO.:-77-987 THERAPEUTICE USE:-HYPOLIPDAEMIC TACROLIM US CAPSULES 0.5MG 100 S NDC C ODE:68462068501 GABAPENTIN TABLETS 600MG 500 S NDC CODE: 68462012605 FDA PRODUCT CODE NO: 61 N C A 69 H. T. S NO.: 3004.90.92.30 ANDA NO.:-77- 662 THERAPEUTICE USE:-ANTICO NVULSANT AGENT COMMERCIAL & CUSTOM INVOICE NO. F2238700 0269 DT. 27.05.2022 F22387000 270 DT. 27.05.2022 F223870002 71 DT. 27.05.2022 F2238700027 2 DT. 27.05.2022 F22387000273 DT. 27.05.2022 F22387000277 DT. 27.05.2022 S/BILL NO: 40 07631 DT: 27.05.2022 S/BILL N O: 4007630 DT: 27.05.2022 S/ BILL NO: 4007629 DT: 27.05.20 22 S/BILL NO: 4007627 DT: 27 .05.2022 S/BILL NO: 4007628 DT: 27.05.2022 S/BILL NO: 40 07623 DT: 27.05.2022 NET WT. 6,075.63 KGS 02 DATA LOGGERS HUMIDITY:65% SET TEMPERATUR E : +18 DEGREES NOTIFY PART Y:2 GLENMARK PHARMACEUTICALS INC 750, CORPORATE DRIVE, NE W JERSEY MAHWAH - 07430 USA<br/>
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
8374
KG
31
PKG
0
USD
MAEU218491002
2022-06-15
621300 GLENMARK PHARMACEUTICALS INC US GLENMARK PHARMACEUTICALS LTD 44 PALLETS 1646 CARTONS P HARMACEUTICALS AS UNDER VER APAMIL HCL ER TABS 120MG 100S NDC CODE:68462029201 FDA PRO DUCT CODE NO.: 62 O C B 13 H . T. S NO.: 3004.90.92.20 AN DA NO.: 90-700 THERAPEUTICE U SE: - ANGINA OMEPRAZOLE DR CAPSULES 20MG 1000 S NDC C ODE:68462039610 FDA PRODUCT C ODE NO.: 62KCF10 H. T. S NO. : 3004.90.9160 ANDA NO.: 916 72 THERAPEUTICE USE: - TREAT MENT OF TREAT GASTROESOPHAGEA L REFLUX DISEASE PRAMIPEXO LE TABS 1MG 90 S NDC CODE:684 62033390 FDA PRODUCT CODE NO. : 62 J C A 15 H. T. S NO.: 3004.90.92.40 ANDA NO.: 90-78 1 THERAPEUTICE USE: USED IN PARKINSON#S DISEASE MUPIROC IN OINTMENT 2% 22GM NDC CODE: 68462018022 FDA PRODUCT CODE NO.: 61 G J J 81 H. T. S NO. : 3004.90.92.45 ANDA NO.: 90 -480 THERAPEUTICE USE: - ANT I-BACTERIAL CALCIPOTRIENE C REAM 0.005% 60GM (GS) NDC COD E:51407060560 FDA PRODUCT COD E NO.: 62 N C J 04 H. T. S N O.: 3004.90.92.45 ANDA NO.: 205772 THERAPEUTICE USE: TOP ICAL ANTI-PSORIATIC CALCIPO TRIENE CREAM 0.005% 120GM (GS) NDC CODE:51407060512 FDA PR ODUCT CODE NO.: 62 N C J 04 H. T. S NO.: 3004.90.92.45 A NDA NO.: 205772 THERAPEUTICE USE: TOPICAL ANTI-PSORIATIC COMMERCIAL & CUSTOM INVOICE NO. F22352000632 DT. 18.05.20 22 F22352000633 DT. 18.05.202 2 F22352000634 DT. 18.05.2022 F22352000635 DT. 18.05.2022 F22352000636 DT. 18.05.2022 S/BILL NO: 1505141 DT 19-MAY-2 022 S/BILL NO: 1505060 DT 19- MAY-2022 S/BILL NO: 1505063 D T 19-MAY-2022 S/BILL NO: 1505 155 DT 19-MAY-2022 S/BILL NO: 1505059 DT 19-MAY-2022 NET W T: 7,856.28 KGS 06 DATA LOG GERS HUMIDITY:65% SET TEMPER ATURE : +18 DEGREES TEMPERATU RE RANGE : +15 DEGREES TO +25 DEGREES NOTIFY PARTY:2 GLENM ARK PHARMACEUTICALS INC 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 USA<br/>
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
9613
KG
44
PKG
0
USD
MAEU216628676
2022-03-16
326760 GLENMARK PHARMACEUTICALS INC US GLENMARK PHARMACEUTICALS LTD 1X40 REF HC 32 PALLETS CONT AINS 676 CARTONS. PHARMACE UTICALS AS UNDER CLOBETASOL PROP SOLUTION 0.05% 50ML NDC CODE:68462053253 FDA PRODUCT CODE NO.: 64 L C L 67 H. T. S NO.: 3004.90.92.45 ANDA N O.: 210190 THERAPEUTICE USE: - GLUCOCORTICOID / HUMAN - R X/SINGLE INGREDIENT / NONSTER ILE LIQUID / CLOBETASOL PROPI ONATE (GLUCOCORTICOID) MOM ETASONE FUROATE OINTMENT 0.1% 15GM NDC CODE:68462022517 FD A PRODUCT CODE NO.: 62 F C J 53 H. T. S NO.: 3004.40.49.5 0 ANDA NO.:78-571 THERAPEUTI CE USE: ANTI-INFLAMMATORY- D ERMATOLOGIC MOMETASONE FURO ATE OINTMENT 0.1% 45GM NDC CO DE:68462022555 FDA PRODUCT CO DE NO.: 62 F C J 53 H. T. S NO.: 3004.40.49.50 ANDA NO.: 78-571 THERAPEUTICE USE: ANT I-INFLAMMATORY- DERMATOLOGIC GROSS WT.: 6422.21 KGS NET WT: 3069.89 KGS COMMERCIAL & CUSTOM INVOICE NO. F222350 04639 DT. 09.02.2022 F2223500 4610 DT. 06.02.2022 32 DATA LOGGERS SET TEMPERATURE : +20 DEGREES CONTAINER NO. MNBU3482234<br/>
INDIA
UNITED STATES
52330, SALALAH
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
6422
KG
32
PKG
0
USD
MAEU216470953
2022-03-09
616900 GLENMARK PHARMACEUTICALS INC US GLENMARK PHARMACEUTICALS LTD 1 X 40 FCL REEFER CONTAINER 48 PALLETS CONSISTING 2252 C ARTONS PHARMACEUTICALS AS UNDER GABAPENTIN TABLETS 6 00MG 500 S NDC CODE: 68462 012605 FDA PRODUCT CODE NO: 61 N C A 69 H. T. S NO.: 3004.90.92.30 ANDA NO.:-77- 662 THERAPEUTICE USE:-ANTI CONVULSANT AGENT TOPIRAMAT E TABLETS 25MG 60 S NDC CO DE: 68462010860 FDA PRODUC T CODE NO.:-61 M C A 40 H. T. S NO.: 3004.49.00.20 A NDA NO.:- 77-627 THERAPEUTIC E USE:-ANTICONVULSANT VERA PAMIL HCL ER TABS 120MG 100S NDC CODE: 68462029201 F DA PRODUCT CODE NO.: 62 O C B 13 H. T. S NO.: 3004.9 0.92.20 ANDA NO.: 90-700 T HERAPEUTICE USE: - ANGINA MUPIROCIN CREAM 2% 30GM ND C CODE: 68462056435 FDA PR ODUCT CODE NO.: 61GCJ82 H. T. S NO.: 3004.90.92.45 A NDA NO.: 201587 THERAPEUTICE USE: - TOPICAL ANTI-BACTERI AL MUPIROCIN OINTMENT 2% 2 2GM NDC CODE:68462018022 F DA PRODUCT CODE NO.: 61 G J J 81 H. T. S NO.: 3004.90. 92.45 ANDA NO.: 90-480 THE RAPEUTICE USE: - ANTI-BACTER IAL 02 DATA LOGGERS SET TEMPERATURE : +20 DEGREES COMMERCIAL & CUSTOM INV OICE NO. F22252005560 DT. 07.02.2022 F22252005561 DT . 07.02.2022 F22252005562 DT. 07.02.2022 TOTAL NET WT.: 11337.40KGS<br/>
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
13155
KG
48
PKG
0
USD
MAEU914186385
2022-05-11
616900 GLENMARK PHARMACEUTICALS INC US GLENMARK PHARMACEUTICALS LTD 61 PALLETS 3220 CARTONS P HARMACEUTICALS AS UNDER TRO SPIUM CHLORIDE TABLETS 20MG 60 S NDC CODE:68462046160 FDA P RODUCT CODE NO.:-61 K C A 69 H. T. S NO.: 3004.49.00.70 ANDA NO.:-91-575 THERAPEUTICE USE:- TREATMENT OF VENOUS D ISEASES URINARY INCONTINENCE THERAPY TOPIRAMATE TABLETS 50MG 500 S NDC CODE:68462015 305 FDA PRODUCT CODE NO.: 61 M C A 40 H. T. S NO.: 3004. 49.00.20 ANDA NO.:077627 THE RAPEUTICE USE: ANTICONVULSANT OMEPRAZOLE DR CAPSULES 40M G 90 S NDC CODE:68462039790 FDA PRODUCT CODE NO.: 62KCF10 H. T. S NO.: 3004.90.9160 ANDA NO.: 91672 THERAPEUTICE USE: - TREATMENT OF TREAT GA STROESOPHAGEAL REFLUX DISEASE RILUZOLE TABLETS 50MG 60 S NDC CODE:68462038160 FDA PR ODUCT CODE NO.: 62 J C A 16 H. T. S NO.: 3004.90.92.30 A NDA NO.: 91394 THERAPEUTICE U SE: - A-PARKINSONIAN/ HUMAN - RX/SINGLE INGREDIENT / PROM PT RELEASE TABLETS / RILUZOLE (ANTI-PARKINSONIAN) OMEPR AZOLE DR CAPSULES 40MG 90 S N DC CODE:68462039790 FDA PRODU CT CODE NO.: 62KCF10 H. T. S NO.: 3004.90.9160 ANDA NO.: 91672 THERAPEUTICE USE: - T REATMENT OF TREAT GASTROESOPH AGEAL REFLUX DISEASE CLIND AMYCIN PHOSPHATE GEL 1% 30GM NDC CODE:68462086635 FDA PROD UCT CODE NO.: 56 J D J 31 H. T. S NO.: 3004.49.00.50 AND A NO.:214251 THERAPEUTICE USE : CLINDAMYCIN PHOSPHATE GEL IS INDICATED IN THE TREATMENT OF ACNE VULGARIS MUPIROCI N OINTMENT 2% 22GM NDC CODE:6 8462018022 FDA PRODUCT CODE N O.: 61 G J J 81 H. T. S NO.: 3004.90.92.45 ANDA NO.: 90- 480 THERAPEUTICE USE: - ANTI -BACTERIAL NORETHINDRONE 0. 35MG 84 NDC CODE:68462030529 FDA PRODUCT CODE NO.: 65 J C A 26 H. T. S NO.: 3006.60.0 0.00 ANDA NO.:91-209 THERAPE UTICE USE: PREVENTION OF PREG NANCY. COMMERCIAL & CUSTOM INVOICE NO. F22352000103 DT. 12.04.2022 F22352000104 DT. 1 2.04.2022 F22352000110 DT. 13 .04.2022 F22352000102 DT. 12. 04.2022 F22352000100 DT. 12.0 4.2022 S/BILL NO: 9695842 D T:14.04.2022 S/BILL NO: 96958 15 DT:14.04.2022 S/BILL NO: 9 695836 DT:14.04.2022 S/BILL N O: 9697988 DT:14.04.2022 S/BI LL NO: 9695833 DT:14.04.2022 NET WT. 8,738.83 KGS 02 DA TA LOGGERS HUMIDITY:65% SET TEMPERATURE : +18 DEGREES TEM PERATURE RANGE : +15 DEGREES T O +25 DEGREES NOTIFY PARTY:2 GLENMARK PHARMACEUTICALS INC 750, CORPORATE DRIVE, NEW JE RSEY MAHWAH - 07430 USA<br/>
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
10814
KG
61
PKG
0
USD
MAEU217386697
2022-04-20
615500 GLENMARK PHARMACEUTICALS INC US GLENMARK PHARMACEUTICALS LTD 35 PALLETS 1829 CART ONS PHARMACEUTICALS AS UNDER METFORMIN HCL ER TABS (Z) 5 00MG 100 S NDC CODE:684620520 01 FDA PRODUCT CODE NO.: 61 P C A 55 H. T. S NO.: 3004.9 0.92.40 ANDA NO.:212969 THER APEUTICE USE: THE MANAGEMENT OF TYPE 2 DIABETES POTASSI UM CL ER CAPS 10MEQ (750MG) 10 0 S NDC CODE:68462035701 FDA P RODUCT CODE NO.:65 R C F 14 H. T. S NO.: 3004.90.92.90 ANDA NO.:202868 THERAPEUTICE USE: - TREATMENT OR PREVENTI ON OF HYPOKALEMIA TOPIRAMA TE ER CAPSULES (Q) 200MG 30 S NDC CODE:68462037130 3004.49 .00.20 61 M C B 40 210278 CHLORPROMAZINE HCL TABS 10MG 100 S NDC CODE:68462086101 6 1 T C A 04 3004.90.92.40 212 144 TO TREAT PSYCHOTIC DISOR DERS SUCH AS SCHIZOPHRENIA OR MANIC-DEPRESSION IN ADULTS CHLORPROMAZINE HCL TABS 50M G 100 S NDC CODE:68462086301 61 T C A 04 3004.90.92.40 2 12144 TO TREAT PSYCHOTIC DIS ORDERS SUCH AS SCHIZOPHRENIA OR MANIC-DEPRESSION IN ADULT S CHLORPROMAZINE HCL TABS 1 00MG 100 S NDC CODE:684620864 01 61 T C A 04 3004.90.92.40 212144 TO TREAT PSYCHOTIC DISORDERS SUCH AS SCHIZOPHREN IA OR MANIC-DEPRESSION IN AD ULTS FENOFIBRATE CAPSULES 1 34MG 100 S NDC CODE:684620581 01 FDA PRODUCT CODE NO.: 61 JCE 09 H. T. S NO.: 3004.90. 92.20 ANDA NO.: 205566 THERA PEUTICE USE: - INDICATED AS A DJUNCTIVE THERAPY TO DIET FOR THE REDUCTION OF LDL-C, TOT AL-C, TRIGLYCERIDES AND APO B IN DULT PATIENTS WITH PRMAR Y HYPERCHOLESTEROLEMIA OR MI XED DYSLIPIDEMIA GABAPENTIN TABLETS 600MG 500 S NDC CODE :68462012605 FDA PRODUCT CODE NO: 61 N C A 69 H. T. S NO. : 3004.90.92.30 ANDA NO.:-77 -662 THERAPEUTICE USE:-ANTIC ONVULSANT AGENT PRAVASTATI N SODIUM TAB 20MG 90 S NDC CO DE:68462019690 FDA PRODUCT CO DE NO.:-61 J C A 13 H. T. S NO.: 3004.90.92.20 ANDA NO.: -77-987 THERAPEUTICE USE:-HY POLIPDAEMIC COMMERCIAL & CU STOM INVOICE NO. F22287002025 DT. 22.03.2022 F22287002026 DT. 22.03.2022 F22287002032 D T. 22.03.2022 S/BILL NO: 4004 200 DT:23.03.2022 S/BILL NO: 4004198 DT:23.03.2022 S/BILL NO: 4004206 DT:23.03.2022 NET WT. 5,509.71 KGS 02 DATA LOGGERS SET TEMPERATURE : + 18 DEGREES NOTIFY PARTY:2 GLENMARK PHARMACEUTICALS INC 750, CORPORATE DRIVE, NEW J ERSEY MAHWAH - 07430 USA<br/>
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
7982
KG
35
PKG
0
USD
MAEU913675854
2022-02-03
615500 GLENMARK PHARMACEUTICALS INC US GLENMARK PHARMACEUTICALS LTD 17 PALLETS CONSISTING OF 654 C ARTONS PHARMACEUTICALS AS UND ER METFORMIN HCL ER TABS (Z) 1000MG 90 S NDC CODE:6846 2052190 FDA PRODUCT CODE NO.: 61 P C A 55 H. T. S NO.: 3004.90.92.40 ANDA NO.:212969 THERA PEUTICE USE: THE MANAGEME NT OF TYPE 2 DIABETES PRAVASTATIN SODIUM TAB 80MG 90 S NDC CODE:68462 019890 FDA PRODUCT CODE NO.:-61 J C A 13 H. T . S NO.: 3004.90.92.20 ANDA NO.:-77-987 THERA PEUTICE USE:-HYPOLIPDAEMI C EZETIMIBE-SIMVAST ATIN TAB 10/10MG 30 S NDC CODE:68462032130 FDA PRO DUCT CODE NO.: 61 J D C 1 5 H. T. S NO.: 3004. 49.00.10 ANDA NO.: 208699 THERAPEUTICE USE: - THIS COMBINATION MEDICATION IS USED TO HELP LOWER BAD CHOLESTEROL AND FATS (SUCH AS LDL, TRIGLYCERI DES) AND RAISE GOOD CHOLE STEROL (HDL) IN THE BLOOD . EZETIMIBE WORKS BY REDU CING THE AMOUNT OF CHOLES TEROL YOUR BODY ABSORBS F ROM YOUR DIET. SIMVASTATI N BELONGS TO A GROUP OF DRUGS KNOWN AS STATINS. IT WORKS BY REDUCING THE AMOUNT OF CHOLESTEROL MADE BY THE LIVER. FROVATRIPTAN SUCCINATE TABLE TS 2.5MG 9 S NDC CODE:684 62069497 FDA PRODUCT CODE NO.:60 L C A 93 H. T. S NO.: 3004.90.92.28 ANDA NO.:204730 THERA PEUTICE USE: - USE:THE TR EATMENT OF MIGRAINE HEADACHES AND FOR SHORT T ERM PREVENTION OF MENSTRU AL MIGRAINE TACROLI MUS OINTMENT 0.1% 30GM ND C CODE:68462053435 FDA PR ODUCT CODE NO.: 64 T C J 08 H. T. S NO.: 3004 .49.00.50 ANDA NO.: 21039 3 THERAPEUTICE USE: - TACROLIMUS IS A TOPICAL IMMUNOSUPPRESSIVE OINTME NT USED FOR THE TREATMENT OF MODERATE-TO-SEVERE ATOPIC DERMATITIS (ECZ EMA). PIMECROLIMUS CREAM 1% 100GM NDC CODE:6 8462060994 FDA PRODUCT CO DE NO.: 61 S C J 04 H. T. S NO.: 3004.90.92.4 5 ANDA NO.: 211769 T HERAPEUTICE USE: - AS SEC OUND-LINE THERAPY FOR THE SHORT-TERM AND NON-CONTI NUOS CHRONIC TRERTMENT OF MILD TO MODERATE ATOPIC DERMATITIS IN NONIMM UNOCOMPROMISED ADULT AND CHILDREN 2 YEARS OF AGE EZETIMIBE-SIMVASTATI N TAB 10/10MG 90 S NDC CO DE:68462032190 FDA PRODUC T CODE NO.: 61 J D C 15 H. T. S NO.: 3004.49. 00.10 ANDA NO.: 208699 THERAPEUTICE USE: - THIS COMBINATION MEDICATION IS USED TO HELP LOWER BA D CHOLESTEROL AND FATS (S UCH AS LDL, TRIGLYCERIDES ) AND RAISE GOOD CHOLESTE ROL (HDL) IN THE BLOOD. E ZETIMIBE WORKS BY REDUCIN G THE AMOUNT OF CHOLESTER OL YOUR BODY ABSORBS FROM YOUR DIET. SIMVASTATIN BELONGS TO A GROUP OF DRUGS KNOWN AS STATINS. IT WORKS BY REDUCING THE AMOUNT OF CHOLESTEROL M ADE BY THE LIVER. 08 DATA LOGGERS COMMERCIAL & CUSTOM INVOICE N O. F22287001552 DT. 29.12.202 1 F22287001553 DT. 29.12.2021 F22287001554 DT. 29.12.2021 NET WT : 1,643.31 SBILL NO. DT. 4020683 29/12/2021 4020684 29/12/2021 4020685 29/12/2021<br/>
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
2880
KG
17
PKG
0
USD
MAEU218832447
2022-07-01
652400 GLENMARK PHARMACEUTICALS INC US GLENMARK PHARMACEUTICALS LTD 40 PALLETS 1990 CARTONS PHARMACEUTICALS AS UNDER ALYACEN 1/35 TAB 1 /0.035MG 84 NDC CODE:68462039 429 FDA PRODUCT CODE NO.: 65 J D A 24 H. T. S NO.: 3006. 60.00.00 ANDA NO.: 091634 TH ERAPEUTICE USE: ORALCONTRACEP TIVE NORGEST/EE TAB .18,.21 5,.25/.035MG 84 NDC CODE:6846 2056529 FDA PRODUCT CODE NO.: 65 J D A 27 H. T. S NO.: 3 006.60.00.00 ANDA NO.: 200494 THERAPEUTICE USE: - ORAL CO NTRACEPTIVES COMMERCIAL & C USTOM INVOICE NO. F2235200085 1 DT. 31.05.2022 S/BILL NO: 1 855721 DT 02-JUN-2022 NET WT. 5,722.68 KGS 02 DATA LOGGE RS SET TEMPERATURE : +18 DE GREES NOTIFY PARTY:2 GLE NMARK PHARMACEUTICALS INC 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 USA.<br/>
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
7392
KG
40
PKG
0
USD
MAEU218832312
2022-07-07
652400 GLENMARK PHARMACEUTICALS INC US GLENMARK PHARMACEUTICALS LTD 48 PALLETS 2032 CARTONS P HARMACEUTICALS AS UNDER ALY ACEN 1/35 TAB 1/0.035MG 84 ND C CODE:68462039429 FDA PRODUC T CODE NO.: 65 J D A 24 H. T . S NO.: 3006.60.00.00 ANDA NO.: 091634 THERAPEUTICE USE: ORALCONTRACEPTIVE NORETH ACE/EE TAB 1MG/5MCG 90 NDC CO DE:68462065790 FDA PRODUCT CO DE NO.: 65 J D A 25 H. T. S NO.: 3006.60.00.00 ANDA NO.: 203038 THERAPEUTICE USE: - TREATMENT OF MODERATE TO SEVE RE VASOMOTOR SYMPTOMS DUE TO MENOPAUSE; OSTEOPOROSIS PREV ENTION OMEPRAZOLE DR CAP 40 MG 1000 NDC CODE:68462039710 FDA PRODUCT CODE NO.:62KCF10 H. T. S NO.: 3004.90.9160 ANDA NO.:91672 THERAPEUTICE U SE: - TREATMENT OF TREAT GAS TROESOPHAGEAL REFLUX DISEASE NAPROXEN TAB 500MG 500 NDC CODE:68462019005 FDA PRODUCT CODE NO.:-62 G C A 49 H. T. S NO.: 3004.90.92.40 ANDA N O.:-78-250 THERAPEUTICE USE: -ANTI-INFLAMMATORY, ANALGESIC CARVEDILOL TAB 6.25MG 500 NDC CODE:68462016305 FDA PRO DUCT CODE NO : 62 O C A 22 H . T. S NO.: 3004.90.92.20 AN DA NO.:- 78-251 THERAPEUTICE USE:-BETA- ADRENOACEPTOR AN TAGONIST OXCARBAZEPINE TAB 300MG 100 NDC CODE:6846201380 1 FDA PRODUCT CODE NO.:-61 M C A 45 H. T. S NO.: 3004.90 .92.30 ANDA NO.:-77-802 THER APEUTICE USE:-ANTI CONVULSANT AGENT COMMERCIAL & CUSTOM INVOICE NO. F22352000899 DT. 03.06.2022 F22352000903 DT. 0 3.06.2022 F22352000892 DT. 03 .06.2022 F22352000896 DT. 03. 06.2022 F22352000897 DT. 03.0 6.2022 S/BILL NO: 1894018 DT 04-JUN-2022 S/BILL NO: 189391 1 DT 04-JUN-2022 S/BILL NO: 1 894077 DT 04-JUN-2022 S/BILL NO: 1893907 DT 04-JUN-2022 S/ BILL NO: 1894071 DT 04-JUN-202 2 NET WT: 7,640.13 KGS 02 DATA LOGGERS HUMIDITY:65% SE T TEMPERATURE : +18 DEGREES T EMPERATURE RANGE : +15 DEGREES TO +25 DEGREES NOTIFY PARTY: 2 GLENMARK PHARMACEUTICALS IN C 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 USA<br/>
INDIA
UNITED STATES
52330, SALALAH
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
9245
KG
48
PKG
0
USD
MAEU218682329
2022-06-22
652400 GLENMARK PHARMACEUTICALS INC US GLENMARK PHARMACEUTICALS LTD 41 PALLETS 1810 CART ONS PHARMACEUTICALS AS UNDER HEATHER NORETHINDRONE 0.35M G 84 NDC CODE:68462030329 FD A PRODUCT CODE NO.: 65 J C A 24 H. T. S NO.: 3006.60.00.0 0 ANDA NO.:90-454 THERAPEUTI CE USE: PREVENTION OF PREGNAN CY. NORETHINDRONE 0.35MG 84 NDC CODE:68462030529 FDA PR ODUCT CODE NO.: 65 J C A 26 H. T. S NO.: 3006.60.00.00 A NDA NO.:91-209 THERAPEUTICE U SE: PREVENTION OF PREGNANCY. HAILEY24FE NORE ACE/EE-FE 1 /0.02-75MG 84 NDC CODE:684620 73129 FDA PRODUCT CODE NO.: 65 J D A 25 H. T. S NO.: 300 6.60.00.00 ANDA NO.: 204847 THERAPEUTICE USE: - CONTRACEP TION TO PREVENT PREGNANCY ASHLYNA LEVO/EE 0.15/0.03MG 18 2 NDC CODE:68462064693 FDA P RODUCT CODE NO.: 64 G D A 2 H. T. S NO.: 3006.60.0000 AN DA NO.: 203163 THERAPEUTICE U SE: - INDICATED FOR USE BY W OMEN TO PREVENT PREGNANCY COMMERCIAL & CUSTOM INVOICE NO . F22352000700 DT. 25.05.2022 F22352000701 DT. 25.05.2022 F22352000702 DT. 25.05.2022 NET WT: 4,450.30 KGS 02 DAT A LOGGERS S/BILL NO: 165441 7 DT 25-MAY-2022 S/BILL NO: 1 654291 DT 25-MAY-2022 S/BILL NO: 1654415 DT 25-MAY-2022 NOTIFY PARTY:2 GLENMARK PHARM ACEUTICALS INC 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 USA<br/>
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
6100
KG
41
PKG
0
USD
MAEU218446372
2022-06-08
623200 GLENMARK PHARMACEUTICALS INC US GLENMARK PHARMACEUTICALS LTD 25 PALLETS 1159 CARTONS PH ARMACEUTICALS AS UNDER FELO DIPINE ER TABS 10MG 100 S NDC CODE:68462023501 FDA PRODUCT CODE NO.: 62OCB32 H. T. S N O.: 3004.90.92.20 ANDA NO.: 90-365 THERAPEUTICE USE: - T REATMENT OF HYPERTENSION N APROXEN TABLETS 500MG 500 S N DC CODE:68462019005 FDA PRODU CT CODE NO.:-62 G C A 49 H. T. S NO.: 3004.90.92.40 ANDA NO.:-78-250 THERAPEUTICE US E:-ANTI-INFLAMMATORY, ANALGES IC OXCARBAZEPINE TABLETS 30 0MG 100 S NDC CODE:6846201380 1 FDA PRODUCT CODE NO.:-61 M C A 45 H. T. S NO.: 3004.90 .92.30 ANDA NO.:-77-802 THER APEUTICE USE:-ANTI CONVULSANT AGENT PRAVASTATIN SODIUM T AB 20MG 500 S NDC CODE:684620 19605 FDA PRODUCT CODE NO.:- 61 J C A 13 H. T. S NO.: 300 4.90.92.20 ANDA NO.:-77-987 THERAPEUTICE USE:-HYPOLIPDAEM IC CARVEDILOL TABS 25MG 500 S NDC CODE:68462016505 FDA PRODUCT CODE NO : 62 O C A 22 H. T. S NO.: 3004.90.92.20 ANDA NO.:- 78-251 THERAPEUTI CE USE:-BETA- ADRENOACEPTOR ANTAGONIST COMMERCIAL & CUST OM INVOICE NO. F22352000398 D T. 30.04.2022 F22387000220 DT . 13.05.2022 F22387000221 DT. 13.05.2022 S/BILL NO: 128678 3 DT: 10/05/2022 S/BILL NO: 4 006892 DT:13/05/2022 S/BILL N O: 4006891 DT: 13/05/2022 NET WT: 4831.90 KGS 07 DATA LO GGERS SET TEMPERATURE : +18 DEGREES NOTIFY PARTY:2 GL ENMARK PHARMACEUTICALS INC 75 0, CORPORATE DRIVE, NEW JERSE Y MAHWAH - 07430 USA NOTIFY PARTY:3 GLENMARK PHARMACEUTI CALS LTD. PLOT NO 2, ISEZ, PH ASE II,PHARMA ZONE PITHAMPUR, DIST DHAR, MADHYA PRADESH IND IA GST NO. : 23AAACG2207L2ZZ<br/>
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
5678
KG
25
PKG
0
USD
MEDUMG224964
2020-10-19
651400 GLENMARK PHARMACEUTICALS INC GLENMARK PHARMACEUTICALS LIMITED 10 PALLETS 581 CARTONS PHA RMACEUTICALS AS UNDER POTA SSIUM CL ER CAPS 10MEQ (75 0MG) 500 S NDC CODE:684620 35705 FDA PRODUCT CODE NO. : 65 R C F 14 H. T. S NO.: 3004.90.92.90 ANDANO.: 2 02868 THERAPEUTICE USE: - TREATMENT O R PREVENTION OF HYPOKALEMIA PO
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
2130
KG
10
PKG
0
USD
MAEU214106719
2021-11-18
624900 GLENMARK PHARMACEUTICALS INC GLENMARK PHARMACEUTICALS LTD 1X 40 REEFER FCL 41 PALLETS CONSISTING OF 3143 CARTONS PH ARMACEUTICALS AS UNDER TELMIS ARTAN TABLETS 20MG 30 S NDC C ODE:68462019930 FDA PRODUCT C ODE NO.: 62 O C A 09 H. T. S NO.: 3004.90.92.20 ANDA NO. :090032 THERAPEUTICE USE: IN DICATED FOR THE TREATMENT OF HYPERTENSION, TO LOWER BLOOD PRESSURE NAPROXEN TABLETS 50 0MG 500 S NDC CODE:6846201900 5 FDA PRODUCT CODE NO.:-62 G C A 49 H. T. S NO.: 3004.90 .92.40 ANDA NO.:-78-250 THER APEUTICE USE:-ANTI-INFLAMMATO RY, ANALGESIC INDOMETHACIN C APS 25MG 100 S NDC CODE:68462 040601 FDA PRODUCT CODE NO.: 62 G C E 42 H. T. S NO.: 30 04.90.92.40 ANDA NO.:91-276 THERAPEUTICE USE: ANTI-INFLAM ATORY ROPINIROLE TABS 0.5MG 1 00 S NDC CODE:68462025401 FD A PRODUCT CODE NO.:-62 J C A 17 H. T. S NO.: 3004.90.92.4 0 ANDA NO.:- 90-135 THERAPEU TICE USE:-TREATMENT OF PARKI NSONISM OXCARBAZEPINE TABLETS 300MG 100 S NDC CODE:684620 13801 FDA PRODUCT CODE NO. :-61 M C A 45 H. T. S NO.: 3004.90.92.30 ANDA NO.:-77- 802 THERAPEUTICE USE:-ANTI CONVULSANT AGENT LITHIUM CA RBONATE CAPS 150MG 100 S NDC CODE:68462022001 FDA PRODUC T CODE NO.:-61 N C E 37 H. T. S NO.: 3004.49.00.20 A NDA NO.:- 79 -139 THERAPEUTI CE USE:-ANTIMANIC AGENT LA MOTRIGINE TABLETS FOR OS(CD)25 MG100 S NDC CODE:68462022901 FDA PRODUCT CODE NO.:-61 M C A 38 H. T. S NO.: 3004.90. 92.30 ANDA NO.:-79 # 099 T HERAPEUTICE USE:-ANTICONVULSAN T 02 DATA LOGGERS SET T EMPERATURE : +20 DEGREES TEM PERATURE RANGE : +15 DEGREES T O +25 DEGREES COMMERCIAL & C USTOM INVOICE NO. F2225200379 1 DT. 22.10.2021 SBILL NO DT 5495765 23.10.20 21 TOTAL GR.WT.:10911.61KGS TOTAL NT.WT.:8849.48KGS<br/>
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
10911
KG
41
PKG
0
USD
MEDUMA708665
2021-01-28
624900 GLENMARK PHARMACEUTICALS INC GLENMARK PHARMACEUTICALS LIMITED 13 PALLET CONTAINING 840 C ARTONS PHARMACEUTICALS A S UNDER NAPROXEN TABLETS 500MG 500 S NDC CODE:6846 2019005 FDA PRODUCT CODE N O.:-62 G C A 49 H. T. S NO .:3004.90.92.40 ANDA NO.:- 78-250 THERAPEUTICE USE:-A NTI-INFLAMMATORY,ANALGESIC TOPIRAMATE TABLETS 25MG 60 S NDCCODE:68462010860 FDA PRODUCT CODE NO.:-61 M C A 40 H. T. S NO.:3004.4 9.00.20 ANDA NO.:- 77-627 THERAPEUTICE USE:-ANTICONV ULSANT ZONISAMIDE CAPSULE S 50MG 100 S NDC CODE:6846 2012901 FDA PRODUCT CODE N O.:-61 M C E 44 H. T.S NO .3004.49.00.20 ANDA NO.:-7 7-651 THERAP EUTICE USE:-AN TISEIZURE DRUG 01 DATA LO GGERS HUMIDITY:65% SET TEM PERATURE : +20 DEGREESCO MMERCIAL & CUSTOM INVOICE NO. F2005200374 4 DT. 22.12 .2020 NET WT:2,083.02 F REIGHT PREPAID THE TEMP ERATURE TO BE SET AT +20 D E GREE CELCIUS IN ACCORDANC E WITH SHIPPER INSTRUCTION S ON BEHALF OF : GLENMARK PHARMACEUT ICALS LIMITED N AME ACCOUNT : GLENMARK PHA RMACEUTICALS LIMITED<br/>
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
2550
KG
13
PKG
0
USD
MEDUM6528407
2021-03-13
624900 GLENMARK PHARMACEUTICALS INC GLENMARK PHARMACEUTICALS LIMITED 6 PALLET CONTAINING 211 CA RTONS PHARMACEUTICALS AS UNDER NAPROXEN TABLETS 500MG 500 S NDCCODE:68462 019005 FDA PRODUCT CODE NO .:-62 G C A 49 H. T. S NO. : 3004.90.92.40 ANDA NO.:- 78-250 THERAPEUTICE USE:-A NTI-INFLAMMATORY,ANALGESIC NAPROXEN TABLETS 500MG 5 00 S NDCCODE:68462019005 FDA PRODUCT CODE NO.:-62 G C A 49 H. T. S NO.:3004.9 0.92.40 ANDA NO.:-78-250 T HERAPEUTICE USE:-ANTI-INFL AMMATORY,ANALGESIC NAPROX EN TABLETS 500MG 500 S NDC CODE:68462019005 FDA PROD UCT CODE NO.:-62 G C A 49 H. T. S NO.:3004.90.92.40 ANDA NO.:-78-250 THERAPEUT ICE USE:-ANTI-INFLAMMATORY ,ANALGESIC DATA LOGGERS H UMIDITY:65% SET TEMPERATUR E : +20 DEGREES COMMERCIA L & CUSTOM INVOI CE NO. F20 052004434 DT. 06.02.2021 F 20052004437 DT. 06.02.2021 F20052004438 DT. 06.02.2021 NET WT:848.520 FREIGH T PREPAID THE TEM PERATU RE TO BE SET AT +20 DEGREE CELCIUS IN ACCORDANCE WIT H SHIPPER INSTRUCTIONS<br/>
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
944
KG
6
PKG
0
USD
MEDUM6438755
2021-03-13
662800 GLENMARK PHARMACEUTICALS INC GLENMARK PHARMACEUTICALS LIMITED 8 PALLET CONTAINING 130 CA RTONS PHARMACEUTICALS AS UNDER NITROGLYCERIN SUB LING TABS 0.4MG 4X25 NDC C ODE:68462063945 FDA PRODUC T CODE NO.:66 S C A 28 H. T. S NO.:3004.90.9020 ANDA NO.:206391 THERAPEUTIC US E:MEDICATION USED FOR HEAR T FAILURE,HIGH BLOOD PRESS URE,ANDTO TREAT AND PREVE NT CHEST PAIN FROM NOT EN O UGH BLOOD FLOW TO THE HEAR T APREPITANT CAPSULES 125 -80MG 3UOU NDC CODE:68462 011233 FDA PRODUCT CODE NO .:61 T C E 32 H. T. S NO.: 3004.90.92.40 ANDA NO.:207 777 THERAPEUTICE USE:APREP ITANT IS USED WITH OTHER M EDICATIONS TO HELP PREVENT NAUSEA AND VOMITING CAUSE DBY CANCER DRUG TREATMENT (CHEMOTHERAPY). THI S MEDI CATION IS ALSO USED TO PRE VENT NAUSEA AND VOMITING A FTER SURGERY.A-EMETIC/NAUS EA NT /HUMAN - RX/SINGLE IN GREDIENT / DELAYED RELEASE TABLETS / APREPITANT 08 DATA LOGGERS HUMIDITY:65% SET TEMPERATURE : +20 DEGR EES COMMERCIAL & CUSTOM I NVOICE NO. F20087001803 DT . 05.02.2021 F20087001812 DT. 08.02.2021 NET WT: 45 .39 FREIGHT PREPAID T HE TEMPERATU RE TO BE SET A T 20 DEGREE CELCIUS IN ACC ORD ANCE WITH SHIPPER INSTR UCTIONS NAME ACCOUNT :GLE NMARK PHARMACEUTICALS LIMI TED ON BEHAL F OF GLENMARK PHARMACEUTICALS LIMITED<br/>
INDIA
UNITED STATES
53313, JAWAHARLAL NEHRU
4601, NEW YORK/NEWARK AREA, NEWARK, NJ
1018
KG
8
PKG
0
USD